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The recommended nomenclature (Nelson et a!, (1993)) for 
cytochrome P-450 genes and their products has been adopted 
throughout this work. 
Standard abbreviations for nucleotides, and both the single letter 
and three-letter abbreviations for amino acids were used throughout 
the text. 
Standard abbreviations and symbols recommended by the IUPAC-
TUB Commission on Biochemical Nomenclature have generally been 
used. 
Non-standard abbreviations are listed below. 
APS ammonium persuiphate 
ATP adenosine triphosphate 
bp base pair(s) 
cDNA complementary DNA 
dNTP deoxynucleotide triphosphate 
dH20 distilled water 
DEPC diethylpyrocarbonate 
DNA deoxyribonucleic acid 
DNase deoxyribonuclease 
DTT dithiothrietol (Cleland's reagent) 
EDTA ethyienediaminotetraacetic acid (disodium salt) 
EGTA ethylene glycol-bis(b-aminoethyl ether) N,N,N',N'- 
tetraacetic acid 
ES embryonic stem 
1-JEPES N-2-hydroxyethylpiperazine-N-2-ethanesulphonjc acid 
IPTG isopropyl 3-D-thiogalactopyranoside 
kb kilobase 
kD kilodalton 
Kienow DNA polymerase I, large fragment 
MOPS 3-[N-Morpholino] propanesulphonic acid 
mRNA messenger ribonucleic acid 
lv 
nt nucleotide(s) 
O.D. optical density 
oligonucleotide oligodeoxyribonucleo tide 
PAGE polyacrylamide gel electrophoresis 
PEG polyethylene glycol 
RNA ribonucleic acid 
RNaseA ribonuclease A 
rpm revolutions per minute 
SDS sodium dodecyl sulphate 
SM phage resuspension buffer 
TAE Tris.Cl-acetate electrophoresis buffer 
TBE Tris.Cl-borate electrophoresis buffer 
TE 10 mM Tris.Cl (pH 7.4); 1 mM EDTA 
TEMED N,N,N',N'-tetramethyl-ethylenediamine 
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Neuropsychological studies in amnesiac patients and surgical 
lesioning in animals have demonstrated that the integrity of the 
hippocampal formation is essential for the establishment of some but 
not all types of memory. The exact mechanism by which the 
hippocampus contributes to memory formation and the underlying 
molecular and biochemical processes are not understood. One 
approach to understanding hippocampal function is through 
transgenesis. The identification of genes specifically expressed in this 
formation would provide promoters capable of directing reporter gene 
expression to the hippocampus. Conditional cellular ablation of the 
hippocampus, or subregions thereof, could address more precisely its 
role in memory. In addition, molecular mechanisms of memory and 
hippocampal function may be investigated through the targeted 
expression of suitably modified components of signalling pathways 
thought to be involved. 
This thesis aims to identify genes expressed in the hippocampus. 
Such genes would permit targeting hippocampus-specific gene 
expression, while their identity and function within the hippocampus 
may also be characterised. 
Differential hybridisation techniques, employing cDNA libraries 
prepared from hippocampus or other brain regions, have been used in 
an attempt to identify genes expressed either specifically or 
predominantly in the hippocampus. One cDNA clone isolated, Hctl 
(h.ippocampal transcript), is further characterised. The expression 
pattern of Hctl, by Northern analysis and in situ hybridisation, shows 
significantly enriched expression within the adult rat hippocampus, as 
well as weak expression in the liver. However, Hctl expression in the 
adult mouse brain is not hippocampus enriched and is found 
throughout the central nervous system. Although there is no clear 
justification of using the Hctl regulatory elements in transgenic mouse 
experiments, there may be possibilities in rat. Sequencing of cDNA and 
genomic clones of Hctl identified the encoded protein as a novel 
member of the cytochrome P-450 superfamily, a large group of enzymes 
involved in the oxidative metabolism of a variety of steroids, fatty 
acids and xenobiotics. Hctl may represent a new family of cytochrome 





1.1 Memory and the hippocampus 
1.1.1 Memory 
Learning, perhaps the major means by which behaviour is 
determined by the environment, can be defined as the acquisition of 
knowledge from the environment, while memory is the ability to store 
and subsequently recall such information. However such simple 
definitions do not distinguish between the different types of memory 
that can be recognised (Figure 1.1). For example, depending on the 
duration of the change in a behaviour, a memory may be termed short 
term (seconds to hours) or long term (days to years). Different types of 
memory have become apparent through a number of different 
paradigms (reviewed in Squire, 1992). Less complex invertebrate 
models have been used to demonstrate simple forms of learning, while 
more complex types of memories have been defined through the 
analysis of human amnesia and animal models. Moreover, these latter 
studies have shown that the formation of memory is not confined to a 
single centre within the brain, rather, that different types of memories 
are effected by different regions of the brain. 
Two defensive behaviours in the marine snail Aplysia californica 
have been used to investigate certain types of learning (reviewed in 
Kandel, 1991). One behaviour is the siphon-gill withdrawal reflex 
where a tactile or electrical stimulus to the siphon results in reflex 
withdrawal of the siphon and gill into the mantle cavity. The tail-
siphon reflex, where the stimulus is delivered to the tail, similarly 
results in the coordinated withdrawal of the tail, siphon and gill. It 
should however be noted that, while Aplysia is the example used here, 
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different forms of learning can be demonstrated in a variety of 
organisms, including flies (reviewed in Davis, 1993) and mammals. 
Two simple forms of memory which can be demonstrated with 
these behavioural reflexes are habituation and sensitisation (Byrne et 
al., 1991). Habituation is the learned, reduced response from a subject to 
a stimulus which is not noxious. Thus, a mild, tactile stimulus to the 
tail of ApI ysia will result in habituation of the response after repeated 
stimulation. The subject learns that the stimulus is not a threat and 
reduces the reflex response on repeated stimulation. Sensitisation 
refers to an enhancement in the behavioural response to a strong, 
noxious stimulus. Sensitisation in the tail-siphon reflex would be 
measured as an increase in the duration of withdrawal of the siphon, 
that is, the animal responds more effectively to a previously 
encountered noxious stimulus. Both sensitisation and habituation are 
examples of non-associative, reflexive learning. Non-associative 
learning results when the organism is exposed once or repeatedly to 
one stimulus only, occurring without any specific temporal 
relationship between a test stimulus and a second reinforcing stimulus. 
Associative learning requires the organism to learn the relationship 
of one stimulus to another (Byrne et al., 1990). Classical conditioning is 
an example of associative learning where the subject learns the 
temporal association of two distinct stimuli. The gill-withdrawal reflex 
of Aplysia can be classically conditioned by pairing a conditioned 
stimulus with an unconditioned stimulus to the tail. When repeatedly 
paired, the gill withdrawal response becomes much greater than if 
either stimulus is delivered alone, and is retained for several days 
(Byrne et al., 1990). 
While classical conditioning establishes a contingency between a 
stimulus and a reinforcement, in contrast, operant conditioning 
produces an association between a response of the subject and 
reinforcement. The head-waving behaviour of Api ysia has been used 
by Cook and Carew (1986) to demonstrate operant conditioning. Head-
waving is a naturally-occurring behaviour used by Aplysia to explore 
their environment. In this example, a strong light is used as a noxious 
stimulus, and is shone whenever the snail turns its head in a 
particular direction, while moving its head in the other direction will 
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result in no aversive signal. Aplysia can be operantly trained to modify 
the direction of their head-waving behaviour in order to avoid the 
noxious stimulus. Thus operant conditioning relies on the behaviour 
of the subject in response to a stimulus. 
MEMORY 
REFLEXIVE 	 DECLARATIVE 
I 	 I 
	





	 (facts) 	(events) 
habituation 	concitioning - classical 
sensitisation - operant 
Figure 1.1 A classification of different types of memory. The 
classification presented is not exhaustive, rather it is intended to 
illustrate the complexity of memory, and some of the types which can 
be distinguished experimentally. 
The types of learning so far described can be classified according to 
the experimental procedure used to establish them. However, all of 
these can be grouped together on the basis of the type of knowledge 
acquired and its formation in each case. As shown in Figure 1.1, 
habituation, sensitisation, and conditioning are all reflexive, or non-
declarative, types of memory. These memories are formed through 
repetition over many trials, and are automatic, motor responses of a 
subject to avoid a noxious stimulus or to encourage a pleasant one. 
Such memories require no awareness or cognitive understanding. 
In contrast, declarative memory includes the learning of facts, 
events and experiences, and the ability to report or 'declare' such 
memories. Such declarative memories include the ability to 
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remember faces and spatial layouts, where the 'declaration' is not 
necessarily verbal. 
1.1.2 Memory in vertebrates 
Experimental systems such as Aplysia are to the advantage of 
neuroscientists as their relatively simple nervous systems afford 
examination of the neurons and circuitry involved in a particular type 
of learning. More complex types of declarative memory can be defined 
in the nervous systems of vertebrates where the size and complexity of 
the nervous system is greatly increased. Thus, studies on amnesiac 
patients, and surgical manipulation of the nervous system of rodents 
and primates, have been used to address higher order cognition. In 
addition, certain forms of neurological dysfunction, where cognitive 
function is impaired, have been exploited in the study of processes 
underlying learning and memory in mammals. 
(a) Human amnesia 
Amnesia is defined as the impaired ability to learn new material 
(anterograde amnesia) against a background of intact intellectual 
ability. Retrograde amnesia is the loss of access to material stored before 
the onset of the memory impairment. As severely amnesiac patients 
can be entirely normal at some kinds of learning and memory, patients 
with a relatively selective memory deficit are of particular value and 
further define multiple memory systems. Thus, not only can the 
region of the brain responsible for the impairment be identified, 
particular types of memory formation can be assigned to that area. 
In 1957, a severe but specific memory impairment was described in 
patient H.M. following bilateral surgical removal of the medial 
temporal lobe to alleviate severe epilepsy (Scoville and Milner, 1957). 
This lesion, known as included the hippocampal formation 
(dentate gyrus, CA fields of the hippocampus proper, and subiculum), 
the amygdaloid complex, and adjacent cortical areas (entorhinal, 
perirhinal, periamygdaloid, and parahippocampal cortices). 
Unexpectedly, the surgery resulted in a selective impairment to 
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memory alone, leaving non-mnemonic functions intact. Long-term 
anterograde amnesia is severe in H.M., while immediate or "working" 
memory is spared. Retrograde amnesia is also restricted so that remote 
childhood memories are intact, but those more recent to the surgery 
date are lost. More specifically, however, the learning deficit in H.M. is 
in declarative types of memory. Procedural memory, where a skill is 
memorised through repetition (like learning to ride a bicycle) is non-
declarative and is not affected in patients like H.M. who have 
hippocampal lesions (described in Cohen and Eichenbaum, 1993). 
While this large lesion locates the medial temporal lobe as a region of 
the brain involved in a specific cognitive function, it was not obvious 
which of the lost components (if not all) were essential for the lost 
function. 
Patient R.B. provided evidence for a role of the hippocampus itself 
in memory, when global ischemia resulted in bilateral lesions of the 
full rostral-caudal extent of the CAl region of the hippocampus 
(described in Squire, 1992). This very specific lesion resulted in a 
moderately severe memory impairment, with no other obvious 
intellectual deficits. Thus the hippocampus was shown to be a critical 
component of the memory system present in the medial temporal lobe 
of the brain. However, because R.B. was much less amnesiac than 
H.M., removal of other parts of the hippocampal formation may 
contribute to the severity of H.M.'s impairment. Thus, the CA2 and 
CA3 fields of the hippocampus, the dentate gyrus and the amygdala, as 
well as associated cortical regions may well also participate in memory 
processes. 
(b) Animal models of learning and memory 
Animal models, particularly the rat and primates, allow for the 
systematic investigation of anatomical structures important for 
memory. Primates have provided the best animal model to 
approximate human amnesia. This is mainly because several 
neuropsychological tests used for humans can be applied directly or 
adapted to primates. In addition, the life span of primates allows long 
term memory and retrograde amnesia to be tested several years after 
surgery. 
Initial experiments, intended to reproduce the lesion incurred by 
patient H.M., the H+A+  lesion, were followed by a series of more 
specific lesions in an attempt to define the critical regions within the 
medial temporal lobe (Table 1.1) (reviewed in Squire, 1991). 
LESION 	 AREA 	 SEVERITY OF 
REMOVED DEFICIT 









A 	 amygdala 	 - 
H++ 	 H+ + anterior 	 +++ 
entorhinal, 
perirhinal cortex 
PRPH 	 perirhinal and 
nrahinnnramri1 rrr 
cortex 
Table 1.1 A summary of surgical lesions in primates designed to 
analyse memory impairment. H refers to the hippocampus, A to the 
amygdala and + to the cortical regions adjacent to the hippocampus 
and amygdala. Memory impairment was determined using the 
'delayed non-matching to sample' task. Recognition memory is tested 
by presenting an object to the subject, then after a delay the subject is 
presented with the same object and a novel one. The subject must pick 
the novel object to be rewarded (summarised from Squire, 1991). 
* "adjacent cortex" includes periamygdaloid, perirhinal, entorhinal and 
parahippocampal cortices. 
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H+A+ lesions produce severe memory impairment in monkeys, 
but do not impair the acquisition or retention of motor skills. The H 
lesion, which leaves the amygdala, adjacent cortex, and the entorhinal 
cortex unaffected, results in less severe memory impairment. This 
confirmed the role of the hippocampus but also confirmed a role for 
either the amygdala, associated cortical regions or both in memory 
formation. The A lesion and the lesion established that 
disruption to the entorhinal cortex, the major input pathway into the 
hippocampus from the neocortex, also contributed to memory 
impairment. The A lesion selectively removed the amygdala without 
any resulting disruption to declarative memory. The H"F  lesion 
extended the H lesion (hippocampal formation and parahippocampal 
cortex) to include anterior entorhinal cortex and perirhinal cortex. The 
H lesion resulted in memory impairment equal in severity to the 
HA lesion. Finally, the PRPH lesion, where only the perirhinal and 
parahippocampal cortex was removed, resulted in deficits similar to 
those of the HA lesion. The PRPH effectively cut off all neocortical 
input into the entorhinal cortex and thus the hippocampus. 
The lesion studies described confirmed a role for the hippocampus 
in the declarative memory system and identified the entorhinal cortex 
and its cortical input from the perirhinal and parahippocampal cortices 
as additional anatomical structures required for normal memory 
function. 
(c) Neurodysfunction resulting in cognitive impairment 
Memory impairment is associated with certain neuropathological 
conditions, the aetiology of which has also contributed to our current 
understanding of cognitive function. Alzheimer's disease is the most 
common form of dementia, resulting from chronic neuronal 
degeneration (Masters et al., 1994). The pathology of Alzheimer's 
disease is associated with the deposition of amyloid plaques and the 
formation of neurofibrillary tangles, resulting in neuronal loss. In 
addition, memory impairment is an early and prominent 
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manifestation of the disease. A study of the medial temporal lobe in 
patients with Alzheimer's disease (Hyman et al., 1984) revealed a 
specific cellular pattern of the pathology consistent with memory 
impairment. Cell types that are preferentially affected include those 
which provide the connections between the hippocampus and other 
regions of the brain. Cortical input into the hippocampus is from the 
projection neurons of the entorhinal cortex, while hippocampal output 
to the cortex is from projection neurons of the subiculum (reviewed in 
Amaral, 1993). Cell types invariantly affected in Alzheimer's disease 
included those of the subiculum and layers II, III and IV of the 
entorhinal cortex (Van-Hoesen et al., 1991). 
The destruction of the major input and output neurons of the 
hippocampus effectively isolates the structure from the rest of the 
brain. The disruption of memory processes in Alzheimer's patients 
further supports a role for the hippocampus as an integral part of 
memory formation. It should be noted, however, that Alzheimer's 
pathology is not exclusive to the above areas; other types of memory 
deficits may result from other damaged areas of the brain. In addition, 
the subiculum projects from the hippocampus to a number of targets 
including the amygdala and the cerebral cortex. The consequences of 
lack of innervation to these targets has not yet been addressed. 
1.1.3 The hippocampus 
Neuropsychological studies on amnesia models have shown that 
damage to the hippocampal formation produces an impairment of the 
declarative memory system. The hippocampus, together with the 
amygdala and the medial parts of the frontal, parietal and temporal 
cortical lobes, constitutes the limbic system, which is associated with 
learning, memory and emotion (described in Kandel, 1991). 
To clarify terminology, it should be noted that hippocampus proper 
comprises the CA fields and the dentate gyrus, while the hippocampal 
formation includes the hippocampus, the entorhinal cortex and the 
subiculum. 
The hippocampus, and thus hippocampus-dependent memory 
systems, has received further attention due to the relatively simple 
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structure of the formation. The hippocampus is laminar, allowing slice 
preparations for electrophysiology which conserve the circuitry of the 
structure. Electrophysiology and morphology define three major 
excitatory neuronal cell types in the hippocampus which connect 
afferent input from other parts of the brain (Figure 1.2). The major 
afferent input to the hippocampus is from the entorhinal cortex, 
although the septum and locus ceruleus also project to the 
hippocampus. The entorhinal cortex receives afferents from several 
neocortical regions and sends major projections from layers II and III 
through the perforant path to the hippocampus. Projections from layer 
II of the entorhinal cortex extend to the granule cells of the dentate 
gyrus and CA3 pyramidal cells, while projections from layer III 
innervate the CAl field. Mossy fibre axons from the dentate granule 
cells project to CA3 cells, while CA3 pyramidal cells project via Schaffer 
collateral axons to area CAl. CAl axons then project out of the 
hippocampus to the entorhinal cortex and the subiculum (summarised 
in Amaral, 1993). 
Schaffer collateral 
mossy fibre 
Figure 1.2 A diagram of the hippocampus, indicating the major 
excitatory neuronal subtypes and basic trisynaptic circuitry. Adapted 
from Bliss et al. (1990). 
Further distinction of the cell types within the hippocampus 
requires the identification of genetic markers for specific cell types. 
GABAergic inhibitory interneurons within the hippocampus can be 
distinguished by the specific expression of GABA (y-amino-butyric 
acid), however expression patterns of the calcium-binding proteins 
parvalbumin, calbindin D28k and cholecystokinin have identified 
subpopulations of GABAergic neurons in the hippocampus (Gulyas et 
al., 1991). While the pyramidal cells of CA1-3 are morphologically 
indistinguishable, a serotonin receptor subtype described by Wisden et 
al. (1993) and Erlander et al. (1993) is expressed only in CAI pyramidal 
cells within the hippocampus, distinguishing these cells from the rest 
of the structure. Dentate gyrus-specific gene expression has been 
reported following induction of synaptic activity (Nedivi et al., 1993), 
further defining this cell type. Also, the "flip" and "flop" alternatively 
spliced mRNAs for the AMPA-responsive glutamate receptor subunit 
G1uR-B are expressed differentially in CA pyramidal cells; G1uR-B flip 
is expressed in CA3 cells and GluR-B flop is expressed in CAI and 
dentate gyrus (Sommer et al., 1990). 
1 .2 Long term potentiation 
The cellular and molecular events underlying learning and 
memory are not understood. However, synapses have been shown to 
have adaptive qualities, for example, during the development of visual 
cortex synapses (reviewed in Shatz, 1990). Synaptic plasticity refers to 
structural and functional alterations of synaptic efficacy as a result of 
neuronal activity and is the underlying basis for the currently proposed 
model of learning. 
Long-term potentiation (LTP) is an enduring increase in synaptic 
efficacy, first demonstrated by Bliss and Lømo (1973) in the 
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anaesthetised rabbit, then subsequently shown in vitro in 
hippocampus slice preparations (reviewed in Bliss and Collingridge, 
1993). LTP is not exclusive to the hippocampus and has been 
demonstrated in a number of other brain regions including the visual 
cortex (Artola and Singer, 1987). LTP can be induced in a number of 
ways, though most typically by delivering a tetanus (a train of 50-100 
stimuli at 100 Hz or more) to the presynaptic cell. The strength of 
synaptic transmission is measured by recording the excitatory 
postsynaptic potential (epsp); LTP is expressed as the increase in that 
postsynaptic response to constant test stimuli. 
The major synaptic pathways in the hippocampus, the perforant 
path/dentate gyrus, mossy fibre/CA3, and Schaffer collateral/CAl, are 
all capable of exhibiting LTP. However the mechanisms underlying 
LTP in each are not necessarily the same, perhaps reflecting 
qualitatively different forms of synaptic plasticity. Of particular note is 
UP produced at the mossy fibre/CA3 synapse, where, though these 
neurons are glutamatergic, neither NMDA receptor antagonists or 
calcium chelators injected into the postsynaptic cell appear to affect the 
induction of UP (Zalutsky and Nicoll, 1990) (see section 1.2.1(a)). 
1.2.1 Biochemistry of UP 
In the following section, discussion of UP is restricted to the 
mechanisms thought to operate in CAl of the hippocampus, or more 
specifically, at CAl synapses receiving inputs from CA3 axons. 
(a) The induction of LTP 
The biochemical events which occur during the induction of CAl 
UP are initiated by an influx of calcium ions into the postsynaptic cell. 
Calcium entry has been shown to be critical as LTP can be prevented by 
injecting the Ca 2 chelator EGTA into postsynaptic neurons (Lynch et 
al., 1983). Calcium ions enter through the NMDA (N-methyl-D-
aspartate) receptor-associated channel. The NMDA channel is blocked 
by magnesium in a voltage-dependent manner. Fast synaptic 
transmission in the hippocampus is mediated by glutamate activation 
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of AMPA (alpha-amino-3-hydroxy-5-methyl-4 isoxazole proprionic 
acid) (non-NMDA) receptor-associated channels, which allow entry of 
sodium ions to depolarise the postsynaptic cell. Calcium enters the 
postsynaptic cell via the NMDA channel only when the cell is 
sufficiently depolarised to relieve the voltage-dependent block by Mg 2 
(such as during tetanus in experimental situations) and bound to 
glutamate. Thus the NMDA receptor-associated channels are gated by 
both ligand and voltage, providing a specific window of conditions for 
activation. 
(b) Maintenance of UP 
The maintenance or expression of LTP, that is the alterations which 
take place at the synapse to maintain the potentiated state, are a 
consequence of NMDA receptor activation and calcium entry. The 
potential targets of calcium in the dendritic spine 'compartment' of the 
postsynaptic cell are numerous, suggesting the involvement of a 
number of specific signalling pathways. Ca 2 + / phospholipid-dependent 
protein kinase (PKC) is activated during the induction of LTP and 
remains active during the maintenance phase, independent of calcium 
and diacyiglycerol (Klann et al., 1993; Sacktor et al., 1993). Such 
persistent autonomous activation of a kinase by autophosphorylation 
is consistent with a role in sustained changes at a synapse. 
Ca 2 /calmodulin-dependent protein kinase (CaMKII), a major 
component of the postsynaptic density, also becomes 
autophosphorylated when activated by calmodulin-associated calcium 
ions. Once autophosphorylated, the enzyme no longer requires calcium 
for activity and can maintain the phosphorylated state after the initial 
activation (Miller and Kennedy, 1986). CaMKII was subsequently 
shown to be required for the induction of LTP by Malinow et al. (1989) 
by delivering a selective inhibitor of the kinase into the postsynaptic 
CAl cells. This is supported by more recent experiments where gene 
inactivation of CaMKII results in a block of LTP (Silva et al., 1992a) (see 
section 1.4.2(a)). 
Several other kinases have been implicated in LTP although their 
activation as a result of calcium influx is not clear. The protein tyrosine 
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kinases (PTK) have been implicated through the use of specific 
inhibitors which, in blocking PTK activity, also block UP (O'Dell et al., 
1991b). More direct evidence for PTK involvement comes from mice 
which lack the non-receptor PTK Fyn, where both UP and spatial 
learning are impaired (Grant et al., 1992) (see Section 1.4.2(a)). NMDA 
receptor activation has also been shown to result in the activation of 
MAP-2 kinase (Bading and Greenberg, 1991), which is normally 
activated as a part of the receptor PTK- Ras signalling pathway. 
In addition to kinases, a number of other gene products are 
activated during LTP. The Ca2+dependent protease, calpain, has been 
proposed to be involved in a mechanism whereby structural changes to 
the synapse might sustain the potentiation (Lynch and Baudry, 1987). 
Calpain and its preferred substrate, spectrin, are localised in synaptic 
structures, and calpain inhibitors can block UP (Denny et al., 1990). 
Inhibition of Ca2 -dependent phospholipase A2,  (PLA2), inhibits 
UP in vivo and in vitro (Lynch et al., 1989). PLA2 activity produces 
arachidonic acid, a proposed retrograde messenger in the expression of 
UP (see section 1.3.2). Arachidonic acid may also be converted to a 
number of metabolites whose exact role in UP is not fully resolved 
(for review see Shimizu and Wolfe, 1990). Thus, while a number of 
signalling pathways are implicated in the induction of LTP, the precise 
nature and sequence of events which lead to structural modifications, 
changes in gene expression, or both, is not clear. Attempts to define 
upregulation of gene expression as a consequence of UP have 
identified immediate early genes such as zif268 (Cole et al., 1989) and 
tPA, tissue plasminogen activator (Quian et al., 1993). 
1.2.2 LTP and memory 
UP in the hippocampus exhibits a number of properties which are 
relevant to a proposed role in memory. Firstly, UP occurs in the 
hippocampus, a major site of learning, as well as other regions in the 
brain. It is induced rapidly and the increased strength in synaptic 
efficacy can persist for hours in vitro and for days and possibly weeks in 
the intact animal. Furthermore, UP is described as associative 
(reviewed in Bliss and Collingridge, 1993) that is, as in many forms of 
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learning described, induction of LTP requires the association of two 
events, presynaptic stimulation and postsynaptic depolarisation. 
It should be acknowledged, nevertheless, that while LTP is currently 
the best model for memory in mammals, experimental methods used 
to induce LTP are not likely to occur naturally in the animal. However, 
LTP has been produced in CAl by very brief trains of stimulation 
delivered to simulate discharge patterns of hippocampal neurons in 
animals during exploratory situations (Larson et al., 1986). Theta 
rhythm (4-7 Hz) is an intrinsic pattern of rhythmic oscillations 
observed in the rat hippocampus electroencephalogram (reviewed in 
Stewart and Fox, 1990). In rat, theta rhythm occurs primarily during 
exploratory movement, olfactory learning and REM sleep. Surgical 
manipulations which eliminate theta rhythm have produced spatial 
learning deficits in the rat similar to those obtained by hippocampus 
lesions (Winson, 1978). 
(a) NMDA antagonists and spatial learning in rats. 
Spatial learning in rats has been shown to be dependent on an intact 
hippocampus. Ibotenic acid-produced lesions in the rat hippocampus 
and anatomically related regions have supported findings in primates 
and humans, while amygdaloid damage failed to result in an obvious 
impairment (reviewed in Jarrard, 1993). The role of the NMDA 
receptor has also been confirmed in the rat. The NMDA antagonist D-
APV (2-amino-5-phosphonovalerate) has been administered to rats 
and effectively blocks LTP in vivo in a dose-dependent manner 
(Collingridge et al., 1983). 
Perhaps the best pharmacological evidence to date for a role of LTP 
in learning and memory has come from rat studies. If LTP can be 
blocked experimentally in vivo, then behavioural or learning deficits 
might also be predicted if UP is involved in learning and memory. 
Morris et al. (1986) applied such reasoning to a spatial learning test. In 
the spatial learning test, an escape platform is submerged in a fixed 
location within a tank of opaque water. The animal is released into the 
pool from variable positions and uses visual cues around the tank to 
navigate to the platform. In the experiments by Morris et a!, APV was 
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administered intraventricularly to the rats for four days, then their 
performance in the spatial water maze assessed. The APV-treated 
animals showed an impairment in spatial learning compared to 
control groups, and escape latencies between the two groups were 
significantly different. Analysis of the swimming paths with the 
platform removed showed that, while the control groups spent most 
time in the quadrant which previously contained the platform, the 
experimental animals continued to swim around the extent of the 
pool. These pharmacological experiments provided the first 
experimental evidence to support a relationship between LTP and 
memory. 
1.3 Second and retrograde messengers 
1.3.1 Second messengers in LTP 
While section 1.2.2 describes the requirement and consequences of 
ionotropic receptor activation in the formation of LTP, the 
involvement of metabotropic glutamate receptor (mGluR) activation 
has been described in the induction of LTP. Using a specific antagonist, 
Bashir et al. (1993) showed a requirement for metabotropic glutamate 
receptors in the induction of NMDA receptor-dependent LTP in the 
hippocampus. Metabotropic glutamate receptors belong to a large 
family of membrane-spanning proteins which principally initiate a 
second-messenger cascade in the cell. The metabotropic receptors are all 
structurally similar, spanning the membrane seven times, and several 
different types of second messenger systems may operate 
postsynaptically as a consequence of metabotropic receptor activation 
(reviewed in Hille, 1992). 
The metabotropic receptors are coupled to G-proteins, through 
which activation of adenylate cyclase and the production of the second 
messenger, cyclic AMP (cAMP), results (reviewed in Hille, 1992). cAMP 
activates the cAMP-dependent protein kinase A (PKA), by binding to 
the regulatory subunit of the kinase. This releases the catalytic subunit, 
resulting in the phosphorylation of substrate proteins. PKA is involved 
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in the maintenance phase of LTP, as inhibitors of PKA can block the 
late phase of LTP, having no effect on normal synaptic transmission or 
the induction of UP (Frey et al., 1993). cAMP has also been shown to 
modulate directly channel conductance in olfactory neurons without 
phosphorylation (Nakamura and Gold, 1987), which is initiated by 
activation of the large 7-TM' family of odourant receptors. 
Metabotropic receptor activation can also result in the activation of 
phospholipase C, which produces inositol triphosphate (1P3) and 
diacyiglycerol (DAG) from membrane phospholipids. 1P3 binding to its 
receptor triggers release of Ca2+  from intracellular stores, which can 
then activate Ca 2 -dependent kinases. DAG is confined to the 
membrane, where, together with phospholipids and calcium ions, it 
activates protein kinase C (PKC), which translocates from the 
cytoplasm to the membrane. PKC exists as ten different isoforms, seven 
of which are expressed in the brain, and some of which,such as PKCi, 
are brain-specific (Schwartz, 1993). The major forms of PKC are 
activated by calcium, however Ca2+independent forms also exist and 
these are proposed to function in the maintenance phase of LTP 
(Saktor et al., 1993). Activation of PKC results, for example, in the 
phosphorylation of NMDA receptor subunits on a number of different 
sites of the intracellular domain (Tingley et al., 1993), and stimulation 
of PKC has been shown to modulate NMDA-receptor channel currents 
(Chen and Huang, 1992). 
1.3.2 Retrograde messengers in LTP 
While the induction of UP requires the postsynaptic activation of 
ionotropic and metabotropic receptors and an elevation in intracellular 
calcium levels, the sustained efficacy of the synaptic connection is 
thought to require a presynaptic modification to sustain the observed 
increase in glutamate release (Bliss et al., 1990) and synaptic vesicle 
mobilisation (Bekkers and Stevens, 1990). A membrane-permeable 
retrograde messenger, which facilitates synaptic communication from 
the postsynaptic cell to the presynaptic terminal, has been proposed to 
communicate the potentiated state to the presynaptic cell. At present 
the best candidates for a retrograde messenger are nitric oxide (NO) and 
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arachidonic acid, however other molecules such as carbon monoxide 
(Zhuo et al., 1993) and platelet activating factor (Wieraszko et al., 1993) 
have also been proposed. 
Arachidonic acid, as well as 11- and 12-hydroxyeicosatetraenoic acids 
(metabolites of arachidonic acid), was shown by Dumuis et al. (1988) to 
be produced from striatal neurons upon glutamate or NMDA 
application. Subsequently, arachidonate was shown to be released upon 
production of LTP by tetanic stimulation of the perforant path (Lynch 
et al., 1989). Furthermore, when the perforant path is stimulated 
weakly in the presence of arachidonic acid, a slow-onset increase in 
synaptic strength is observed in the dentate gyrus (Williams et al., 
1989b). This is accompanied by an increase in glutamate release. O'Dell 
et al. (1991a), however, repeated these latter experiments at the Schaffer 
collateral/CAl synapse and found that while the synapse was 
potentiated, the effect could be blocked with the NMDA antagonist, 
APV. Such a finding is inconsistent with an exogenously applied 
retrograde messenger, which should act independently of the NMDA 
receptor. 
Nitric oxide is produced from arginine by the Ca 2 -calmodulin-
dependent enzyme nitric oxide synthase (NOS). NO is a diffusible gas 
with a very short half-life, making it a candidate for a retrograde 
messenger across the synaptic cleft. Schuman and Madison (1991) 
showed that injection of a specific inhibitor of NOS, NGmethy1L 
arginine, into the postsynaptic cell inhibits LTP. In addition, perfusion 
of the hippocampal slice with haemoglobin, which will sequester NO 
released from the postsynaptic cell, also inhibits LTP. However, 
although a brain isoform of NOS exists, it is not expressed in the CA 
pyramidal cells of the hippocampus (Bredt et al., 1991a). It should be 
noted, however, that an endothelial isoform of NOS is expressed in 
CAl pyramidal cells (O'Dell et al., 1994) and NOS inhibitors can still 
block UP in mice which lack the brain isoform, suggesting that the 
endothelial NOS is responsible or compensatory for NO production in 
the hippocampus. 
1.3.3 Arachidonic acid metabolism 
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As a result of transmembrane signalling, the potential retrograde 
messenger, arachidonic acid, can be produced from phospholipids from 
the plasma membrane by calcium-activated phospholipase A2 (PLA2), 
or from diacyiglycerol after phospholipase C (PLC'y) and DAG lipase 
activities (reviewed in Piomelli and Greengard, 1990). Arachidonic acid 
can either diffuse out of the cell, reincorporate into the phospholipid 
bilayer, or undergo metabolism to a number of arachidonic acid-
derived metabolites such as prostaglandins and leukotrienes. Enzymes 
mediating the metabolism of arachidonic acid include lipoxygenases, 
cyclooxygenases and cytochromes P450. 
Lipoxygenases are a group of enzymes involved in the arachidonic 
acid cascade which results in the formation of leukotrienes and other 
diverse metabolites. Leukotrienes participate in the local inflammatory 
response, acting as vasoconstrictors (reviewed in Rang and Dale, 1987). 
5- and 12- lipoxygenases are expressed in the brain and formation of 12-
lipoxygenase metabolites has been shown after NMDA receptor 
activation. Dumuis et al. (1988) demonstrated the production of 
arachidonic acid, as well as an increase in 12-hydroxyeicosatetraenoic 
acid (12-HETE), a product of 12-lipoxygenase activity, after the 
activation of NMDA receptors. Williams et al. (1989a) have shown that 
nordihydroguaiaretic acid (NDGA), an inhibitor of lipoxygenase 
activity, can attenuate the induction and maintenance of LTP. 
Cyclooxygenase (COX-1), prostaglandin H (PGH) synthase, is the 
rate-limiting enzyme in prostaglandin and thromboxane synthesis 
from arachidonic acid (Yamagata et al., 1993). An inducible form of 
cyclooxygenase (COX-2) was identified from differential screens to-
identify mRNAs induced upon seizure (Yamagata et at., 1993). 
Prostaglandins are produced in the brain, as is the immediate 
precursor, arachidonic acid, as well as PLA2 and PLC, the enzymes 
responsible for arachidonic acid production. The observed range of 
actions for prostaglandins as potent vasodilators is diverse (reviewed 
in Rang and Dale, 1987). COX-2 expression appears to be tightly 
regulated, being rapidly and transiently induced in the brain after 
seizure and NMDA-mediated synaptic activity (Yamagata et al., 1993). 
However it should be noted that Williams et al. (1989a) found no effect 
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of indomethecin, a cyclooxygenase inhibitor, on LTP in CAl of 
hippocampal slices. 
Peppelenbosch et al. (1993) have demonstrated a role for 
cyclooxygenase and 5-lipoxygenase metabolites of arachidonic acid as 
second messengers in actin remodelling in vitro. Epidermal growth 
factor (EGF) -induced changes in fibroblast cell morphology are 
inhibited by the PLA2 inhibitor, 4-bromophenylacyl bromide, 
implicating arachidonic acid metabolism in the morphological 
changes. Using the cyclooxygenase inhibitor, indomethacin, and the 5-
lipoxygenase inhibitor, nordihydroguaiaretic acid, prostaglandins and 
leukotrienes were shown to regulate depolymerisation and 
polymerisation of actin respectively. Members of the Rho family of 
small GTP-binding proteins are known regulators of this growth factor-
induced actin reorganisation (Ridley et al., 1992) and interestingly, Han 
et al. (1991) have shown that prostaglandins and arachidonic acid can 
directly modulate that pathway. Because arachidonic acid production 
has been described in examples of induced synaptic activity (Dumuis et 
al., 1988; Lynch et al., 1989), the possible involvement of prostaglandins 
and leukotrienes in modulating synaptic efficacy is of great interest. 
1.3.4 Cytochromes P-450 
Cytochromes P-450 are a large superfamily of monoxygenases, 
members which are represented in bacteria, yeast, plants and 
mammals. While the roles of cytochromes P-450 are diverse they all 
carry out essentially the same function, that is, to render substrates less 
hydrophobic and, in the case of a foreign compound, more easily 
excreted. Cytochromes P-450 cleave molecular oxygen to water, 
inserting the remaining oxygen into the hydrocarbon bond of an 
aromatic or aliphatic molecule (reviewed in Poulos, 1988). This 
requires a coenzyme (NADPH-cytochrome P-450 reductase) for the 
transfer of electrons and a protoporphyrin IX haem group non-
covalently bound to the cytochrome P-450. 
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According to Nelson et al. (1993), there are currently more than 200 
CYP genes, which are grouped into 36 families on the basis of sequence 
homology. Of these, 12 families exist in mammals, which are further 
subdivided to comprise 22 mammalian subfamilies of cytochrome P-
450. 
Cytochrome P-450 genes encode membrane-anchored proteins of 
approximately 500 amino acids (Nelson and Strobel, 1988) and all share 
a number of common amino acid motifs which are not only relevant 
structurally and functionally to the protein, but are also diagnostic for 
cytochrome P-450 identification. Protein crystallographic studies of the 
bacterial CYP10I, although not membrane-associated, have detailed 
functionally important domains of cytochromes P-450 (Poulos et al., 
1985). 
There is absolute conservation of a cysteine residue towards the 
ca rb oxy- terminus of all cytochromes P-450, which provides contact 
with the haem group (Poulos, 1988). The homology extends to amino 
acids surrounding the cysteine, where a fairly strict consensus 
sequence, FXXGXXXCXG (cysteine is amino acid 357 in CYP101) is 
diagnostic for a cytochrome P450 (Nelson et al., 1993). The three-
dimensional structure around the cysteine is conserved, providing a 
consistent environment for the protein-haem interaction. The 02 -
binding pocket, though less-tightly conserved, can generally be 
predicted by the GIAGXXT motif (threonine is amino acid 252 in 
CYP10I), where the threonine creates a local widening of the protein 
structure, creating a part of the 02 pocket (Poulos et al., 1988). There are 
a number of other conserved amino acids within different cytochrome 
P.450 proteins which may predict the type of function for a P-450. Thus, 
for example, xenobiotic-metabolising types of cytochromes P-450 are 
generally, though not exclusively, grouped in the same gene families 
(reviewed in Gonzalez, 1992). 
(a) Biosynthetic pathways mediated by cytochromes P-450 
Aside from xenobiotic activities of cytochromes P-450 (for review 
see Gonzalez, 1992), a number of cytochrome P-450 family members are 
involved in normal steroidogenic and catabolic activities. The three 
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major biochemical pathways with cytochrome P-450 involvement are 
steroid biosynthesis, the arachidonic acid cascade and bile acid 
biosynthesis. The enzymes involved in these pathways are the sole 
identified members of families CYP7, CYPI7, CYP19, CYP21 and CYP27, 
and family CYP1I which has two members to date. Members of the 
CYP4 family, while not involved in steroidogenesis, are responsible for 
the hydroxylation of fatty acids and their derivatives. 
The principal site for steroid hormone biosynthesis is the adrenal 
gland, however other tissues, including the brain, are steroidogenic. 
Cytochromes P-450 play a major part in the conversion of cholesterol to 
the various types of steroids (Figure 1.3) (reviewed by Miller, 1988). 
Cholesterol is derived either from low density lipoproteins (LDL), 
which transport insoluble cholesterol molecules through plasma to the 
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Figure 1.3 A summary of steroid biosynthesis, indicating cytochrome P-
450 involvement. 
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The first and rate-limiting step in the synthesis of all steroid 
hormones is the hydroxylation of cholesterol to pregnenolone by the 
mitochondrial cytochrome P-450, CYPIIAI, which is localised on the 
mitochondrial membranes (Morohashi et al., 1987). Pregnenolone is 
then converted through one of three pathways to either 
glucocorticoids, mineralocorticoids or the sex hormones (Figure 1.3) 
through a combination of cytochromes P-450, as well as other 
enzymatic activities. 
Arachidonic acid, released from the cell membrane upon receptor 
activation, is also a cytochrome P-450 substrate (Piomelli and 
Greengard, 1990). CYP4A1 has a rather narrow substrate specificity for 
the hydroxylation of arachidonic acid, as well as lauric acid and 
palmitic acid, and is expressed predominantly in liver (Hardwick et al., 
1987). A large number of metabolites are produced from arachidonic 
acid, and it is possible that the effects attributed to arachidonic acid in 
UP (Williams et al., 1989b), for example, may be due to downstream 
metabolites of the fatty acid. Cytochromes P-450 are also capable of 
modifying the lipoxygenase and cyclooxygenase metabolites of 
arachidonic acid. CYP4A4, for example, catalyses the co-hydroxylation of 
several prostaglandins in lung (Matsubara et al., 1987). 
In liver, cytochromes P-450 participate in a series of reactions which 
result in the conversion of cholesterol into bile acids (Bjorkhem, 1985). 
This functions as a means of cholesterol disposal, thereby regulating 
cholesterol levels in the body. The principal bile acids formed from 
cholesterol in mammals are cholic acid and chenodeoxycholic acid, 
which are then converted to deoxycholic- acid and lithocholic acid 
respectively, by microbial activity. Three cytochromes P-450 participate 
in the series of reactions to produce bile acids. The first and rate-
limiting step is controlled by the cytochrome P-450, cholesterol 7a-
hydroxylase (CYP7) (Li et al., 1990). This is the first reaction of the 
pathway where CYP7 hydroxylates cholesterol at position seven of the 
cholesterol backbone. CYP27 also participates in bile acid production, by 
hydroxylation of the cholesterol side chain (Cali and Russell, 1991). 
Thirdly, the 12a-hydroxylation step, is catalysed by an enzyme for 
which no gene has yet been identified. 
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CYP7, as the rate-limiting enzyme in cholesterol degradation, is 
under tight regulatory control. Its transcription is subject to negative 
feedback activity by bile acid build-up, while cholesterol and 
cholestyramine, a resin that binds bile acids, exert positive control 
(Ramirez et al., 1994). In addition, CYP7 transcription is under circadian 
control in the liver, with the highest amounts of CYP7 being produced 
in the evening in rats (Lavery and Schibler, 1993). Such levels of 
regulation are not unexpected for a protein which must balance the 
requirement for cholesterol in membrane assembly and 
steroidogenesis, and the requirement for bile acids in digestion. The 
consequences of improper regulation of this pathway could therefore 
be a factor in diseases such as artheroscierosis which is associated with 
increased levels of circulating cholesterol (Breslow, 1993). 
(b) Evidence for cytochrome P-450 activity in the brain 
Specific roles for cytochromes P-450 in the brain are not fully 
defined. Members of both xenobiotic and steroidogenic families of 
cytochromes P-450 are expressed in the brain, however, suggesting that 
metabolism of steroids, fatty acid derivatives and exogenous 
compounds takes place here. Most of the studies to detect cytochrome 
P-450 activity in the brain have not used in situ methods of detection, 
thus the regional localisation of individual P-450s within the brain is 
not well characterised. 
Expression of cytochrome P-450 proteins including CYP4A, CYPI 
and CYP2 family members in rat brain was detected using Western 
analysis by Warner et al. (1993). In addition, these enzymes were shown 
to be differentially upregulated in brain under different conditions 
such as pregnancy and ethanol treatment. CYP19, also known as 
aromatase, the enzyme responsible for the conversion of testosterone 
to the female sex hormone estradiol, is expressed in the brain (Martini 
and Melcangi, 1991). Thus the effects of these sex hormones is 
determined by aromatase expression in the target neuron. 
Distribution of the coenzyme, NADPH cytochrome P-450 reductase, 
as a marker of cytochrome P-450 activity, was shown by Haglund et al. 
(1984) to be restricted to catecholamine-producing neuronal 
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populations in rats and monkeys. However, this may not be a complete 
reflection of the expression pattern, as Bredt et al. (1991b) allude to 
unpublished results of the expression of NADPH cytochrome P-450 
reductase in other sites within the rat brain, such as Purkinje cells of 
the cerebellum. 
(c) Nitric oxide synthase as a combined cytochrome P-450 system. 
As described in section 1.3.2(b)), nitric oxide synthase (NOS) is the 
enzyme responsible for the production of nitric oxide, a putative 
retrograde messenger in the maintenance of long-term potentiation. 
The brain isoform of NOS has been cloned, and amino acid sequence 
comparisons have shown significant homology to NADPH-
cytochrome P-450 reductase (Bredt et al., 1991b). This region of 
homology is confined to the carboxy-terminal of NOS, and includes 
conservation of the NADPH binding site, the cofactor necessary for 
electron transfer. 
It has been proposed that NOS represents a complete cytochrome P-
450 system (White and Marietta, 1992). NOS contains a haem group, 
and shows the characteristic shift in absorbance at 450 nm in reduced 
conditions. The presence of a haem and a reductase in the same 
molecule suggests that NOS may be a self-sufficient P-450 system. If so, 
NOS represents the first soluble P-450 in eukaryotes. 
However this biochemical data is not supported by sequence 
comparisons. Assuming that the amino-terminal half of NOS mediates 
the cytochrome P-450 function, no significant homologies have been 
found (Nelson et al., 1993). In addition, the highly conserved amino 
acid motifs, such as the haem-binding domain (FXXGXXXCXG) of 
cytochromes P-450, are not present. Crystallographic studies of NOS 
may shed light on this discrepancy. 
1.4 Methodologies to test brain function 
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As described in section 1.2, strategies to understand brain function 
and memory have been based largely on neuropsychological studies of 
human amnesia and animal models. The development of long-term 
potentiation at the synapse as a working model for memory has led to 
several proposed mechanisms underlying the formation of memory in 
the hippocampus. The dissection of the biochemical pathways, such as 
those described above, and the role of specific molecules in LTP and 
memory can be approached through molecular intervention. 
Gene replacement and gene addition technologies, where animals 
are created with new genetic combinations which can be transmitted 
through the germline, can be used to dissect the role of the 
hippocampus and specific molecular pathways involved in LTP and 
the formation of memory. 
1.4.1 Addition transgenesis 
Transgenesis results in the expression of extra copies of a selected 
gene under the control of a promoter chosen to specify spatial and 
temporal expression. The DNA construct is injected into one of the 
pronuclei of fertilised eggs, which are then reimplanted in a foster 
mother and allowed to develop to term. The exogenous DNA 
integrates randomly into the host genome, usually in multiple tandem 
copies, and can be transmitted to their offspring. Thus each line of 
animals generated is distinct in terms of transgene copy number and 
integration site. This technology is applicable to mice and rats, as well 
as several other species (reviewed in Lathe and Mullins, 1993). 
In order to direct a specific pattern of expression, large pieces of 
DNA (up to 30-40 kb) containing the coding region and associated 
regulatory region(s) can be injected. As much as 650 kb, containing the 
entire amyloid precursor protein gene, has been introduced using a 
YAC (yeast artificial chromosome) vector (Lamb et al., 1993). 
Alternatively, chimaeric genes can be created using a defined promoter 
and the coding region of a gene to express gene products ectopically, or 
restrict expression to a specific location. 
Transgenesis has been used to assess the role of specific genes in the 
nervous system and to generate animal models of human disease. 
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Transgenic mice harbouring a 34 kb genomic fragment containing the 
complete human neurofilament heavy chain gene (NF-H) were created 
to assess the role of this structural protein in axons (Cote et al., 1993). 
Neurofilaments, comprising NP-H together with light (-L) and 
medium (-M) subunits, are the main cytoskeletal component of axons, 
and therefore a component of axonal transport. Abnormal 
neurofilament accumulation is a prominent feature of a common 
form of motor neuron disease, amyotrophic lateral sclerosis (ALS). The 
human transgene was expressed exclusively in the nervous system, 
and resulted in the development of neurological abnormalities similar 
to those found in ALS. The neuronopathy in these mice is 
characterised by swellings in motor neurons and some axonal atrophy, 
and an impairment in axonal transport is proposed as a result of NP-H 
overexpression. 
Transgenic technology has been used to direct expression of cellular 
toxins in order to selectively ablate tissues or cell types (reviewed in 
Bernstein and Breitman, 1989). In this approach, the function of a 
specific cell type or tissue can be addressed rather than that of a specific 
gene product. Animals expressing HSV thymidine kinase under a 
specific promoter can be treated with ganciclovir which, upon 
phosphorylation by HSV-TK, can result in selective loss of cells which 
express the transgene. Expression of HSV-TK without its substrate is 
otherwise completely harmless to the mouse. The advantage of such a 
system is that the investigator can choose when to ablate the cell type. 
Such conditional cellular ablation has been used successfully to analyse 
the role of follicle cells of the thyroid, and the selective removal of 
thyroxin hormone from circulation, by ablating non-dividing thyroid 
follicle cells from mice (Wallace et al., 1991). Conditional cellular 
ablation has not been reported as yet in the nervous system but can be 
envisaged to be a powerful technique together with suitable promoters. 
1.4.2 Homologous recombination 
(a) Gene inactivation 
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The generation of animals with specific mutations in genes allows 
the analysis of the gene product's function in the intact animal. This 
avoids the use of pharmacological inhibitors, the exact specificity of 
which is not always known. Unlike classical genetics where an 
interesting phenotype leads to a search for the gene responsible, gene 
targeting asks what phenotype will result from disruption of a given 
gene. 
Embryonic stem (ES) cells are derived from the inner cell mass of 
the mouse blastocyst and are totipotent, being able to give rise to all cell 
types (Evans and Kaufman, 1981). They can be maintained in cell 
culture in an undifferentiated state in the presence of the cytokine 
DIA/LIF (differentiation inhibitory activity/leukaemia inhibitory 
factor) (Smith, 1991). DNA constructs containing the mutated form of 
the gene (usually by inclusion of the neomycin gene as selectable 
marker) are electroporated into embryonic stem cells, where at low 
frequency homologous recombination at the genetic locus occurs. ES 
cell clones with the desired recombination event are injected into host 
blastocysts, which are then introduced into a pseudopregnant female. 
Resulting chimaeric mice, where the ES cells have contributed to the 
germline, are used for breeding to produce mice homozygous for the 
mutated gene (for review see Hooper, 1992). 
This technique is being applied to the analysis of learning and 
memory in mice and a number of genes with proposed roles in LTP 
and memory have been disrupted. The generation of mice mutant for 
the neural-specific a-isoform of Ca 2+/ca1modulindependent protein 
kinase (CaMKII) was the first gene-knockout with deficits in both LTP 
(Silva et al., 1992a) and learning (Silva et al., 1992b). No obvious 
structural changes to the hippocampus were observed and normal 
synaptic transmission was unchanged, however no increase in synaptic 
strength between the Schaffer collaterals and CAl neurons was 
observed after tetanus in mice lacking CaMKII. Silva et al. went on to 
assay for learning deficits in the mutant mice, using the water maze 
spatial learning test developed for rats (described in section 1.3(c)). 
While the mutant mice show no lack of motivation or deficits in 
motor skills, the escape latency of the mutant mice is always greater 
than wild type littermates. In addition, if the platform is removed, wild 
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type mice preferentially search the quadrant where the platform was 
located, while mutant mice fail to do so. Thus CaMMI-deficient mice 
show deficits in both spatial learning and LTP. 
Mice lacking a functional PKCy gene have also been generated, with 
effects on both LTP and spatial learning (Abeliovich et al., 1993a and b). 
While UP is greatly diminished in these mice, LTP can be produced 
when the tetanus is preceded by low frequency stimulation. This is in 
contrast to the conclusions drawn from the inhibition studies described 
(iiC ri / i). The exact role for PKCi in LTP is thus inconclusive. 
The presence of seven other forms of PKC expressed in neuronal tissue 
(Schwartz, 1993) may compensate for the loss of PKCy, perhaps after 
activation by low frequency stimulation. In addition, Saktor et al. (1993) 
propose that the generation of a constitutively active PKC, the 
isoform, after translocation to the membrane, is required for LTP 
maintenance. 
Because protein tyrosine kinase inhibitors are known to block LTP 
(O'Dell et al., 1991), Grant et al. (1992) analysed mice with null 
mutations in the non-receptor protein tyrosine kinases fyn, yes, abi and 
src. Each kinase is expressed in the hippocampus, which together with 
the inhibition studies, suggested a possible role in UP for one or more 
of the tyrosine kinases. UP in CAl of hippocampal slices was the same 
as wild type for yes, src and abi mutant mice, however there was a 
reduction of LTP in the fyn mutant mice. In addition, the escape 
latency for the mutant mice was increased in the spatial water maze 
test, again confirming a link between UP and memory. A direct role 
for Fyn in spatial learning and UP is not conclusive, however, because 
the fyn mutant mice have alterations in the cellular organisation of the 
hippocampus. The arrangement of the granule cells in the dentate 
gyrus and the pyramidal cells of CA3 appears as an undulation in the 
structure possibly as a result of increased cell numbers in these 
structures. This developmental defect complicates the interpretation of 
the phenotype, as developmental effects cannot be separated from adult 
phenotypes. 
Mice which lack the cytokine LIF (leukaemia inhibitory factor) also 
appear to have selective damage to the hippocampus. LIF is a 
pleiotropic factor with a wide range of activities including maintenance 
of undifferentiated embryonic stem cells and cholinergic neuron 
differentiation (reviewed in Hilton, 1992). Initial phenotypic analysis of 
the mutant mice revealed no overt abnormalities apart from a failure 
of blastocyst implantation into the uterine wall of female mice lacking 
LIF (Stewart et al., 1992). A preliminary abstract report claims that mice 
lacking LIF have several changes to the structure of the hippocampus 
(Patterson, 1994). There is extensive loss of pyramidal neurons, as well 
as decreased staining for parvalbumin, suggesting a loss of 
interneurons in the hippocampus. This phenotype is similar to what 
might have been predicted using a tissue-specific promoter directing 
expression of a cellular toxin (described in 1.4.1). The developmental 
effects of this phenotype must be considered, however, these mice 
potentially represent an interesting sub-region lesion of the 
hippocampus, worthy of electrophysiological and behavioural analysis. 
(b) Gene replacement 
Homologous recombination provides the means not only to delete 
a gene from a mouse, but also to replace the endogenous gene with a 
mutant version of the gene. This approach can provide more 
information about the gene product itself and may also provide a more 
subtle phenotype, especially in cases where gene inactivation results in 
embryonic lethality. 
Hasty et al. (1991) developed a strategy based on homologous 
recombination called "hit and run" to create such subtle mutations in 
the mouse genome. This technique has been used to create a 
constitutively active tyrosine kinase, Hck, in ES cells (Ernst et al., 1994). 
Phosphorylation negatively regulates the activity of Hck, and thus by 
mutating a conserved tyrosine residue in the cytoplasmic domain to 
phenylalanine, the role of Hck in the maintenance of the 
undifferentiated state of ES cells could be addressed. ES cells expressing 
constitutively active Hck were less dependent on LIF to prevent 
differentiation, suggesting that signalling through the IF receptor 
complex is at least in part mediated through Hck. The creation of 
transgenic mice carrying this mutation will facilitate further analysis of 
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Hck in the haemopoietic system, the major site of hck expression 
(Holtzman et al., 1987). 
(c) Tissue-specific gene targeting 
As alluded to earlier, the consequences of gene inactivation on 
other parts of the animal requires consideration when behavioural and 
learning deficits are being analysed. Non-specific effects like 
motivation, for example, may be affected in the mutant mice, and this 
will affect performance in a particular task. Also memory and learning 
are not restricted to the hippocampus per Se. Connections between the 
neocortex and the hippocampus are required for declarative learning 
(Section 1.1.2(b), (c)) and the consequences of gene activation in these 
regions warrants consideration. Finally, inactivation of genes such as 
the NMDARI receptor subunit which results in perinatal lethality (Li 
et at., 1994), would more likely be of considerable value if the gene were 
inactivated in the adult hippocampus alone. 
The use of site-specific homologous recombination systems, 
combined with tissue-specific promoters, has recently been 
demonstrated to produce gene inactivation in a chosen site of gene 
expression. Gu et al. (1994) have applied site-specific recombination, 
using the Cre-loxP system (Sauer and Henderson, 1988), to generate 
mice which lack the DNA polymerase P gene in T cells only. Cre is a 
site-specific recombinase from the bacteriophage P1, which will bind 
loxP sequences, and delete the intervening DNA, leaving one loxP site. 
The loxP sequence is composed of two 13 bp inverted repeats separated 
by an 8 bp spacer region. Cell type-specific gene inactivation is achieved 
by the generation of two transgenic mice: the first contains loxP sites 
flanking the DNA to be deleted in all cell types, and the second is a 
conventional transgenic mouse, with a cre transgene under the control 
of a tissue-specific promoter. Interbreeding will result in mice where 
recombination between the loxP sites will occur only where Cre is 
expressed. 
1.4.3 Limitations of transgenesis 
There are a number of limitations associated with both knockout 
technology and addition transgenesis. Addition transgenesis relies on 
the existence and characterisation of promoters which are capable of 
producing the desired spatial and temporal pattern of transgene 
expression and at sufficient levels. While promoters do exist to direct 
expression to some specific cell types, as yet no promoters have been 
characterised which will direct transgene expression specifically to the 
hippocampus. 
Knockout technology also lacks specificity in that there is no 
selective loss of gene expression in the animal: every cell in the 
homozygote is affected by the deleted gene, and at all stages of 
development. Thus phenotypic interpretation can be complicated by 
the perhaps subtle deficits incurred during development. Cell type-
specific gene inactivation circumvents some of the limitations 
associated with conventional knockout technology (see section 1.4.2(a)). 
However, the application of such technology to the hippocampus is 
entirely dependent on the identification of promoters capable of 
directing specific transgene expression. 
The interpretation of the phenotypes generated by gene-targeting do 
not prove straight forward in all cases. Genetic redundancy, where the 
function of the targeted gene is compensated in part or in full by a 
related gene, has been used to explain the lack of overt phenotype in a 
number of knockouts. Increasingly, it is becoming clear, mainly 
through PCR-based approaches, that many genes are members of gene 
families. The lack of overt or predicted phenotype in a number of 
knockout mice suggests the existence of a related gene which can 
compensate for its loss. The fibroblast growth factor family, for 
example, consists of nine related proteins, which may compensate for 
the lack of phenotype in the FGF-5 knockout mouse (apart from 
sustained growth of fur) (reviewed in Mason, 1994). 
Conversely, the analysis of genes which are essential for viability is 
limited. The NMDAR1 subunit, in combination with other NMDA 
receptor subunits, is required for a functional NMDA channel (Monyer 
et al., 1992), and activation of the NMDA receptor-associated channel is 
the first event in the induction of LTP. Thus the role of the individual 
NMDA receptor subunits in the context of hippocampal LTP is of 
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interest, but cannot be addressed in the knockout mice, as homozygotes 
die shortly after birth (Li et al., 1994). 
Finally, the remaining limitation to knockout technology is that at 
present no ES cells have been derived from species other than mouse. 
Thus knockouts in rats, for which much of the learning and memory 
work was done previously, cannot complement such studies. 
1.5 Gene expression in the hippocampus 
An investigation of gene expression in the hippocampus would be a 
complementary avenue of investigation to the above-described 
research. Our understanding of the role of the hippocampus in 
memory and learning can be expanded by the application of 
transgenesis and gene-targeting. Indeed, as described (section 1.4.2), 
gene-targeting has already made substantial progress in elucidating the 
roles of kinases and phosphorylation in memory and LIP. However, 
modifications directed specifically to the hippocampus would add a 
level of refinement to such experimental approaches. In addition, 
hippocampus-specific gene inactivation requires expression of Cre 
directed specifically to the hippocampus. 
An investigation of gene expression in the hippocampus is a 
prerequisite for such experiments. A knowledge of which genes are 
expressed in the hippocampus, and the exact spatial and temporal 
distribution of their products will provide markers to distinguish 
different cell types in the hippocampus. The function of such genes in 
terms of synaptic plasticity and long-term potentiation can also be 
addressed. Finally, if the expression of such genes is restricted to the 
hippocampus or subregions thereof, then their transcriptional 
regulatory elements can be exploited to direct gene expression to the 
hippocampus. With such promoters conditional ablation of the 
hippocampus or subregions could define the role of specific regions of 
the hippocampus in memory. In addition, over-expression of candidate 
regulatory molecules, dominant-negative variants or other suitably 
modified versions specifically in the hippocampus can be used to assess 
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IDENTIFICATION OF MOLECULAR CLONES ENCODING 
HIPPOCAMPUS-SPECIFIC TRANSCRIPTS 
Differential hybridisation has been widely used to identify cDNA 
clones encoding transcripts whose expression is restricted to particular 
tissues or stages of development (Sambrook et al., 1989, and references 
therein). 
cDNA clones expressed in a particular cell or tissue type can be 
isolated using such techniques as differential hybridisation. cDNAs of 
interest are isolated by screening a cDNA library with a probe made 
from mRNA from the tissue of interest. At the same time, the library is 
screened with a probe made from mRNA from a tissue that does not 
contain the sequences of interest. Clones which hybridise with the first 
probe and not the second are purified for further analysis. 
More refined methods include enrichment steps for either the 
library or the probe to remove selectively common or highly repeated 
sequences. This has been used in the case of subtracting libraries where 
the floor plate-specific F-spondin was isolated (Klar et al., 1992). The 
myogenic determination factor, MyoD, was isolated using subtracted 
cDNA probes (Davis et al., 1987). Both differential and subtractive 
hybridisation increase the probability of isolating clones of interest. 
To identify transcripts whose expression is enriched in or restricted 
to the hippocampus, a differential hybridisation screen was performed. 
The rat was chosen because most behavioural analysis and 
hippocampus lesions have been performed with the rat. In addition, 
the rat hippocampus allowed for greater ease of dissection and 
provided more starting material. Rats were sacrificed and the 
hippocampus removed with no obvious contamination from other 
brain regions; the remainder of brain ('ROB') was similarly excised. 
For the preparation of the hippocampus library, these dissections were 
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performed by Prof. R. Morris, Dept. Pharmacology. Po1yA-selected 
RNA was purified and used to prepare cDNA libraries in lambda ZAP 
II by Dr. J. Mason. 




hippocampus cDNA probe 	 'remainder of brain" cDNA probe 
Figure 2.1: Differential hybridisation of a hippocampus cDNA library. 
2.1 Differential screening of a rat hii2l2ocaml2us cDNA library 
A total of 106  recombinant clones from the hippocampus cDNA 
library was plated out at a density of 50,000 recombinant phage per 15 
cm plate. Duplicate lifts of the library were hybridised to cDNA probes 
prepared from reverse transcribed RNA from the hippocampus and 
"ROB". After overnight hybridisation, the filters were washed and 
exposed for autoradiography (for example, see Figure 2.2). 
From this primary screen, 361 recombinant phage plaques gave a 
differentially hybridising signal and were picked. The intensity of the 
signals varied, possibly indicating relative abundance of the transcripts. 
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Figure 2.2 Differential hybridisation filters. (a) a representative filter 
from the primary screen, and (b) the secondary screen. For both 
panels, filters on the left hand side were probed with radiolabelled 
hippocampus cDNA, and the filters on the right side were probed 
with a cDNA probe prepared from "remainder of brain" after 
hippocampus removal. Exposure times in these examples were 2 
days for the primary filters and 17 hours for the secondary filters. 
Primary hybridisation screen 
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The differential signals were dependent on exposure time, and this was 
optimised so that the greatest differences between duplicates could be 
visualised. Of the 361 clones, 75% of these gave no signal on the 
negative filter, while the remaining 25% gave a very faint signal with 
the "ROB" probe. This latter group might represent highly enriched 
transcripts in the hippocampus with perhaps restricted expression 
elsewhere in the brain. Of the former 75%, again the signal intensity 
varied: 10% of the clones gave a very strong hybridising signal, 51% 
gave a 'medium' signal intensity, and 39 9% gave a very weak signal. 
Again this may reflect the relative abundance of different transcripts 
within the hippocampus. 
As an initial step, a representative sample of 49 differentially 
hybridising plaques was characterised further. Each recombinant was 
purified by secondary screening using the same probes used in the 
initial screen. The cDNAs were then rescued from each lambda ZAP II 
phage as pBluescript II SK plasmids using the ExAssist/SOLR system 
(Stratagene), and partially sequenced from each end using primers 
hybridising to the T3 and T7 polymerase binding regions which flank 
the cloning site. Sequence data were compared with the 
GenBank/EMBL sequence database, using the Fasta programme 
(UWGCG version 7.0) to detect previously described transcripts. The 
outcome of this search is summarised in Table 2.1. 
Of the 43 cDNA clones selected, 9 were identified in the database 
(21%), 11 contained repeat sequences (25%), 2 contained plasmid 
sequences, and the remaining 21 were novel (49%). 
The average size of the inserts in the hippocampus cDNA library is 
approximately 1.0 kb (personal communication, Dr. J. Mason). Because 
the library was oligo-d(T)-primed, the majority of sequence analysed 
would be derived from the 3'UTR of each transcript, complicating 
clone identification. Rat orthologues of already identified genes from 
other species may not be identified unless the 3' untranslated region 
was highly conserved between species. Similarly, structural and 
functional motifs contained within the coding sequence, such as DNA 
binding or trans-membrane domains would not be represented in 
partial length clones. 
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3.28a 0.3 mouse PDGFR (91%,127 bp) Yarden et al., 1986 
4.5a 0.35 mitochondrial gene Gadaleta et al., 1989 
6.19d 5.0 -adaptin KircFthausen et al., 
1990 
9.9a 1.2 caireticulin Murthy et al., 1990 
11.2a 2.1 ++ mouse ECA39 (72%,161 bp) Niwa et al., 1990 
13.9c 0.6 ++ mouse ribosomal MacMurray and 
protein S13 (93%,231 bp) Shin, 1990 
14.4a 2.0 calmodulin RCM3 Nojima et al., 1987 
14.15a 1.1+1.5 ++ APP Shivers et al., 1988 
16.26b 1.3 ++++ mouse SNAP Oyler et al., 1989 
(98%, 123 bp) 
Table 2.1 Sequence analysis of hippocampus cDNA clones. 
Of the identified cDNAs, all were reported as high abundance 
mRNAs. Rat amyloidogenic glycoprotein (rAG) is the orthologue of 
the human amyloid precursor protein (APP) which is associated with 
the neuropathology of Alzheimer's disease. The adult expression 
pattern of rAG mRNA in the brain is widespread and abundant, with 
the hippocampus one of the highest regions of expression (Shivers et 
al., 1988). SNAP-25 (synaptosomal-associated protein) is a protein of as 
yet unknown function, but is localised in the presynaptic regions of 
specific but diverse populations of CNS neurons. Transcripts for 
SNAP-25 are enriched in the mossy fibres and the molecular layer of 
the dentate gyrus as well as several other areas of the brain (Oyler et al., 
(1989) (neocortex, piriform cortex, anterior thalamic nuclei, pontine 
nuclei, and granule cells of the cerebellum.) The identification of these 
three hippocampus-enriched transcripts indicated that the differential 
screening procedure had been at least partly successful. 
However, the other identified cDNA clones showed no enrichment 
for the hippocampus. 13-adaptin is a component of clathrin-coated 
vesicles that mediates constitutive transport through the Golgi 
apparatus (Kirchhausen et al., 1989). In the mouse, the receptors for 
platelet-derived growth factor (PDGF-R) are expressed throughout the 
brain as are the ligands PDGF-A and PDGF-B (Sasahara et al., 1991). 
Calmodulin is a calcium binding protein, which together with calcium 
are involved in the regulation of a variety of enzyme systems. The 
RCM3 transcript is derived from the CaM1I gene, and expression as 
measured by Northern analysis is highly enriched in the brain (Nojima 
et al., 1987) Calreticulin is a calcium binding protein of the endoplasmic 
reticulum lumen (Murthy et al., 1990). ECA39 is a transcript found 
overexpressed in a teratocarcinoma cell line which, upon 
differentiation, down regulates (Niwa et al., 1990). In the mouse, ECA39 
expression has been reported in brain and kidney, however no 
function is yet known for the gene product. 
Clone 12.10a, although not listed in Table 2.1, showed no significant 
homology to previously identified sequences in the database, however 
further sequencing of longer 12.10a cDNA clones revealed a high 
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degree of homology with human fetal liver tropomodulin (Sung et al., 
1992) (Figure 2.3). 
clone 12.10a 	1 KVNKTLKSLNVESNFITGAGILALVEALRENDTLTEIK!DNQR. 	43 
I II. II. I I 111111. I 1111 I I I II. I.. I. I: 11111. 
tropomodulin 249 KENKVLKTLNVESNF!SGAGILRLVEALPYNTSLVEMKIDNQSOPLG 295 
Figure 2.3 Alignment of translated partial sequence of clone 12.10a with 
human tropomodulin. Partial sequence from the 5' end of 12.10a 
clones revealed nucleic acid homology with human tropomodulin. 
The clone 12.10a open reading frame was used for an amino acid 
alignment using the GAP programme (UWGCG). 
Tropomodulin is a regulatory protein associated with the 
membrane skeletal network, and functions to regulate tropomyosin-
actin interactions by binding to tropomyosin and thus inhibiting 
association with actin. Given the high degree of amino acid identity 
between clone 12.10a and human tropomodulin in the short stretch of 
identified sequence (Figure 2.3), it is possible that clone 12.10a 
represents the rat orthologue of tropomodulin. 
Eleven clones showed homology to repeat elements in the database. 
Repeat elements are short interspersed sequences throughout the 
genome, which are estimated to comprise 20-30% of the genome 
(Schmid and Jelinek, 1982). The function of these elements in the 
genome is not known, however repeat elements are associated with 
RNA polymerase II transcription. Thus, Northern analysis of these 
clones resulted in a black smear (see clone 11.2a, Figure 2.4). The 
cDNAs containing these repeats are still of potential interest, however 
no attempt to remove the repeat region and further characterise these 
clones was made. 
Each of the twenty-six novel hippocampus cDNA clones was 
screened preliminarily by Northern analysis to detect a corresponding 
Ere 
transcript and those with enriched expression in the hippocampus. 
Radiolabelled probes prepared from the novel cDNAs were used on 




TRANSCRIPT(S) (kb) HIPPOCAMPUS 
EXPRESSION 
3.22a 4.8 enriched 
3.3a 2.4 ubiquitous 
4.5b 1.6 ubiquitous 
11.2a 2.9 enriched 
12.10a 7.0; 3.9; 3.5; 2.7; 1.9 7.0 kb 'specific' 
14.4b 1.6 ubiquitous 
14.5a 5.0; 2.2; 1.8 enriched 
14.15b 2.25 'specific' 
15.13a 4.4; 3.2; 2.45 4.4 kb 'specific' 
16.26c 1.8 enriched 
Table 2.2 Northern Analysis of unidentified hippocampus cDNAs. 
Northern analysis identified six clones which showed transcripts 
enriched in the hippocampus relative to "ROB". Several cDNA clones 
gave no signal on a Northern blot. These clones might correspond to 
very rare transcripts, where Northern analysis is not sensitive enough 
to permit their detection. It is noteworthy that a recently described 
cDNA from rat brain, MR22 (also known as 5-HT5B (Wisden et al., 
1993)), which encodes a novel serotonin receptor, was only detected by 
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Figure 2.4 Primary Northern analysis of positive clones from the 
hippocampus differential hybridisation screen. The cDNA clone 
inserts were excised from the plasmid vector, radiolabelled by 
random primer, and used as probes on RNA blots. 1 tg of polyA-
selected hippocampus RNA was used; all other samples were 10 tg 
of total cytoplasmic RNA. 
clone 12.10a (3 day exposure) (lower blot reprobed with 3-actin), 
clone 11.2a (upper blot was probed with entire 2.1 kb clone 0 day 
exposure); the lower blot was probed with a 0.1 kb 3' piece of the 
clone (4 day exposure)), (c) clone 15.13a (7 day exposure), (d) clone 
3.22a (7 day exposure), (e) clone 14.15b (7 day exposure), (0 clone 
14.5a (7 day exposure) (lower blot reprobed with actin). Intensifying 
screens were used for the autoradiographic exposure times 
indicated. 
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Northern using 5 jig of polyA RNA and autoradiography for 2-3 
weeks (Erlander et al., 1993). These sequences could also be derived 
from non-coding sequences which contaminated the original RNA 
used for the library preparation. 
Figure 2.4 illustrates the hippocampus enrichment that was 
observed at this preliminary stage of analysis. This analysis was 
performed using a hippocampus po1yA-selected RNA sample, while 
the other samples were prepared as total cytoplasmic RNA. This 
proved to be misleading as the relative loading of samples was always 
biased in favour of the hippocampus sample. The ultimate assay, 
however, for hippocampus specific expression was to be in situ 
hybridisation. 
Of the clones analysed, clone 14.5a was chosen for further 
characterisation, as concurrent analysis of this clone (see Chapter 2) 
indicated that it offered the most restricted expression pattern. 
Subsequent analysis of the expression pattern of the remaining 
clones in tissues other than brain revealed less restricted patterns of 
expression. Clone 14.15b is expressed in testis, liver and kidney by 
Northern analysis (Figure 2.4(e)). Ongoing in situ hybridisation 
analysis revealed expression of clone 11.2a throughout the brain at 
high expression levels (in situ hybridisation data not shown), as well as 
non-restricted expression patterns of clones 12.10a, 15.13a and 3.22a in 
mouse (personal communication, Dr. M. Steel). 
2.3 Attempts to characterise the remaining primary clones 
From the 'mini-analysis' of the differential screen, indications 
were that cDNAs had been isolated with some enrichment seen in the 
hippocampus. A large scale screening method of the remaining 
primary isolates was used in an attempt to eliminate ubiquitously 
expressed cDNAs. 
Two different strategies were used to screen for hippocampus 
selectivity. Firstly, each of the primary isolates was dot-blotted onto a 
membrane in duplicate. Duplicate filters were then hybridised with 
either a hippocampus cDNA probe or the "ROB" probe. The dot-blot 
method was unsuccessful as no differential signal was observed after 
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several attempts. Each primary isolate is a mixture of up to 10 clones, 
with only one contributing to a differential signal. Thus any 
differential signal using the dot-blot method was most likely being 
concealed by the hybridisation from the other clones. 
To circumvent this problem, a PCR-based method described by 
Mutchler et al. (1992) was used where the T3 and T7 primer sites 
flanking the insert are used to PCR amplify each insert in the mixture 
of clones. These amplified inserts are then fractionated on an agarose 
gel in duplicate, Southern blotted, and probed with either the 
hippocampus cDNA probe or the 'ROB" probe. This approach was also 
unsuccessful. Each of the bands hybridised with the same intensity, 
regardless of the probe (data not shown). This may indicate that there 
were in fact no differentially hybridising cDNA clones in the primary 
isolates. This seems unlikely, given the positive outcome of the 
prescreening. Alternatively, the complexity of both the primary isolates 
and the cDNA probes together may not allow detection of differential 
signals. In addition, inserts amplified may comigrate, potentially 
masking differential hybridisation signals. 
2.4 Discussion 
A differential hybridisation screen was used to isolate transcripts 
whose expression is restricted to the hippocampus. Of 361 primary 
mixed isolates, 48 were analysed further, leaving six whose expression 
patterns showed apparent hippocampus enrichment. 
The transcript complexity in the brain is higher than in any other 
tissue (Sutcliffe, 1988). Of the estimated 100,000 genes in the 
mammalian genome, it is estimated that approximately one third are 
found in the brain, and of these, 20,000 are brain specific. Thus the 
probes used for the screen were highly complex, and low abundance 
messages would be biased against in this screen. This is reflected in the 
genes identified in the screen, which are all expressed at high levels. 
Constitutively expressed genes such as ribosomal, mitochondrial 
and general housekeeping genes should not be represented after a 
differential screen. However several such genes inluding 3-adaptin, 
calreticulin, and mitochondrial and ribosomal genes were detected. It is 
unclear why they should give a differential signal, but in other 
differential screens described in the literature, a small percentage of 
non-specific transcripts was isolated in most cases. One possible 
explanation is that, while constitutive, levels of these transcripts vary 
in different tissues or under certain conditions (Adams et al., 1992). 
Differential hybridisation utilizes no enrichment steps. Because of 
the transcriptional complexity of brain, enrichment procedures could 
be included in either library preparation or probe preparation. Thus 
hippocampal libraries or probes which have been subtracted against the 
remainder of brain, possibly through several rounds, will require less 
screening and may yield higher hippocampal specificity. 
Differential display is a relatively new technique which may allow 
access to very low abundance hippocampus transcripts (Liang and 
Pardee, 1993). Differential display uses PCR to amplify sequences, using 
a primer pair where one is anchored to the polyA tail, the other being 
short and random in sequence. The differentially amplified products 
from different mRNJA sources may be visualised by electrophoresis and 
subsequently cloned. 
While the use of cDNA screening was employed for the isolation of 
spatially restricted genes, these strategies may also be applied to 
different induced or treated states of the hippocampus. This approach 
has previously been used for the isolation of seizure-induced gene 
expression (Qian et al., 1993), and for 'candidate plasticity genes' in the 
hippocampus after kainate injection (Nedivi et al., 1993). 
HIM 
CHAPTER THREE 
HIPPOCAMPUS-ENRICHED EXPRESSION OF cDNA CLONE Hctl 
3.1 Introduction 
As a candidate hippocampus-specific cDNA, clone Hctl (14.5a) was 
chosen for further expression analysis. Northern blot analysis was used 
to examine the adult expression pattern in other tissues of the rat, 
while in situ hybridisation was used to reveal the regional distribution 
of Hctl mRNA in the adult rat brain. 
The expression pattern of Hctl in the adult mouse brain was also 
investigated. As embryonic stem cells are as yet only available from the 
mouse, any transgenic experiments utilising homologous 
recombination and gene targeting, would employ the mouse Hctl 
genomic DNA. It was therefore necessary to confirm the expression 
pattern of Hctl in the mouse brain. 
3.2 Expression of Hctl mRNA in the adult rat. 
The rat hippocampus cDNA library used in the original differential 
hybridisation screen was rescreened to isolate longer cDNA clones of 
Hctl. As with the differential screen, 106  recombinant phage clones 
were plated at a density of 50,000 clones per 15 cm dish, and duplicate 
lifts of each plate were hybridised with a random-primer labelled probe 
of the 300 bp cDNA. (The analysis of Hctl cDNA clones will be 
described in Chapter Four.) The longest clone isolated was 1.4 kb in 
length, clone 14.5a(12), and this was used as a probe in Northern blot 
experiments. 
Total cytoplasmic RNA from various rat tissues was prepared by 
homogenisation in guanidinium isothiocyanate followed by 
purification by ultracentrifugation through caesium chloride. RNA 
from hippocampus was either polyA selected RNA or total 
WIC 
cytoplasmic RNA. RNA was also prepared from discrete regions of the 
brain, such as cerebellum and olfactory bulb, which were easily 
dissected away from other contaminating tissue. The RNA was 
fractionated by denaturing gel electrophoresis and transferred to a 
membrane by Northern blotting. 
Equivalent sample loading for initial Northern blot experiments 
proved difficult as quantitation by optical density was not always 
consistent with the intensity visualised by ethidium bromide staining. 
In addition, initial Northern analysis was performed using polyA.-
selected mRNA for the hippocampus sample only, while all other 
samples were total cytoplasmic RNA. Equal loading of samples in this 
situation was thus not possible. To circumvent this problem, 
standardisation of RNA loading was determined by relative 
hybridisation to a cDNA probe for ribosomal protein S26. S26 has been 
described as a reliable internal control, as RNA levels are reported to be 
invariant in a range of eukaryotic cells and tissues (Vincent, 1993). 
Probe 14.5a detected three transcripts of 1.8 kb, 2.2 kb, and 5.0 kb by 
Northern blot (Figure 3.1(a)). These transcripts were largely restricted to 
the brain. Low expression was detected in the liver, and even lower 
levels in the kidney, but this was always the two smaller transcripts. 
The 5.0 kb transcript appeared to be present only in the brain samples. 
This may be because the level of this mRNA in other tissues is below 
the level detectable in Northern blots. All other tissue types tested were 
negative for Hctl expression by Northern analysis. Within the brain, 
the hippocampus had the highest level of all three Hctl transcripts, 
however lower levels were found in all other regions tested, that is, the 
cerebellum, the cortex and the olfactory bulb. On re-examination of the 
ethidium bromide-stained gel, the cortex sample was grossly 
overloaded relative to other samples, despite the relative S26 
hybridisation. Subsequent RNA preparations of cortex total RNA were 
made which did not give this result. In Figure 3.1(b) all samples were 
prepared as total cytoplasmic RNA and loaded so that ethidium 
bromide staining of the 18S and 28S ribosomal subunits was 
equivalent. The cortex sample now showed no significant enrichment. 
In addition, Hctl signal in the hippocampus was not enriched, 
however the relative hybridisation of S26 was also lower, suggesting 
differential expression levels of S26 ribosomal protein in the 
hippocampus. 
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Figure 3.1 Northern analysis of Hctl expression in various tissues 
of the adult rat. 
Expression levels of Hctl message, when RNA loading was 
standardised using hybridisation to the internal control ribosomal 
protein S26 mRNA. Autoradiographic exposure was for seven days. 
Relative Hctl expression levels in sub-regions of brain (RNA 
loading was standardised by ethidium bromide staining of the 18S 
and 28S ribosomal RNA subunits). Autoradiographic exposure was 
for four days. Approximately 10 p.g of total cytoplasmic RNA was 
used for all tissues except the hippocampus sample in (a) where 1 tg 
of polyA-purified RNA was used. 
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In situ hybridisation was used to examine in more detail the 
regional distribution of Hctl mRNA in the adult brain. A 42-mer 
oligonucleotide, corresponding to a region of the cDNA 26 bases from 
the polyA tail (see Figure 4.2(b)) was labelled with 35S-a-dATP using 
terminal transferase. 10 p.m coronal sections of a rat brain, which were 
cut by Dr. M. Steel, were hybridised with the labelled oligonucleotide. 
The hybridisation was detected by dipping in photographic emulsion 
and examining the distribution of silver grains over the sections. Using 
dark field optics, the distribution of silver grains was visualised as 
white spots on a dark background (Figure 3.2). 
An exposure time of six weeks was required to detect Hctl 
expression in the rat brain. The major site of Hctl expression was in the 
principal cell layers of the hippocampus (Figure 3.2). Elsewhere in the 
brain, Hctl expression was barely detectable above the background 
signal of hybridisation in the cortex. In the rest of the brain, 
hybridisation signals equivalent only to the background signal of the 
silver grains could be detected throughout the rest of the brain sections. 
Within the hippocampus, the distribution of Hctl expression was 
not uniform (Fig. 3.2(e)). Expression was highest over the cell bodies of 
the dentate gyrus. Throughout the CA regions of the hippocampus, 
Hctl mRNA levels appeared to be graded. Expression was highest in 
area CA3, but moving through the formation, expression was lower in 
area CA2, and was barely detectable in the CAl field. 
At higher magnification using bright field optics, the cell bodies of 
pyramidal neurons within the hippocampus could be visualiscd, with 
the silver grains appearing over expressing cells as black spots. Again 
the expression of Hctl appeared not to be uniform within sub-
structures of the hippocampus (Fig. 3.3). Silver grains were localised to 
a sub-population of cell bodies within the dentate gyrus, while other 
cell bodies appeared completely devoid of silver grains. This was also 
true of the CA3 and CAl fields of the hippocampus (data not shown). 
In contrast, an in situ hybridisation performed in parallel using a probe 
to Hct2 (clone 13) (refer to section 4.5) showed silver grains distributed 
evenly over all the cell bodies of the dentate gyrus (Figure 33(b)). 
Figure 3.2 Distribution of Hctl transcripts in the adult rat brain. In 
situ hybridisation using radiolabelled oligonucleotides specific for 
Hctl on 10t coronal sections. Exposure time for autoradiography 
was six weeks. (Magnification (a -d) x7.5; (e, f) x20). 
Bright field view of rat brain coronal section stained with methyl 
green. 
Dark field view of rat coronal section through the hippocampus, 
hybridised with Hct-1 specific oligonucleotide. 
Dark field view of rat coronal section through the hippocampus, 
hybridised with Hctl-specific oligonucleotide. 
Dark field view of rat brain coronal section hybridised with an 
oligonucleotide derived from opsin (negative control). 
Dark field view of hippocampus hybridised with Hctl-specific 
oligonucleotide.. 
(0 Bright field view of a coronal section through the hippocampus 
stained with methyl green. 
(Boxed area refers to the region shown in Figure 3.3). 
CAl, CA3 pyramidal cell layers; DG, dentate gyrus 
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Figure 3.3 Cellular localisation of Hctl transcripts within the 
hippocanipus. 
(Figure 3.2(f) indicates the area of the dentate gyrus which is 
magnified in Figure 3.3) 
Bright field high power magnification (x200) of the dentate gyrus 
granule cells stained with methyl green. The silver grain 
distribution, showing discrete localisation of Hctl signal over the 
granule cells of the dentate gyrus, is not uniform (see arrowed cells). 
Hct2 cellular localisation in the dentate gyrus. 





Cellular localisation of Hctl hybridisation signal in rat dentate granule 
cells. 
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Cellular localisation of hybridisation signal of Hct2 (clone 13) 
Thus it seemed unlikely that the differential distribution of silver 
grains over the cell bodies was an artefact of the in situ hybridisation. 
Rather, a sub-population of cells in the hippocampus appears to be 
marked by their expression of Hctl. 
Hctl mRNA expression was analysed in the mouse. Current 
technology permits only addition transgenesis to be performed in the 
rat. Thus conditional ablation technology, as described in Chapter One, 
could be achieved in the rat to parallel traditional ablation studies 
already done in the rat. However, homologous recombination in 
mouse embryonic stem cells would allow for the disruption or 
modification of the endogenous gene. This technology is not yet 
developed for the rat, and so the range of genetic manipulations 
available would be restricted. To expand the range of potential 
experiments, the expression pattern of Hctl in the adult mouse brain 
was also analysed. 
The distribution of Hctl mRNA in mouse was examined by in situ 
hybridisation, however to confirm Hctl transcript sizes in mouse, a 
Northern blot of mouse RNA samples was probed with a rat Hctl 
probe (Figure 3.4). Northern analysis revealed one transcript of 1.8 kb 
present in hippocampus, as well as other brain regions and liver. This 
is in contrast to the three transcripts detected in rat. Expression in 
kidney was not detected, however a longer exposure may be needed to 
detect the low level of expression in this tissue 
An oligonucleotide based on rat Hctl sequence was initially used as 
a probe for the in situ hybridisation on mouse brain sections. Later, 
when a mouse cDNA was cloned for Hctl (Chapter Four), a mouse 42-
mer oligonucleotide was designed to confirm the expression pattern 
seen with the oligonucleotide derived from rat Hctl sequence (Figure 
3.5). 
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Figure 3.4 Northern analysis of Hctl mRNA in mouse tissues. 
Total cytoplasmic RNA from mouse tissues was Northern blotted 
and probed with the radiolabelled rat 1.4 kb cDNA clone 12. 
Autoradiography was for seven days with intensifying screens. The 
presence of RNA in all lanes was confirmed by reprobing the filter 
with a probe for ribosomal protein 526. 
1, 
I I 
1.8 kb 	40 
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Figure 3.6 In situ hybridisation analysis of Hctl in the adult mouse 
brain. 
(x7.5 magnification) 
Bright field view of mouse coronal section through the 
hippocampus, stained with 1% neutral red (section provided by Dr. 
M. Steel). 
Dark field view of mouse coronal section through the 
hippocampus, hybridised with a Hctl-specific oligonucleotide. 
Dark field view of mouse coronal section (rostral to section in 
(b)), showing strong Hctl signal in corpus callosum, fornix and 
anterior commissure. 
Dark field view of mouse brain coronal section (rostral to section 
in (c)), showing strong Hctl signal in corpus callosum and anterior 
commissure. 
Dark field view of Hctl signal in a coronal section through the 
hippocampus (x20 magnification). 
Dark field view of mouse brain coronal section hybridised with 
an oligonucleotide specific for opsin (negative control). 
CAl, CA3 pyramidal cell layers; DG, dentate gyrus; cc, corpus 
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ATCACGGACCTCAGCACATGCAGCCTTACTCTGCAAACCTTC mouse - - - 	 / 
/ 
5' I 	 JAAA 
GACAGGTTTTGTGACCCAAAACAAACTGGATGCATCGCAATC rat 
C 	I 	I 	C 
Figure 3.5 Relative positions of oligonucleotides used for Hctl in situ 
hybridisation in mouse and rat. 
The rat oligonucleotide was situated 37 nucleotides from the beginning 
of the polyA tail. The four nucleotide differences between mouse and 
rat have been indicated. The mouse oligonucleotide was situated a 
further 58 nucleotides upstream from the position of the rat 
oligonucleotide. 
Hctl was found to be widely expressed throughout the adult mouse 
brain (Figure 3.6). In the hippocampus, expression was highest in the 
dentate gyrus as was found in rat. However in contrast to rat, Hctl 
mRNA was detected at equivalent levels in areas CA3, CA2 and CAl. 
In addition, within the hippocampal formation, a layer of expression 
was detected outside of the principal cell bodies which may correspond 
either to interneuron expression or dendritic mRNA localisation 
(Figure 3.6(e)). Elsewhere in the mouse brain, expression of Hctl was 
widespread. The strongest expression of Hal in the mouse brain was 
detected in the corpus callosum, the anterior commissure and fornix 
(Figure 3.6(c) (d)). Moderate expression levels, comparable to that seen 
in the hippocampus, were also observed in the cerebellum, cortex and 
olfactory bulb (data not shown). 
3.4 Discussion 
Analysis of the expression pattern of Hctl in the rat has revealed a 
distinct distribution of Hctl transcripts. Extra-neuronal tissues 
expressing Hctl, the liver and kidney, contain very low levels of Hctl 
MCI 
relative to the brain. In situ hybridisation revealed not only the 
hippocampus as the predominant site of expression, but also a distinct 
pattern of expression within the hippocampus itself. A subset of 
neurons within the principal cell layers of the hippocampus express 
Hctl while adjacent cells do not. The cell bodies within this layer are 
predominantly the excitatory pyramidal cells in the CA areas and the 
granule cells in the dentate gyrus. However, the cell layers are not 
homogeneous, and interneurons such as the three different types of 
basket cells are also present in these layers. Hctl, therefore, might be 
produced only by a particular cell type within these layers. 
Alternatively, Hctl expression may be highlighting differences between 
morphologically indistinguishable pyramidal or granule cells within 
the hippocampus. Double in situ labelling techniques at either the 
RNA or protein level could address this question. For example, 
colocalisation of Hctl with other known cell markers such as GABA (y -
amino-butyric acid), a marker for GABAergic inhibitory interneurons, 
could confirm Hctl expression as confined to a defined subset of cells 
within the hippocampus. Nevertheless, such a specific pattern of 
expression for Hctl suggests a defined role for this gene product within 
the hippocampus. With the use of antibodies it would be possible to 
address Hctl distribution at an even higher level of resolution, that is, 
the subcellular distribution of Hctl within the neuron. For example, 
localised gene expression only within the dendritic spines of a neuron 
could support a role for the gene product at the post-synaptic cell. 
Expression of the protein kinase, CaMKII, for example, is confined to 
the post-synaptic density (Schulman and Lou, 1989) 
Expression of mRNA in a sub-population of cells within the 
hippocampal formation has been noted in other in situ analyses. 
mRNA for brain-derived neurotrophic factor (BDNF) has been shown 
to be confined to a subset of neurons in all regions of the hippocampus 
(Hofer et al., 1990). However, while the authors suggested differential 
expression within the principal pyramidal neurons of the different CA 
regions and granule cells of the dentate gyrus, equally the differential 
expression could be due to the cell bodies of a discrete type of neuron 
such as interneurons which are also dispersed in this layer of cells. 
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Nerve growth factor (NGF), too, has been shown to be differentially 
expressed within cells of the hippocampus (Ayer-Lelievre et al., 1988). 
The use of Northern and in situ hybridisation to analyse rat Hctl 
expression has yielded different results in terms of relative distribution 
of the transcript within the brain. Northern analysis gave no indication 
of enrichment of Hctl expression in rat hippocampus, while in situ 
hybridisation indicated preferential expression in this tissue. 
The use of ribosomal protein S26 mRNA levels to standardise 
sample loading is open to question. Ethidium bromide staining of 
rRNA bands to standardise sample loading is not optimal as it is not 
sensitive enough to detect subtle differences in loading. In addition, 
this method does not control for relative RNA amounts after the RNA 
is transferred from the gel to the membrane. It must therefore be 
assumed that the efficiency of transfer was equivalent for all samples. 
Using this latter method, S26 levels were shown to vary in the 
hippocampus which affected interpretation of Hctl expression within 
different brain regions. While neither standardisation method proved 
satisfactory, the Hctl expression pattern was decided by in situ 
hybridisation. 
When sample loading was standardised according to relative 
ethidium bromide staining of rRNA, the Northern data still did not 
reflect the in situ results. The discrepancies observed may perhaps be 
explained from the in situ results, where only a subset of hippocampal 
neurons is expressing Hctl. Thus, the prepared hippocampus RNA is 
diluted by a proportion of non-expressing cells. While in the cortex or 
olfactory bulb, for example, although expression of Hctl is very low, all 
cells may be expressing it (This could be confirmed by counting silver 
grains in these brain regions, however the level is barely above 
background hybridisation and would thus be difficult to interpret.) 
Thus RNA prepared from these two tissues and then analysed by 
Northern blot would mask the relative amounts of Hctl expressed in 
each sample. This dilution effect can also be seen in Figure 3.1(a), 
where the Hctl signal from "remainder of brain" relative to 
cerebellum, cortex and olfactory bulb samples is much lower, even 
though these samples are represented in "ROB". 
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From this study, it would seem that in situ hybridisation offers the 
more accurate method of detecting relative expression levels, while 
Northern analysis provides a primary level of detection and transcript 
patterns between different tissues. This also suggests that the use of 
Northern analysis to identify differential Hct clones was not perhaps 
the method of choice, and that the use of in situ hybridisation to 
identify potential Hct clones may be more informative. 
A striking difference in Hctl expression patterns was observed 
between the rat and mouse. While both species express Hctl in the 
liver at similar levels, the distribution of Hctl throughout the adult 
brain is quite different. Rat Hctl is highly enriched in the 
hippocampus, with very low levels detected elsewhere in the brain by 
in situ hybridisation. This is consistent with the differential screen by 
which it was isolated. However, mouse Hctl is not enriched in the 
hippocampus, but appears to be most abundant in the corpus callosum. 
Further, transcripts of mouse Hctl are widespread throughout the 
brain, and are present at much higher levels than in rat. Mouse Hctl 
transcripts could be detected by in situ hybridisation after a three week 
exposure, while in parallel experiments with the same probe, detection 
of the rat orthologue required exposure times of six to eight weeks. 
Within the hippocampus, the expression of Hctl in mouse and rat 
is not conserved. While both express Hctl to similar levels in the 
dentate gyrus, expression in the CA areas of the hippocampus are not 
conserved. Rat Hctl is expressed in area CA3, with barely detectable 
levels in CAl, while mouse Hctl is expressed equally throughout the 
CA fields of the hippocampus. 
The possibility that the oligonucleotide used in the mouse 
experiments cross-reacted with a related gene cannot be excluded but 
seems unlikely as the oligonucleotides correspond to the 3 ends of the 
cDNAs, a region which tends to be less conserved between paralogues. 
In addition, both rat and mouse oligonucleotides on mouse brain 
sections gave the same pattern of expression. Thus, unless the related 
gene is present in mouse but not in rat, the in situ hybridisation results 
have revealed an example of non-conserved orthologous gene 
expression. 
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Other examples of non-conserved expression patterns of 
orthologous genes are rare in the literature. This may be in part because 
detailed in situ expression patterns of genes are rarely checked in 
different species. The II-1 receptor, however, appears to be widely 
distributed in the rat brain, with highest densities in the cerebellar 
cortex, olfactory bulb and choroid plexus. The mouse expression 
pattern is more restricted, with highest expression in the granule cell 
layer of the dentate gyrus and the choroid plexus (Linthorst et al., 1994 
and references therein). A serotonin receptor, 5-HT5B, which is 
expressed at very high levels in the rat hippocampus CAl cells with 
low levels detected in the medial habenulae (Wisden et al., 1993), has a 
reversed expression pattern in the mouse (Wisden, personal 
communication). Expression of mouse 5-HT5B is very high in the 
habenulae, but very low in the hippocampus. 
While the non-conservation of the expression pattern for Hctl does 
not support a conserved or required function for the gene product, Hctl 
in the rat is expressed in a spatially regulated fashion, resulting in 
significant hippocampus enrichment. The expression pattern of Hctl in 




GENOMIC AND cDNA STRUCTURE OF CLONE 14.5a (Hctl) 
4.1 Introduction 
Hctl gene expression in the rat was shown to be highly enriched in 
the hippocampus of the adult brain. However, because the original 
clone of Hctl, 14.5a, was only 0.3 kb in length, it yielded very little 
information about the gene product. Molecular cloning of Hctl 
transcripts was used to provide more information about the gene 
product of Hctl. Once the nucleotide sequence of a full-length cDNA is 
obtained, the amino acid sequence of the gene product can be deduced, 
and compared with databases of known sequences for homologies and 
the presence of conserved motifs. 
Hctl appears to have a complex pattern of transcription, as three 
mRNAs of 1.8 kb, 2.2 kb, and 5.0 kb were detected by Northern analysis. 
Variable transcripts from a transcription unit may be formed by a 
number of different mechanisms, including alternative mRNA 
splicing, the use of different promoters, and differential 
polyadenylation within the 3' untranslated region of the gene (for 
review, see McKeown, 1992). Such transcript variability would provide 
a level of regulation, where different forms of a gene product might be 
produced, each with possibly different functions. An interesting 
example of new gene functions as a result of splicing is described by 
Sommer et al. (1990), where the inclusion of alternatively spliced exons 
(flip and flop) alters the electrophysiological properties of the AMPA-
selective glutamate-gated ion channels. To investigate the 
transcriptional complexity of Hctl, rat cDNA libraries were screened 
with clone 14.5a as a probe in order to isolate further Hctl cDNAs. 
Mouse cDNA libraries and mouse genomic DNA libraries were also 
screened to isolate the mouse orthologue and to investigate the 
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organisation of the Hctl gene, with a view to the identification of 
transcriptional regulatory elements controlling Hctl expression. 
4.2 Hctl cDNA structure 
The rat hippocampus cDNA library used in the initial differential 
hybridisation screen was replated so that 10 6 recombinant lambda ZAP 
II phage plaques were screened at a density of 50,000 per 15 cm plate. 
Duplicate filter lifts were made from each plate, and these were 
hybridised to clone 14.5a, labelled by random-primer labelling. A total 
of 21 mixed primary clones were isolated and subjected to secondary 
screening to confirm the clones and to purify each. Of these, only four 
isolates gave a strong signal on rescreening, and these were further 
purified. 
pBluescript II SK plasmids were rescued from each purified lambda 
ZAP II clone by in vivo excision, and the insert sizes were determined 
using EcoRI and Nod digests. To confirm that these clones were related 
to 14.5a, the 3' sequence adjacent to the polyA tail was determined 
using primers which hybridised to the T3 and T7 RNA polymerase 
sites flanking the cloning site in the pBluescript II SK vector (Figure 
4.1). 
14.5a 	 MA 	0.3 kb 
14.5a(12) 	 I 	MA 	1.4 kb 
14.505) 	 I 	I1AAA 	0.7 kb 
14.507) 	 I 	MA 	0.9 kb 
14.5a(13) 	 AAA 	2.5 kb 
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Figure 4.1 cDNA clones isolated from a rat hippocampus cDNA 
library using an Hctl probe. The sizes of each were determined 
by EcoRI and Nod digests of the recombinant plasmids. The hatched 
boxes indicate those clones with the same 3' end as clone 14.5a. 
Filled and broken hatched boxes represent different 3' sequences. 
4.2(a) The 1.8 kb transcript 
Clones 5 and 12 were shown to have the same 3' end as the original 
clone, while the 3' sequences of clone 7 and clone 13 were different to 
the original 14.5a clone and different to each other. 
Clone 12, being the largest clone isolated with 3' sequence homology 
to clone 14.5a (1.4 kb), was chosen for further sequencing and restriction 
mapping. Exonuclease III deletions were created in the cDNA clone and 
these deletions were sequenced directly using a primer which 
hybridised to the T7 polymerase binding site. Sequence contigs of one 
strand were assembled to generate the complete sequence of clone 12 
(Figure 4.2). 
The 1428 bp sequence of clone 12 was compared with previously 
described sequences in the GenBank/EMBL sequence data base. 
Significant homology between clone 12 and the human and rat cDNAs 
for cholesterol 7a-hydroxylase (Noshiro and Okuda, 1990; Li et a!, 1990) 
was found. At the nucleic acid level, the 1428 bp cDNA clone for rat 
Hctl shares 54.6% identity over a 1100 bp overlap with human 
cholesterol 7a-hydroxylase (CYP7) and 53.6% identity over a 1117 bp 
overlap with the rat CYP7 cDNA. Translated sequence from rat Hctl 
shared 37.2 and 36.7% amino acid identity with the human and rat 
CYP7 proteins respectively. The 5' end of clone 5 was sequenced and 
was found to be contained within the 1.4 kb sequence, its 0.7 kb size 
correlating with the position of homology within clone 12. Clone 5 was 
therefore a shorter cDNA of clone 12. 
The Hctl transcripts observed by Northern analysis (1.8 kb, 2.2 kb 
and 5.0 kb) are all larger than clone 12, and in addition, the homology 
to cholesterol 7a-hydroxylase was truncated at the 5' end. Clone 12 is at 
least 400 bp short of the smallest full length transcript. 
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Figure 4.2 a) restriction map of clone 12. 
Restriction enzymes which cut within the pBluescript polylinker 
were used to map the restriction sites of clone 12. The only such 
enzymes that cut the insert were 1-lindlil at nucleotides 42 and 1259, 
PstI at 691, and Sad at 1288. 
b) complete nucleotide and translation sequence of the 
1.4 kb cDNA done of rat Hctl (clone 12), including additional clone 
7 sequence. Clone 12 is 1428 bp (upper case), with an open reading 
frame from nucleotide I to a TGA stop codon at 1243. The 
additional 335 bp of 3' sequence corresponding to the novel 
sequence of clone 7 is indicated by lower case sequence. The two 
putative polyadenylation signals are underlined. (The conserved 
cysteine referred to in Chapter Five is boxed). 
(a) 	
Hindlil 	 PstI 	Hindill Sad 
(uncloned) 42 	 691 	
1259 1288 AA (1428 bp) clone 12 




ALE Y 0 	VII K N P KG L SF E K F SR R 
GCCTTCGAGTACCAGIATGTAATGAAAAACCCAAAACAATTAACCTTICAGAAGTTCAGCCCAAC 	65 
L S AK AF S V K K L L TN 0 DL S 	Dl I-I 
ATTATCAGCGAAACCCTTCTCTGTCAACAAGCTGCTAACTAATGACGACCTTAGCAATGACATTC 	130 
R C Y L L LOCKS L DCL LET II 10 E 
ACACAGQCTATCTTCTTTTACAACCCAAATCTCIGGAIGGTCITCTGGAAACCATCATCCAACAA 	195 
V K El FE SR LL K LTD W 	TAR V F D 
GTAAAAGAAATATTTGACTCCAGACTGCTAAAACTCACAGATTGCAATACAGCAAGAGIATTTGA 	260 
F C S S L VF E LIE TI IV GK IL AA N 
TTTCTGTAGTTCACTGGTATTTGAAATCACATTTACAACTATATATCCAAAAAITCTTCCTGCTA 	325 
K K 011 SE L ROD FL K F 0 OH FP Y 
ACAAAAAACAAATTATCACIGAGCTGACCCATCATTTTTTAAAATTTGATGACCATTTCCCATAC 	390 
L 	SD I PIG LL RN AE FM OK K 11K 
TTAGTATCTCACATACCTATTCAGCTTCIAACAAAIGCACAAITTATGCAGAAGAAAATIAIAAA 	455 
CLIP E 	V A 0M0 R R SE IV GE ROE 
ATGICTCACACCAGAAAAAGTAGCTCACATGCAAACACCCTCACAAAITGTTCACGAGAGGCAGC 	520 
ML K KY V G HE E FE IC A 	HL CL L 
AGATGCTGAAAAAATACTACGCGCATGAAGACTTTCAAATAGGAGCACATCATCTTGCCTTCCIC 	585 
WA SLANT I PA M 	WA MY Y L L OH P 
TCGCCCTCTCIAGCAAACACCATICCAGCTATGITCIGGGCAATCTATIATCTTCTTCAGCATCC 	650 
LAME V 	ROE 10SF LOST GO K KG 
ACAAGCTATGCAAGTCCTCCGTGACGAAAITGACAGCITCCTGCAGTCAACACGTCAAAAGAAAG 	715 
PG I S V H FT RE OLD S L 	CL ES A 
GACCTGGAATTICIGTCCACTTCACCAGAGAACAATTGGACAGCITGTCTGCCTGGAAAGCGCT 	780 
63 
IL E 	L R L Cs Y S Sit REV OE DM0 
ATTCTTGACCTTCTCACGTTCTGCTCC TACTCCAGCATCATCCCTCAACTGCAAGAGCATATCGA 	845 
F S SE SR S Y 	L R K G 	F V A V F P PM 
TTTCAGCTCAGACAGTAGCACCTACCCTCTGCCCAAACCACACTTTGTACCTQTCTTICCTCCAA 	910 
I H ND P E V FD AP KO FR FOR F V  
TGATACACAATGACCCAGAAGTCTTCGATCCTCCAAACCACTTTAGGTTTGATCGCTTCGIAGAA 	975 
DC K K K T I F F KG C K K L K S VII P  
GATCGTAAGAAGAAAACAACGTTTTTCAAAGGACGAAAAAALTCAACAGTTACATTATACCATT 	1040 
CL CT S KDP CRY FAIN EM K L L 	I 
TGCACTTGGAACAAGCAAATGTCCAGGCAGATACTTIGCAATTAATGAAATGAACCTACTAGTGA 	1105 
IL L 	Y F OLE VIOl K Pt CL NHS 
TTATACTTTTAACTTATTTTGATTTACAAGTCATTGACACTAAGCCTATAGCACTAAACCACACT 	1170 
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4.2(b) The 2.2 kb transcript 
DNA sequencing of clone 7 revealed that its 3' end is unrelated to 
the 3' sequence of the original 300 bp probe or of clone 12. Restriction 
mapping of clone 7 did however reveal the same juxtaposed Sad and 
Hindill sites found in clone 12 (Figure 4.2(a)) (data not shown). In 
addition, sequencing of the 5' end of done 7 showed that this sequence 
was contained within clone 12. Deletions were made in clone 7 using 
exonudease III and the subclones were sequenced and assembled into 
contigs (Figure 4.2). Clone 7 and clone 12 share 594 bp of sequence up to 
the 3' end of done 12, however 335 bp of novel 3' sequence, ending in a 
polyA tail, forms the unique 3' sequence of clone 7. From this analysis, 
it seems that clone 7 is derived from the same transcription unit and is 
generated through the use of an alternative polyadenylation site. A 
potential polyadenylation signal, 5'-AUUAAA-3', was found 22 bases 
upstream of the polyA tail of clone 7 (Fig. 4.2(b)). The extra 335 bp of the 
3' end of clone 7 is also in agreement with the observed 2.2 kb 
transcript by Northern analysis. 
4.3 Cloning of the Hctl mouse orthologue (mHctl). 
The longest rat cDNA clone for Hctl (1.4 kb) is approximately 400 bp 
shorter than the expected full length cDNA, based on the sequence 
homology to cholesterol 7a-hydroxylase and the observed minimum 
transcript size (see Figure 3.1). With a view to possible future 
transgenic experiments, particularly gene-targeting, it was decided to 
screen mouse cDNA libraries for a full length cDNA clone of Hctl. 
Northern analysis of mouse tissues (refer to Chapter 3, Figure 3.5) 
using the rat 1.4 kb cDNA as a probe confirmed the existence of Hctl in 
the mouse. 
A mouse liver cDNA library (a gift from Dr. B. Luckow, Heidelberg) 
was screened for Hctl cDNAs. 106  recombinant lambda gtlO plaques 
were plated at a density of 50,000 pfu/15 cm plate, duplicate lifts were 
prepared, and each was probed with the 1.4 kb rat Hctl clone. 
Approximately 400 duplicate plaques gave positive signals, and fifteen 
65 
clones were purified after a secondary screen. The inserts from each 
lambda gtlO clone were excised using EcoRI and NotI restriction 
enzymes. These inserts were subcloned into a pBluescript II KS vector. 
Nine of eleven clones picked contained the largest insert size of 
approximately 1.8 kb. DNA sequencing demonstrated that three clones, 
33, 35 and 38 were identical at their 5' and 3' ends, and that this 
sequence was 71% similar to the 3' end of rat Hctl. Thus the mouse 
clones appeared to encode Hctl. Clones 23 and 40 were also identical to 
each other, and were related to the first three clones except for 59 bp 
extra sequence at the 5' end, and 100 bp less at the 3' end. Clones 35 and 
40 were chosen for further characterisation. Exonuclease III deletions 
were made in the cDNA inserts. These deleted subclones were 
sequenced, and the contigs assembled to produce a full length sequence 
of the clones (Figure 4.3(b)). 
The mouse Hctl open reading frame commences with a 
methionine encoded at nucleotide number 22, and terminates with a 
TGA codon at nucleotide number 1543, encoding a protein of 507 
amino acids. The cDNA clone 40 for mHctl contains an extra 59 
nucleotides at the 5' end, however none of this sequence encoded an in 
frame methionine. cDNA clone 40 is also truncated at the 3' end, being 
100 nucleotides shorter than clone 35, without affecting the open 
reading frame. No polyA tail was associated with either clone and no 
appropriately positioned polyadenylation signal can be found. Thus 
some 3' untranlated sequence may be missing from the clone. 
However the size of the clone and the size of the transcript by 
Northern analysis predict that very little 3' sequence is missing. 
The consensus Kozak sequence for the initiation of translation of a 
messenger RNA is YYAYYATGR (Kozak, 1987). There are two ATG 
codons in the mHctl cDNA, only the first being in frame, however 
neither sequence conforms to the consensus Kozak sequence. Point 
mutation analysis of the sequence surrounding the initiator ATG have 
shown the importance of purines three nucleotides upstream of the 
initiator codon and immediately 3' of the ATG (Kozak, 1986). Because 
neither ATG in Hctl appears to conform to the expected sequence, it 
Figure 4.3 (a) Restriction map of mouse Hctl cDNA. 
A restriction map of mHctl (clone 35) was constructed using 
restriction enzymes such as those found in the polylinker of 
pBluescript. Restriction enzymes found to cut mHctl were BamHI 
at nucleotide 207, 1-lindill at 342 and 1559, BgllI at 819, PstI at 991, and 
SacI at 1588. 
(b) Nucleotide sequence and translation of mHctl. mouse 
Hctl refers to clone 35, and all numbering is based on clone 35. 
Lower case sequence indicates the 59 extra nucleotides in clone 40; 
the arrow head indicates the end of clone 40. Underlined sequence ( 
) represents the oligonucleotide used for in situ hybridisation (see 
section 3.2), and (--) marks the relative position of the rat 
oligonucleotide for in situ hybridisation. The conserved cysteine 
(amino acid 447) in the haem-binding domain (see Chapter 5) is 
circled. 





ggcaggcocogcctctggt ctoogaogagagggcactg+ gcagoagccat 
MO GA TI L 
C9CtCCCtOCAGAGCCGCCAGCTCGTCGGGATGCAGGGAGCCACGACCCT 	41 
D A A S PG PL ALL G L L F A A 
AGATGCCGCCTCGCCAGGGCCTCTCGCCCTCCTAGGCCTTCTCTTTGCCG 	91 
IL LL S AL FL L 	R RI R R 
CCACCTTACTGCTCTCGGCCCTGTTCCTCCTCACCCGGCGCACCAGGCGC 	141 
P R E P P L I K G W 	P Y L G M A 
CCTCGTGAACCACCCTTGATAAAAGGTTGGCTTCCTIATC1"FGGCAIGGC 	191 
L K F 	K OP L T FL K IL OR 0 
CCTGAAATTCTTTAAGGATCCGTTAACIIICIIGAAAACTCTTCAAAGGC 	241 
H G 0 1 F TV F L V G K Y I I F 
AACATGGTGACACTTTCACTGICTTCCTTGTGGGGAAGTATATAACATTT 	291 
V L NP F 0 Y 	Y V T K N P K 0 L 
GTTCTGAACCCTTTCCAGTACCAGTATGTAACGAAAAACCCAAAACAATT 	341 
S F OK F S S R L S A K AF S V K 
AAGCTTTCAGAAGTTCAGCAGCCGATTATCAGCGAAAGCCTTCTCTGTAA 	391 
K L LID D D L NE DV HR A V 
AGAAGCTGCTTACTGATGACGACCTTAAIGAACACGITCACAGAGCC TAT 	441 
L L L 0 G K P L 0 AL L E I M I 0 
CTACTTCTACAAGGCAAACCTTTGGATGCTCTTCTGCAAACTAICATCCA 	491 
E V K 	L FE SO LL KilO W  
AGAAGTAAAAGAATTATTTGAGTCCCAACTGCTAAAAATCACAGATTGGA 	541 
T E R I F AF C G S L V F E I T 
ACACAGAAAGAATATTTGCATTCTGTGGCTCACTGGTATIrGAGATCACA 	591 
F A I L V C K I L AG N K K 0 1 	1 
TTTGCGACTCTATATCGAAAAATTCTTCCTGGTAACAAGAAACAAATTAT 	641 
S E L 	D D F F K F D 0 M 	P V L 
CAGTGAGCTAAGGGATGATTTTITTAAATTTGATGACATGTTCCCATACT 	691 
V S D I P IOL L R N E E S MO 
TAGTATCTCACAIACCTATTCAGCTTCTAAGAAATGAAGAAICTATGCAG 	741 




OS K IV a ES 00 L L KR Y Y  
	
ACAGTCAAAAATTGTTCAGGAAAGCCAACATCTGCTGAAAACATACTATA 	841 
HO DPE I G A H H L G F L WA 
GGCATGACGATCCTGAAATAGGAGCACATCATCTTGGCTTTCTCTGGGCC 	891 
S L ANT I P A M F W A M Y Y IL 
TCTCTACCAAACACCATTCCACCTATGTTCTGCGCAATGTATTATATTCT 	941 
R 	PEA MEAL RD E ID SF L 
TCGGCATCCTGAAGCTATGGAAGCCCTGCGTGACGAAATTGACAGTTTCC 	991 
OS TG 0 K 	G PG I S V H FT 
TCCAGTCAACAGGTCAAAAGAAAGGGCCTGGAATTTCAGTCCACTTCACC 	1041 
R EQLDSLVC LEST! L E  
AGAGAACAATTGGACAGCTTGGTCTGCCTGCAAACCACTATTCTTGACGT 	1091 
L R LC S Y S S I I R E V 	E 0 M 
TCTGAGGCTGTGCTCATACTCCAGCATCATCCCAGAAGTGCAGGAGGATA 	1141 
N L SL E SK SF S L R K G D F 
TGAATCTCAGCTTAGAGAGTAAGACTTTCTCTCTGCGGAAAGQAGATTTT 	1191 
V A L F P P L I H ND P E I F D A 
GTAGCCCTCTTTCCTCCACTCATACACAATCACCCGGAAATCTTCGATQC 	1241 
P K E 	R F D R F I E 0 GK K K S 
TCCAAAGGAATTTAGGTTCGATCGCTTCATAGAAGATGGTAAGAAGAAAA 	1291 
T F F 	G GK R L k i Y V 	P F 
GCACGTTTTTCAAAGGAGGGAAGAGGCTGAACACTTACGTTATCCCTTTT 	1341 
G L CT S KQP CRY F AV NEIl 
CGACTCCGAACAAGCAAATGTCCAGGGAGATATTTTGCAGTGAACGAAAT 	1391 
K L LL I E L L I Y F D LE I 	I D 
GAAGCTACTGCTGATTGAGCTTTTAACTTATTTTGATTTAGAAATTATCG 	1441 
R 	PI G L N H S R M F L G I 0 
ACAGGAAGCCTA1 AGGGC1 AAATCACAGTCCGATGTTTTTAGGTATTCAG 	1491 









must be concluded that recognition of the AUG codon by 40S ribosomal 
subunits is weak, resulting in weak initiation of Hctl translation. 
As predicted, sequence homology to the mouse cDNA for Hctl is 
highest for human cholesterol 7a- hydroxylase, with 55.9% identity 
over 1054 bp of nucleic acids (homologies to be presented in more 
detail in Chapter Five). At the homology criteria employed, database 
homology searches failed to reveal homology to other cytochromes P-
450. Thus, Hctl may represent the second member of the CYP7 family 
of cytochromes P-450. 
4.4 The structure of the mHctl gene. 
The use of homologous recombination to manipulate the mouse 
Hctl gene requires knowledge of the intron-exon structure of the gene. 
Sequences upstream of the first Hctl exon could also be analysed for 
elements which contribute to the transcriptional regulation of Hctl 
expression. For these reasons, the organisation of the mouse Hctl gene 
was investigated. 
To assess the complexity of the Hctl gene in the genome, that is, 
whether the Hctl gene is present as a single copy in the haploid mouse 
genome, and to assist in mapping of mHctl phage clones, the 1.8 kb full 
length mouse Hctl clone was 32P-labelled by random primer labelling 
and used as a probe on a Southern blot of mouse genomic DNA (Figure 
4.4(a)). Under high stringency conditions the Hctl probe recognised a 
small number of bands within the mouse genomic digests, suggesting 
that Hctl is present in the mouse genome as a single copy gene. To 
confirm this, the original 0.3 kb cDNA clone, 14.5a, was used to probe a 
rat genomic Southern blot. The smaller probe hybridised to a single 
band in BamHI-, EcoRI-, and XbaI -digested genomic rat DNA (Figure 
4.4(b)). 
A mouse genomic DNA library (a gift from A. Reaume, Toronto) 
prepared from ES cells derived from the 129 mouse strain was screened 
for genomic clones containing mHctl exonic sequence. 750,000 
recombinant phage of the lambda DASH II library were plated at a 
Me 
Figure 4.4 Genomic DNA Southern blot analysis of Hctl. (a) Mouse 
genomic DNA probed with the full-length mouse Hctl cDNA clone. 
(b) Rat genomic DNA probed with clone 14.5a (original 0.3 kb clone 
of rHctl). 10 p.g of genomic DNA was digested with the indicated 
enzymes. 
(a) 
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density of 50,000 recombinants per 15 cm plate. Duplicate lifts were 
made and probed with the 1.4 kb rat Hctl clone (the mouse clone was as 
yet unavailable). After the primary screen, 5 clones were isolated. After 
secondary screening, three of these phage clones were positive and 
were purified. 
Small scale phage DNA was prepared from each phage lysate and 
cut with Nod to release the inserts. No internal Nod sites were found 
in any of the clones. Clone -2 contained a 14 kb insert; clone A.-6 
contained a 15 kb insert, and clone A.-11 contained a 12 kb insert. 
These phage clones were mapped by a combination of restriction 
enzymes which either cut the lambda clones rarely, or by using 
restriction sites found in the mHctl cDNA sequence (Figure 4.3(a)). A 5' 
probe was created using a 200 bp fragment from the 5' end of mHctl 
cDNA as a probe; this segment extended from the internal BamHI site 
to an EcoRI site located in the polylinker. The 200 bp 3' cDNA probe 
extended from the Sacl site to the polylinker Nod site. Exon-intron 
boundaries were determined by subcloning of exon-containing 
genomic DNA fragments and sequencing (Figure 4.5). 
Phage clones A.-6 and X-11 represented 20 kb of contiguous sequence 
of the Hctl locus. A.-2 does not overlap with A.-6 or A.-11, thus the map of 
the Hctl gene in mouse is incomplete. However, the present map 
shows that mHctl spans at least 25 kb of the genome. At least two exons 
are contained within ?-6. The first exon (referred to as exon II) contains 
133 bp of coding sequence, followed by exon III, located 4.0 kb 
downstream. The 3' boundary of this latter exon is not defined, 
however approximately 400 bp downstream of its 3' boundary 
commences exon IV, which together comprise 797 bp of coding 
sequence. Exon III and IV are also represented in the overlapping 
sequence of A.-11. A fourth exon of at least 345 bp was identified in ?-2 
(referred to as exon VI). The 3' boundary of this exon has not been 
identified, thus it is not known whether this contains the remaining 
coding sequence or if there are additional exons. 
As Table 4.1 shows, cDNA sequence from nucleotides 1073 - 1246 is 
not represented in the identified exons and must be represented in a 
separate exon. 142 bp of 5' sequence and 227 bp of 3' sequence have not 
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B(205) 	 5(1591) 
mHctl cDNA 	I 	 IAAA 
5' probe 	 3' probe 
100 bp 
mouse Hctl gene 
I 	11 In  
II 111 IV 	 VI 
ii 	 ii: — i_i 
X 	B B 	HH H H 
A.-11 —I_II_I 
S 	 BX 	S 
SS 	B 	X 
1.0 kb 
Figure 4.5 Genomic map of mouse Hctl (incomplete). Exons II, III, IV and VI are represented on the phage 
clones (filled boxes). Exons I and V are not located. As indicated in Table 4.1, the boundaries of exons II, III 
and VT are not fully defined (stippled boxes). 
B (BamHII); H (Hindu); S (Sad); X (XhoI) 
yet been located in the genomic clones. The remaining 5' sequence is 
most likely contained in one exon, as the 5' probe (BamHI fragment) 
consistently recognised two bands by Southern analysis (one of which 
is exon II sequence) (data not shown). The remaining 3' sequence has 
not been located and may be part of exon VI or be encoded by a separate 
exon. 
Exon 	cDNA sequence exon size (bp) 	CYP7 exon 
represented 	 (bp) 
1* 1-142 142 144 
II 143-275 133 241 
III 276-? 587 
I "9" 
IV ?-1072 J 131 
V* 1073 - 1246 174 176 
VP 1247-(1821) (575) 1596 
Table 4.1 A summary of the exon-intron structure of Hctl (incomplete) 
and comparison to human CYP7 gene structure. * indicates that these 
exons are not cloned and are not necessarily one exon. ** indicates that 
the 3' boundary of exon VI is not confirmed and may not necessarily be 
the final exon. Human CYP7 exon information is from Nishimoto et 
al. (1993). 
4.5 The 5.0 kb transcript associated with rat Hctl 
The 3' sequence of clone 13 was clearly distinct from the 3' ends of 
either clone 5 or clone 12. The original 300 base pair 14.5a clone that 
recognised the 5.0 kb transcript was used to isolate clone 13 (2.5 kb), 
indicating that clone 13 also derives from the Hctl transcription unit. 
Because clone 13 had a unique 3' end, this link was also assumed to be 
through the use of an alternative polyadenylation site or through 
alternative splicing of a 3' end. To confirm the correspondence between 
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clone 13 and the 5.0 kb mRNA, clone 13 was used as a probe for 
Northern analysis (Figure 4.6(a)). A single 5.0 kb transcript only was 
recognised in all brain subregions tested. Clone 13 never detected the 
1.8 kb or 2.2 kb transcripts even after prolonged autoradiographic 
exposure. 
A 42-mer oligonucleotide designed from clone 13 sequence, situated 
112 bases upstream from the start of the polyA tail, was used to 
examine clone 13 expression in sections of the adult rat brain by in situ 
hybridisation (Figure 4.6). The pattern of expression of clone 13 did not 
resemble that of clone 12 (Hctl) (refer to chapter 3, Figure 3.2). mRNA 
levels detected by the clone 13-specific oligonucleotide were very high 
compared to Hctl clone 12 probe. Hctl (clone 12) expression in the brain 
required exposure times of 6-8 weeks, while clone 13 gave a strong 
signal in 2-3 weeks. Expression of clone 13 appeared highest in the 
hippocampus and the habenulae (Figure 4.6(b)). Within the 
hippocampus, expression was highest in the dentate gyrus with 
uniform expression of clone 13 through the CA fields (Figure 4.6(e). 
Elsewhere in the adult brain clone 13 expression was widespread and 
uniform (Figure 4.6(c) (d)), compared to the very restricted pattern of 
expression observed for Hal clone 12 (Figures 3.2 and 3.3). 
The fact that clones 12 (Hctl) and 13 were initially isolated using the 
same probe suggested that they were highly related, however 
restriction mapping failed to reveal any relationship. To explore this 
further, the hippocampus lambda ZAP II cDNA library was rescreened 
using clone 13 as a probe. Eight clones were purified after the secondary 
screen, and on plasmid rescue into pBluescript H SK, four were shown 
to contain inserts. Sequencing the ends of each showed that the four 
clones shared a common 3' end, though two had a 20 bp insert between 
the common 3' sequence and the polyA tail (Figure 4.7). Because the 
RNA used to make the hippocampus cDNA library was prepared from 
the hippocampus of several rats, this difference in 3' ends could result 
from allelic variation. 
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Figure 4.6 Expression of clone 13 (Hct2) in adult rat. 
Northern analysis of clone 13 expression in subregions of adult 
rat brain. 
In situ hybridisation of an Hct2-specific radiolabelled 
oligonucleotide to lOp, coronal sections of adult rat brain. Dark field 
view of Hct2 signal in rat brain coronal section through the 
hippocampus (magnification x7.5). 
Dark field view of Hct2 hybridisation signal in a coronal section 
of olfactory bulb (magnification x7.5). 
Dark field view of Hct2 signal in a coronal section of cerebellum 
(magnification x7.5). 
Distribution of Hct2 hybridisation signal in the hippocampus 
(magnification x20). 
Dark field view of rat coronal section through the hippocampus 
hybridised with an oligonucleotide specific for opsin (negative 
control). 
CAl, CA3 pyramidal cell layers; DG, dentate gyrus; hb, habenulae 








done 13 	 I 	11 AAA 	2.5kb 
13-8 	 I ti AAA 	3.0kb 
13-2 	 I 	11 AAA 	2.0kb 
131* 	 I EIAAA 	1.0kb 
13-10* 	 AAA 	0.5kb 
E2= conunon 3'sequence 	T1T1CTGCAAA1TICAGGC 
Figure 4.7 Subclones of clone 13. Insert sizes were determined by 
EcoRT, Nod digests of the recombinant plasmids. The 3' sequence is 
common to all clones except for clones 1 and 10 (*) which had an 
extra 20 bases inserted before the polyA tail. 
The longest of the subclones, 13-8, (3.0 kb) was selected for 
sequencing. Exonuclease III deletions were made in the cDNA, the 
subclones sequenced directly using a primer hybridising to the T7 
polymerase site, and the resulting contig sequences assembled (Figure 
4.8). 
The partial nucleotide sequences of clone 13-8 contigs were 
compared to known sequences contained in the GenBank/EMBL 
database. The recently submitted sequence of the human ABR cDNA 
(Tan et a!, 1993) was found to be very similar to clone 13. ABR (active 
BCR-related) is a gene encoding a GTPase-activating protein (GAP), 
which acts on specific members of the Ras superfamily of small GTP-
binding proteins. However, while regions of clone 13 were virtually 
identical to ABR, other stretches of clone 13 were completely unrelated 
to ABR (Figure 4.8). As 13-8 appears to be more closely related to ABR 









contig I contig 2 contig 3 
433 bp 1433 bp 644 bp 
91% identity 74.5% identity 93.4% identity 
in first 307 bp in last 134 bp 
0.5 kb 
Figure 4.8(a) Regions of conservation between Hct2 (clone 13-8) and 
human ABR. 
The white boxed areas in clone 13-8 represent regions in common 
between the two genes. Hatched regions represent non-homologous 
regions between clone 13-8 and ABR. All of contig 1 was 91% identical 
to ABR. The first 307 bp of contig 2 was 74.5% identical, and the last 134 
bp of contig 3 was 93.4% identical to human ABR. The stippled boxes 
represent mapped functional domains in ABR, part of which is also 
found in clone 13-8. The asterisk indicates the position of the stop 
codon(TAG) at nucleotide 2688. 
(b) Amino acid alignment of the racCAP activit y domain of 
human ABR with part of the same domain identified and conserved in 
clone 13-8. 
Hct2 
ABR (621) CVEEVEKRGIEEVGIYR!SGVATDIQALKAVFDANNKDILLMLSDMDINAI 
consensus 	C EJE RG 	C YRVSC 	L 	FD 	 D N 
Hct2 	 YFRELPEPLLTDRLYPAFMEG I ALSDPAAKE I CMMMHLLRSLPDP 
ABR AGTPKLYFRELPEPLLTDRLYPAFMEG I ALSOPAAKENCMM-HLVRSLPOP 
consensus 	AC K YFRELP PL T 	Y F E 	OP A 	 LP 
Hct2 	NL I TFLFLLEHLKRVAEKEP I NKMSLHNLATVFGPTLLRPSE 
ABR NL I TFLFLLEHLKRVAEKEP I NKMSLHNLATVFGPTLLRPSE 
consensus 	N I YL HL RVAE 	VN M 	NLA VFGPTL R E 
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This unusual pattern of homology between human ABR and rat 
Hct2 (clone 13-8) might be explained in at least two ways. It is possible 
that the non-homologous region is a consequence of the cDNA cloning 
and that clone 13-8 is an artefact. Alternatively, this could be a 
previously undescribed form of ABR which has been generated 
through an alternative splicing event. In an attempt to resolve the 
cDNA structure of Hct2 (clone 13), the remaining subclones, numbered 
1, 2 and 10, were sequenced from their 5' ends. These 5' sequences of 
clones 1 and 10 were compared with the GenBank/EMBL database 
sequences, and were shown to be highly homologous to the human 
ABR gene (Figure 4.9). The sequenced ends of clone 2 aligned within 
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Figure 4.9 Comparison of human ABR cDNA clone with partial 
sequences from clone 13 subclones 8 (3.0 kb), 1 (1.0 kb), and 10 (0.5 kb). 
Sequence within the subclones which is homologous to ABR is 
indicated. Non-homologous regions within subclone 8 corresponds to 
the hatched boxes. Stippled boxes in the ABR cDNA locate the 5' BH-1 
or dbl-like domain and the 3' GAP domain. 
Clones I and 10, which are 1.0 kb and 0.5 kb respectively, aligned 
within the ABR gene in regions which do not correlate with their size. 
Based on size, both clones would be expected to align within the 3' 
untranslated region. However, the 0.5 kb clone 10 aligned 5' of the 
conserved GAP domain, while clone 1 aligned within the BH-1 
domain (Figure 4.9). These data suggest that the cDNA clones obtained 
from the hippocampus cDNA library are most likely generated through 
alternative splicing. The possibility that clone 8 is artefactual has not 
been ruled out, however two independent clones (1 and 10) support 
differential transcripts. 
4.6 Discussion 
Transcription of the rat Hctl gene generates two transcripts through 
the use of alternative polyadenylation sites. These two transcripts (1.8 
kb and 2.2 kb) were present in all tissues examined. A third transcript 
can also be seen by Northern analysis, however this is not related to the 
Hctl transcription unit. Clone 13 encodes a novel message of the rat 
ABR gene, where the 5' and 3' ends encode the rat ABR transcript, but 
inserted into this is a novel sequence in place of the ABR 3' 
untranslated region. Smaller subclones of clone 13 contained ABR 
sequence but not at the predicted position relative to their size. These 
isolated cDNA clones of rat ABR predict that alternative splicing of the 
mRNA produces different messages. Although these alternative forms 
of ABR mRNA are not detected by Northern analysis, it may be that 
these messages are less abundant and therefore not detectable by this 
method. Confirmation of these conclusions would require further 
analysis of the subclones and of genomic clones of the rat ABR gene. 
Rat ABR (clone 13) was isolated in a screen using rHctl (clone 14.5a) as 
a probe. Exactly how ABR was isolated from such a screen is not clear. 
No significant homologies between the 0.3 kb probe and the partially 
sequenced clone 13 can be found. 
A full length cDNA for mouse Hctl would be predicted to encode 
the 1.8 kb transcript, consistent with the size of most cloned 
cytochromes P-450, where the transcript size varies between 1.8 - 2.2 kb 
(Paine, 1991). No Hctl cDNA clones longer than 1.8 kb, which would be 
expected to encode the 2.2 kb transcript, were isolated from the mouse 
liver cDNA library. This is supported by mouse Hctl Northern analysis 
which only detects the 1.8 kb transcript (Figure 3.5). 
The consequences of the use of two alternative polyadenylation 
sites for Hctl are not known, however the 3' untranslated regions of 
certain mRNAs have been shown to influence both the stability of the 
transcript and the translation of the RNA (for review, see Sonenberg, 
1994). The human amyloid protein precursor (APP) gene, for example, 
produces two transcripts which are generated through the use of two 
alternative polyadenylation sites. de Sauvage et al. (1992) have shown 
that sequences contained between the two polyadenylation sites cause a 
3-fold increase in translation of APP mRNA. 
Analysis of the genomic structure of Hctl suggests that the gene 
contains at least six exons, although analysis is as yet incomplete. 
Because most cytochrome P-450 gene families have relatively 
conserved gene structures (Paine, 1991), CYP7 and Hctl should have a 
similar gene structure if they are members of the same gene family. 
The human CYP7 gene spans 17 kb, comprising 6.0 kb of 5' flanking 
sequence and 10.5 kb containing the entire transcription unit which 
consists of six exons (Nishimoto et al., 1993). Most cytochrome P-450 
genes are encoded in 7 - 13 exons, however CYP7, and possibly Hctl 
which has a minimum of six exons, is encoded by a smaller number of 
exons. Interestingly, most CYP genes including CYP7, encode the haem-
binding domain(a conserved C-terminal domain (Chapter 5) and the 3' 
untranslated region together in the last exon. Based on this, it might be 
predicted that exon VI is the final exon, although this remains to be 
confirmed. The isolation of further genomic clones to complete the 
Hctl map will help to clarify the relationship between Hctl, CYP7 and 
other cytochrome P-450 genes. However, although Hctl spans a much 
larger piece of the genome, as Table 4.1 shows, the emerging pattern of 
Hctl exons is similar to the CYP7 gene. 
A cDNA for rat ABR (active bcr-related) was isolated. Rat ABR 
expression is widespread in the adult brain and thus is not relevant to 
the main objective of this study, but the potential function of ABR in 
the brain is of considerable interest. ABR is a GTPase activating protein 
(GAP) with activity specific for rac, which is a member of the rho 
family of small GTP-binding proteins (of which ras is the most well 
known) (reviewed in Downard, 1990). Rac and Rho belong to a 
subfamily of Ras-related proteins and their function is one of 
cytoplasmic signalling, acting to couple extracellular signals with the 
cytoskeleton (Hall, 1993). Thus, for example, activation of rac in 
fibroblasts leads to changes in cell morphology by activating actin 
polymerisation (Ridley et al., 1992). GAPs act as regulatory molecules 
on the activity of Ras-related proteins by converting them to an 
inactive state, and the GAP activity of ABR has been shown specifically 
to convert rac to an inactive state. 
The ABR cDNA clones described, while requiring confirmation, 
could be generated by the proposed model of alternative splicing 
described in Figure 4.10. Interestingly, if these cDNAs are not cloning 
artefacts, such splicing products would produce forms of ABR which 
lack the GAP domain of the protein. The role of such proteins in rac 
signalling would prompt further investigation. One possibility is that 
these proteins could bind to rac, but not facilitate the conversion of 
GTP to GDP, maintaining rac in an active, GTP-bound state. 
Alternatively, the BH-1 domain, which has homology (but as yet no 
demonstrated activity) to guanine nucleotide exchange factors, is 
maintained in these cDNA clones. The function of these "GAPlesst' 
cDNA clones could be determined by the activity of the BH-1 domain. 
M. 
BH-1 exon 	GAP exon alternate 3' UTR 	common 
exons 	3' exon 
(approx. 1.8kb) (136bp) 
• .: 	 .: 	 s 	 \%\\\'\ 	 ,,,,,,,, 
human ABR 	 1JJI] AAA 
clone 13-8 	 AAA 
AAA clone 13-1, -10 
Figure 4.10 A model of alternative splicing proposed to explain the 
observed cDNA subclones of rat ABR. 
The common 3' sequence for all clones is 136 bp. The novel 3' UTR 
sequence is approximately 1.8 kb. The GAP domain itself is 447 bp. 
Subclones 1 and 10 are 1.0 kb and 0.5 kb respectively, and subclone 13-8 
is 3.0 kb. 
The role of Rac and ABR in the brain is unknown, however the 
neuronal cytoskeleton has been suggested to participate in synaptic 
plasticity (Lynch and Baudry, 1987). In addition, the effects of 
cytoskeletal elements have been shown on the localisation of nicotinic 
acetylcholine receptors at the neuromuscular junction (Froehner et al., 
1991). More recently, the state of actin polymerisation has been shown 
to affect the activity of the NMDA receptor channel (Rosenmund and 
Westbrook, 1993). It may be of future interest to look at a possible role 
for Rac signalling in effecting postsynaptic changes of the neuronal 
cytoskeleton, in particular, at the postsynapse. 
CHAPTER FIVE 
Hctl STRUCTURE AND FUNCTION 
Introduction 
The analysis of cDNA and deduced amino acid sequences 
demonstrate that Hctl is a previously undescribed member of the 
cytochrome P-450 superfamily. As an initial step towards characterising 
a possible role for Hctl, evidence for conservation of the gene in 
vertebrates, and for conserved domains within Hctl and other 
cytochromes P-450 was investigated. 
Cytochromes P-450 are structurally conserved, and are divided into 
thirty-six distinct families based on sequence homology. While the 
range of functions carried out by cytochromes P-450 is diverse, they all 
carry out essentially the same enzymatic reaction, and this is reflected 
in conservation of protein structure. Structurally conserved domains 
in a protein generally identify regions important for the function of the 
protein, while slight variations within such a domain can provide 
further classification of related proteins. The identification of the 
homeodomain in Drosophila genes, for example, led to the 
identification of a large family of transcription factors conserved 
throughout evolution (Gehring, 1987). Cytochromes P-450 are 
evolutionarily conserved, with representatives from bacteria to 
human. However, not all individual cytochromes P-450 are conserved 
between vertebrate species. For example, the rat CYP2D subfamily has 
five active genes, while the same subfamily in human has only one 
active gene and two pseudogenes (Nelson et a!, 1993). 
The enzymatic activity of Hctl protein was also addressed. In order 
to assay for cytochrome P-450 activity on a proposed substrate, the 
protein must first be expressed in a suitable system where the 
coenzyme, cytochrome P-450 reductase, is also expressed. A yeast 
expression system was chosen both for ease of manipulation and 
because yeast express an endogenous form of cytochrome P-450 
reductase. The successful use of yeast as an expression system for 
cytochromes P-450 has been described (for examples see Black et a!, 
1989; Ching et a!, 1991). 
5.1 Conservation of Hctl in humans. 
The evolutionary conservation of a gene supports a functionally 
significant role for that gene in the organism. The conservation of Hctl 
in rodents has been demonstrated by the cloning of the rat and mouse 
cDNAs for Hctl. To establish the presence of the Hctl gene in the 
human genome, Southern blotting of human DNA was performed. 
The rat 1.4 kb clone of Hal was used as a radiolabelled probe and gave 
strong signals from all three species (Figure 5.1). A number of 
hybridising fragments appear to be conserved between species, 
suggesting conservation of the Hctl gene structure. There is a 
conserved 1.4 kb Hindill band conserved between mouse and rat, while 
human DNA contains a slightly larger Hindlil band of 1.6 kb. Also an 
EcoRI fragment of 11 kb is conserved in human and rat Hctl. 
Conservation of Hctl gene structure is also supported from the cDNA 
digestion patterns of mouse and rat (see Figures 4.4(a) and 4.2(a)), 
where the Sad, Hindlil and PstI sites are conserved between the rodent 
species. 
5.2 Structure of mouse Hctl protein 
The mouse Hctl open reading frame encodes a protein of 507 amino 
acids. Mouse and rat translated sequences show 81% similarity over 414 
amino acids using the Lipman-Pearson algorithm (DNAstar), but the 
absolute value may be slightly different as the full protein sequence for 
rat Hctl is not known. Nevertheless, this order of similarity between 
the mouse and rat is consistent for orthologous genes. Amino acid 
identity between mouse and rat cholesterol 7a-hydroxylase is of a 
similar order of similarity (Figure 5.3). 
MI 
Figure 5.1 Genomic Southern of mouse, rat and human DNA 
probed with the rat 1.4kb done for Hctl. 
10 j.tg of DNA from each species was digested with BamHI, EcoRI, 
Hindill and XbaI; restriction enzymes known to cut rarely in the 
genome, and which are not affected by DNA methylation. 
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mHct 1 MQGATTLDAASPGPLALLGLLFAATLLLSA. LFLLTRRTRRPREPPL 1K 48 
huCYP7 .............. MMTTSLIWGIAIAACCCLWLILGIRRRQTGEPPLEN 36 
mHctl GWLPYLGMALKFFKDPLTFLKTLQRQHGDTFTVFLVGKYITFVLNPFQYQ 98 
huCYP7 GL!PYLGCALQFGANPLEFLRANORKHGHVFTCKLMCKYVHFITNPLSYH 86 
mHct 1 YVTKNPKQLSFQKFSSRLSAKAFSVKKLLT. DDDLNEDVHRAYL. LLOGK 146 
I 	: . 	I : . 	: 	. I 	I 11111::.:. 	I::.I:::.:: 	III. 
huCYP7 KVLCHGKYFDWKKFHFATSAKAFGHRSIDPMDGNTTENINDTFIKTLQGH 136 
mHctl PLDALLETMIQEVKELFESQL. . . LKITDWNTERIFAFCGSLVFEITFAT 193 
huCYP7 ALNSLTESMMENLORIMRPPVSSNSKTAAWVTEGMYSFCYRVMFEAGYLT 186 
mHctl LYGKILA. GNKKO!ISELRDDFFKFDDMFPYLVSDIPIQLLRNEESMQ 240 
................................... 
huCYP7 IFGRDLTRRDTQKAHILNNL. DNFKOFDKVFPALVAGLPIHMFRTAHNAR 235 
mHctl KKI IKCLTSEKVAQMOGQSKIVQESODLLKRYYRHDDPE!GAHHLGFLWA 290 
huCYP7 EKLAESLRHENLQKRESISELISLRMFLNDTLSTFDDLEKAKTHLVVLWA 285 
mHctl SLANTIPAMFWAMYYILRHPEAMEALRDEIDSFLQSTGQKKG. PCISVHF 339 
1111111 	II.:: 	::I:IIII.I 	:1:.. 
huCYP7 SOANTIPATFWSLFQMIRNPEAMKAATEEVKRTLENAGOKVSLEGNPICL 335 
mHctl TREQLDSLVCLESTILEVLRLCSYSSI IREVOEDMNLSLESKSFSLRKCD 389 
huCYP7 SQAELNDLPVLNSI IKESLRLSSASLN!RTAKEDFTLHLEDCSYNIRKDS 385 
rnHctl FVALFPPL!HNDPEIFDAPKEFRFDRF!. EDGKKKSTFFKGCKRLKTYVM 438 
huCYP7 I IALYPQLMHLDPE!YPDPLTFKYDRYLDENGKTKTTFYCNGLKLKYYYM 435 
mHct 1 PFGLGTSKIPGRYFAVNEMKLLL I ELLTYFDLE lID. . RkP I GLNHSRMF 486 
IIIL.IIIIII.H::I:I:II:I.II:II:I: 	L.I:HI 
huCYP7 PFGSGATIUPGRLFA!HEIKQFLILMLSYFELELIEGOAKCPPLDOSRAG 485 
mHctl LGIOHPDSAVSFRYKAKSWRS 507 
huCYP7 LGILPPLNDIEFKYKFKHL. 	504 
Figure 5.2 Amino acid alignment of mouse Hctl and human CYP7. 
Identical amino acids are indicated by a bar, Conserved amino acid 
changes are indicated by (:). Dots in the sequence indicate introduced 
gaps in the alignment. The conserved cysteine (amino acid 447 in mHctl) 
in the haem-binding domain is boxed. Another domain of strong identity 
(amino acids 288 - 301) is underlined. The alignment was constructed 
using the GAP programme (UWGCG) set at default values. 
Evidence for post-translational modifications of mHctl, through 
conservation of specific motifs was considered. Other cytochromes P-
450, such as cholesterol 7a-hydroxylase, are known to contain potential 
glycosylation sites (U et al, 1991). Two N-linked glycosylation sites were 
found in mHctl protein. The consensus motif for N-linked 
glycosylation is Asn-X-Thr/Ser (where X is any amino acid except 
proline) (Marshall, 1972). Asparagines at amino acids 375 and 481 are 
potential glycosylation sites on mHctl. N-linked glycosylation sites are 
also found in cholesterol 7a-hydroxylase, however the positions 
between cholesterol 7a-hydroxylase and mHctl are not conserved (Li et 
a!, 1990). 
Both human and rat cholesterol 7a-hydroxylase are 39% identical to 
mHctl at the amino acid level (Figures 5.2 and 5.3). The decision as to 
whether or not a new cytochrome P-450 constitutes a new gene family 
is based on sequence homology. This will ultimately be decided by the 
P450 Nomenclature Committee, however, in general, two cytochrome 
P-450 proteins are classed as belonging to the same family if they exhibit 
greater than 40% identity (Nebert et a!, 1989). It is not clear therefore 
whether Hctl will represent a new family of cytochrome P450 genes, or 
a new subfamily of CYP7 genes. 
mi-Icti 	- 
rHctl* 	81% 	- 
huCYP7 39.3% 37% 	- 
rat CYP7 38.9% 36.7% 82% 	- 
Figure 5.3 Amino acid identity between Hctl and the nearest 
homologue, cholesterol 7a-hydroxylase. (*) indicates that the rat Hctl 
clone was not full length. Comparisons were made using the GAP 
programme (UWGCG). 
Because the cytochrome P-450 superfamily is so large, a number of 
comprehensive alignment studies have highlighted conserved regions 
within cytochrome P-450 proteins (Nelson and Strobel, 1988). Thus, 
Hctl was aligned with known regions of conservation between a 
cytochrome P-450 from Psuedomonas putida, CYP10I (the only P-450 
for which crystallographic structural information is known). In 
addition, mammalian cytochromes P-450 which are known to act in 
steroidogenic pathways or modify fatty acids were aligned with mouse 
Hctl protein (Figure 5.4). 
The alignment of cytochromes P-450 in Figure 5.4 identifies a 
number of regions of strong amino acid conservation between mHctl 
and the selected CYP proteins. The cysteine at residue 447 is absolutely 
invariant in all cytochromes P-450. Other conserved amino acid 
positions are glu-356, leu-358, arg-359, pro-408, arg-415, phe-440, gly-443, 
gly-449, ala-453, and glu-456. There are also a number of conservative 
amino acid substitutions. Thus, the amino acids surrounding pro-400 
and arg-407 tend to be aromatic (residues 397, 403 and 408), suggesting a 
conserved structure of cytochromes P-450 in this region. 
Figure 5.2 demonstrates the similarity of CYI'7 and mHctl proteins. 
Both proteins are approximately the same length, around 500 amino 
acids, and the degree of identity is broadly equal over the entire length 
of the proteins. The amino acids from 288-301 are strikingly conserved, 
and as shown in Figure 5.4, do not appear to be conserved outside of 
these two proteins. There are regions where mHctl and CYP7 are 
different from otherwise conserved regions of cytochromes P-450. In 
Figure 5.4, a number of amino acid deletions appear to be conserved 
between the two proteins. Amino acid deletions occur after amino 
acids 101, 134, and seventeen amino acids after position 230 are not 
conserved in mHctl and CYP7. Similarly, insertions of amino acids 
[I I] 
[b 4J 
Figure 5.4 Alignment of cytochromes P450 with mouse Hctl. 
8/8 amino acids conserved in the CYP proteins presented (.); 
7/8 amino acids conserved in the CYP proteins presented (o); 
amino adds conserved in steroidogenic CYP proteins (.); 
amino add conserved except in mFIctl and CYP7 (*); and the 
non- conserved glycine at position 283 M. 
The invariant cysteine residue at position 439 is highlighted in 
bold. Columns of amino adds (in bold) at positions 397,403 and 
408 indicate conserved aromatic amino acids. The highlighted amino 
acid motif (residues 280-293) indicates a conserved motif in mHctl 
and CYP7 only. 
The alignment was produced using the UWGCG programme 
PILEUP with all parameters set at default values. 
32 
mHctl .......... ...... 	MGA TTLDAASPGP LALLGLLFAA TLLLSA. . LF 
huCYP7 .......... .......... .......... MMTTSLIWGI AIAACCCLWL 
CYP11A1 .......MLA KGLPPRS. VL VKGYQTFLSA PREGLGRLRV PTGEGAGIST 
CYP11B1 .......... MALRAKA.EV C......MAV PWLSLQRAQA LGTRAARVP. 
CYP27 MAALGCARLR WALRCAGRGL CPHGARAKAA IPAALPSDKA TGAPGAGPQV 
CYP21 .......... .......... .......... . MLLLGLLLL PLLAGARLLW 
CYP4A1 .......... .. MSVSALSS TRFTGSISGF LOVASVLGLL LLLVKAVQFY 
Cyplol.......... .......... ... 	....... .......... ......... 	I 
81 
mHctl LLTRRTRRPR EPPLIKGWLP YLGMALKFFK DPLT. FLKTL QRQHGDTFTV 
huCYP7 ILGIRRRQTG EPPLENGLIP YLGCALOFGA NPLE. FLRAN QRK}IGHVFTC 
CYP11AI . RSPRPFNEI PSPGDNGWLN LYRFWRETGT HKVkLRHVQN FOKYGPIYRE 
CYP11RI . RTVLPFEAM PRRPGNRWLR LLQ!WREQGY EDLHI EVHQT FQELGPIFRY 
CYP27 RRRQRSLEE I PRLGQLRF. FFOLFVO ,.'jYA. LQLHQLQVLY KAKYGPMWMS 
CYP21 NWWKLRSLHL PPLAP. GFLH LLO....... PDLPIYLLGL TQKFGPIYRL 
CYP 1IA1 LRQWLLKAF QQFPSPPFHW FFGHKQFOGD KELQQIMTCV ENFPSAFPRW 
CYP1O1 TETIQSNANL APLPPN. . VP MYNPSNLSAG VQEANAVLQE SNVPDLVWTR 
128 
mHctl FLVGKYITFV LNPFQYOYVT . . . KNPKQLS FOKFSSRLSA KAFSVKKLLT 
huCYP7 KLMGKYVHFI TNPLSYNKVL . . . CHGKYFD WKKFHFATSA KAFGHRSIDP 
CYP11A1 KLGNVESVYV IDPEDVA. . L LFKSEGPNPE RFLIPPNVAY HOYYORPIGV 
CYP11B1 DLGGAGMVCV MLPEDVE. . K LOOVDSLHPH RMSLEPWVAY ROHRGHKCGV 
CYP27 YLGPQMHVNL ASAPLLE. . 0 VMROEGKYPV RNDMELWKEH RDOHDLTYGP 
CYP21 HLGLQDVVVL NSKRTIEEAM VKKWADFAGR PEPLTYKLVS KNYPDLSLGD 
CYP4A1 FWGSKAYLIV YDPDYMKVIL GRSDPKANGV YRLLAPWIG. ....... 	YGL 
CYP1O1 CNGGHWI ....... ATRGOL DREAYEDYRH FSSECPFIPR EAGEAYDFIP 
* 167 
mHctl . DDDLNE...... DVHRAYL . LLOGKPLDA LLETMIOEVK ELFESOL. 
huCYP7 MDGNTTE...... NINDTFI KTLOCHALNS LTESMMENLO RIMRPPVSSN 
CYP11A1 LLKKSAAWKK DRVALNQEVM APEATKNFLP LLDAVSRDFV SVLHRRIKKA 
CYP11B1 FLLNGPEWRF NRLRLNPEVL SPNAVCRFLP MVDAVARDFS OALKKKVLQN 
CYP27 FTTEGHHWYO LROALNORLL KPAEAALYTD AFNEVIDDFM TRLDOLRAES 
CYP21 YSL. . . . LWK AHKKLTRSAL LLGIRDSMEP VVEOLTQEFC ERNR...... 
CYP4A1 LLLNGQPWFO HRRMLTPAF. . . . HYDILKP YVKNMADSIR LMLDKWEQLA 
CYP1O1 TSMDPPEORO FR. ALANQVV GMPVVDKLEN RIOELACSLI ESLEPQCQCN 
U 	 212 
mNctl LKI)DWF'I. . ERIFAFCGSL VFEITFATLY GKILA. . . GN KKQIISELRD 
huCYP7 SKTAAWVT. . EGMYSFCYRV MFEACYLTIF GRDLTRRDTQ KAHILNNL. 0 
CYPI1AI GSGNYSGDIS DDLFRFAFES ITNVIFGERQ GMLEEVVNPE AQRFIDAIYQ 
CYP11BI ARGSLTLDVU PSIFI-IYILEA SNLALFGERL GLVGHSPSSA SLNFLHALEV 
CYP27 ASGNOVSDMA QLFYYFALEA ICYILFEKRI GCLORSIPED TVTFVRSIGL 
CYP21 AQPGTPVAIE EEFSLLTCSI ICYLTFGDKI K. . DDNLMPA YYKCIOEVLK 
CYP4A1 GODS. SIEIF OI-4ISLMTLDT VMKCAFSHNG SVOVDGNYKS YIQA!GNLND 
CYP1O1 FTEDYAEPFP IRIFML .... .......... ... LAGLPEE DIPHLKYLTD 
245 
mHctl DFFKFDDNFP YLVSDIPI .. .......... ..... OLLRN EESMQKKIIK 
huCYP7 NFKOFDKVFP ALVAGLPI.. .......... ..... HNFRT AHNAREKLAE 
CYP11A1 MF. HTSVPML NLPPDLFRLF RTKTW. . KDH VAAWDVIFSK A.... DIYTQ 
CYP11B1 ME. KSIVOLM FMPRSLSRWT SPKVW. . KEH FEAWDCIFOY C.... DNCIO 
CYP27 MF. QNSLYAI FLPK. . WIRP VLPFW. . KRY LDGWNAIFSF GKKLIDEKLE 
CYP21 TWSHWSIOIV DVIPFLRFFP NPGLRRLKOA IEKRDHIVEM QLROHKESL. 
CYP4A1 LFHSRVRNIF HONDTIYNFS SNGHL ..... ... FNRACOL AHDHTDGVIK 
CYP1O1 QMTRPDGSMT FA ........ .......... .EAKEALYDY LIPIIEQRRQ 
W. 
286 
mHctl CLTSEKVAOM OGOSKIVOES QDLLKRY . YRHD DPEIGAHHLG 
huCYP7 SLRHENLQKR ESISELISLR MFLNDTL ... ...... STFD DLEKAKTHLV 
CYP11A1 NFYWELRQKG SVHHDYRGML YRLL ...... .... GDSKMS FEDIKANVTE 
CYP11B1 KIYOEL. . AF SRPOOYTSIV AELL ...... .... LNAELS PDA!KANSME 
CYP27 DMEAQLQAAG PDGIOVSGYL HFLL ...... .... ASGOLS PREAMGSLPE 
CYP21 .......... .VAGOWRDMM DYMLOGVAQP SMEEGSGOLL EGHVHMAAVD 
CYP4A1 LRKDQLQNAG ELEKVKKKRR LDFLDILLLA RMENGDS. LS DKDLRAEVDT 
CYP1O1 KPGTOAISIV ANGOV ..... .......... .... NGRPIT SDEAKRMCGL 
*0 0 0 335 
rnHct1 FLWASLANTI PAMFWAtIYYI LRHPEAMEAL RDEIDSFLOS TGQKKG. PGI 
huCYP7 VLWASOANTI PATFWSLFOM IRNPEAMKAA TEEVKRTLEN AGOKVSLEGN 
CYP11A1 MLAGGVDTTS MTLQWHLYEM ARNLKVQDML RAEV... LAA RHQAOGDM. 
CYP11B1 LTAGSV!TTV FPLLMTLFEL ARNPNVQQAL ROES... LAA AASISEHP. 
CYP27 LLMASYDTTS NTLTWALYHL SKOPEIQEAL HEEV ... .V VPAGQVPQ. 
CYP21 LLIGGTETTA NTLSWAVVFL LHHPEIOORL QEELDHELGP GASSSRVP. 
CYP 1IA1 FMFEGHDTTA SGVSW!FYAL ATHPKHQORC REEVOSVLGD GSSI... 	1. 
CYP1O1 LLVGGLDTVV NFLSFSMEFL AKSPEHRQEL IERPER .... .......... 
. •..o 385 
mHctl SVHFTREQLD SLVCLESTIL EVLRLCSYSS IIREVOEDMN LSLESKSFSL 
huCYP7 PICLSQAELN DLPVLNSIIK ESLRLSSASL NIRTAKEDFT LHLEDGSYNI 
CYP11A1 .....ATMLQ LVPLLKASIK ETLRLHPIS. VT.. LORYLV NDLVLRDYMI 
CYP1IB1 .....QKATT ELPLLRAALK ETLRLYPVG. LF. . LERVAS SDLVLQNYHI 
CYP27 .....HKDFA HMPLLKAVLK ETLRLYPVV. PT.. NSRIIE KEIEVDGFLF 
CYP21 .....YKDRA RLPLLNATIA EVLRLRPVVP LA. . LPHRTT RPSSISGYDI 
CYP4A1 .....WDI-LD QIPYTTMCIK EALRLYPPVP CI. . VRELST SVTFPDGRSL 
CY0101 .......... .... 	 IPAACE ELLRRFSLVA D. . . . GRILl SDYEFHGVOL 
0 	 0 434 
mHctl RKGDFVALFP PLIHNDPEIF DAPKEFRFDR FL EOGKKKS TFFKGGKRLK 
huCYP7 RKDSIIALYP QLMHLDPEIY PDPLTFKYDR YLDENGKTKT TFYCNGLKLK 
CYP11A1 PAKTLVOVAI YALGREPTFF FDPENFDPTR WLSKDKNIT. ......... 	Y 
CYP11B1 PACTLVRVFL YSLGRNPALF PRPERYNPOR WLDIKGSGR. ......... 	N 
CYP27 PKNTOFVFCH YVVSRDPTAF SEPESFQPHR WLRNSQPATP RI ..... QHP 
CYP21 PEGTVIIPNL QGAHLDETVW ERPHEFWPDR FLEPGKNSR . .......... 
CYP4A1 PKGIOVTLSI YGLHHNPKVW PNPEVFDPSR FAPOSPRHSH SF........ 
CYP1O1 KKGDQILLPQ MLSGLDEREN ACPMHVDFSR .................. OK 
•o. •. 	• • 	o 0 482 
mHctl TYVMPFGLGT SKCPGRYFAV NEMKLLLIEL LTYFDLEIID . . RKPIGLNH 
huCYP7 YYYMPFGSGA TICPGRLFAI HEIKQFLILM LSYFELELIE GQAKCPPLOQ 
CYP11A1 FRNLGFGWGV RQCLGRRIAE LEMT!FLINM LENFRVEIOH L. SDVGT!FN 
CYPIIBI FYHVPFGFGM ROCLGRRLAE VEMLLLLHHV LKHLOVETLT Q.EDIKMVYS 
CYP27 FGSVPFGYGV RACLGRRIAE LEMQLLLARL IQKYKVVLAP ETGELKSVAR 
CYP2I . . ALAFGCGA RVCLGEPLAR LELFVVLTRL LOAF ..... I LLPSGDALPS 
CYP4A1 . . . LPFSGGA RNCIGKOFAM SEMKVIVALT LLRFELLPDP TKVPI. PLPR 
CYP101 VSHTTFGHGS HLCLGQHLAR REIIVILKEW LTRIP ..... .OFSIAPGAQ 
507 
mHctl SRMFLGIQHP DSAVSFRYKA KSWRS ..... ......... 
huCYP7 SRAGLGILPP LNDIEFKYKF KHL ....... ......... 
CYPI1B1 L.....ILMP EKPISFTFWP FNOEATOQ........... 
CYP11A1 F.....ILRP SMCPLLTFRA IN................. 
CYP27 I .....VLVP NKKVGLOFLQ ROC................ 
CYP21 L.....OPLP NCSVILKHQP FOVRLQPRGM GAHSPGONQ 
CYP4AI L.....VLKS KNGIYLYLKK LH ........ ......... 
CYP1O1 IOHKSGIVSG VQALPLVWDP ATTKAV .... ......... 
Ertl 
unique to mHctl and CYP7 appear at positions 334-340, 368, 369, and 
427-431. 
Figure 5.4 indicates three amino acids (residues 84, 136 and 294) 
which appear to be generally conserved amongst CYP proteins except 
mHctl and CYP7. In addition, there is described a conserved glycine at 
amino acid position 291 which is always followed by a threonine three 
amino acids towards the C-terminus at position 294. This domain 
(G/AGXXT) is proposed to be the 02-binding  pocket of cytochromes P-
450 (Poulos, 1988), however this structure is not conserved in CYP7 or 
mHctl. The glycine is not conserved at position 291, both CYP7 and 
mHctl having a serine. There is however a threonine in both proteins 
at position 295, and an alanine precedes the position where the glycine 
is not conserved. The motif in CYP7 and mHctl may therefore be 
ASXXNT, or L/QXXT. The same situation is also found in CYP11131, 
however there is a glycine at position 290 (AGX)O(T). Nevertheless, it 
appears that CYP7, mHctl, and possibly also CYP11B1 have a slightly 
modified structure at the 02-binding  pocket. This is supported by the 
high degree of identity in this region (amino acids 288-301) between 
CYP7 and mHctl (see Figure 5.4). 
The N-terminus of the Hctl protein is hydrophobic, which is typical 
of microsomal cytochromes P-450. It is this portion of other 
cytochromes P-450 which has been shown to insert into the membrane 
of the endoplasmic reticulum, holding the main bulk of the protein on 
the cytoplasmic side (reviewed in Kemper and Szczesna-Skorupa, 
1989). Consistent with microsomal cytochromes P-450, the N-terminus 
lacks basic amino acids prior to a hydrophobic core (amino acids 9 - 35). 
Chimaeric proteins which have N-terminal sequences fused to non-
microsomal proteins have shown that 20 - 30 amino acids from the N-
terminus are sufficent for association with microsomal membranes 
(Kemper and Szczesna-Skopura, 1989 and references therein). 
Virtually all cytochrome P-450 sequences have a strictly conserved 
motif, FXXGXXXCXG (Figure 5.5(a)) (amino acids 440-449 in Figure 5.4), 
which is present in 202 of the known 205 sequences (Nelson et al., 
1993). In the three exceptions, the changes involve the non-cysteine 
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Figure 5.5(a) Conservation of the haem-binding domain in mouse 
Hctl protein. 
Mouse Hctl was aligned with the haem-binding regions of CYP7, 
human cholesterol 7a-hydroxylase (Noshiro and Okuda, 1990), 
CYP4A1, rat lauric acid (o-hydroxylase (Hardwick et al., 1987), 
CYP11BI, human steroid 1113-hydroxylase (Mornet et al., 1989), 
CYP21B, human steroid 21-hydroxylase (sequence from Nelson and 
Strobel, 1988), CYP27, human sterol 27-hydroxylase (Cali and 
Russell, 1991), CYP11A1, human P-450scc (cholesterol side chain-
cleavage enzyme) (Morohashi et al., 1987), and CYPIOI, bacterial 
cytochrome P-450cam (Haniu et al., 1982). The alignment was 
produced using the UWGCG program PILEUP with all parameters 
set at default values. 
(1) Alignment of mouse Hctl helix K (conserved 
steroidogenic domain). 











GLG TSKCPGR V F 
; 	S G A I I C P G R L F 
S G G A R NC I GK 0  
GFGMROCL G R  
G C G A R V C L GE P V 
G Y  V R A C L G R R 	I 
G W G V R  CL G RI 
G H G S H L CL GQHL 
helix K (348-362) 




mHcfl V C L E S I I L 
huCYP7 PVLNSI 1K 
CYP4AI P V 1 1 	11 C I K 
CYP11B1 P L L R A A L K 
CYP21B P L L N A TWA 
CYP27 P L L K A V L K 
CYP11A1 P L L K A SLIK 
CYP1OI C E 
V L R L C S 
S L R L S S 
A L R L Y P 
T L R L Y P 
V  R  P V 
T L R L Y P 
T L R L H P 




residues. Thus the cysteine residue is present in all cytochromes P-450, 
and is generally located towards the carboxy terminus. In the case of 
mHctl, this cysteinyl peptide is located at amino acids 440-449. The 
cysteine is believed to be involved in the binding of the haem cofactor. 
The arrangement of amino acids surrounding the cysteine residue 
preserves the three-dimensional structure of this region for ligand 
binding (Poulos, 1988). 
A domain which lies proximal to the haem-binding domain, 
referred to as helix K (Poulos, 1988) or the conserved steroidogenic 
domain by Noshiro and Okuda (1990), also shows conservation, in 
particular, with those cytochromes P-450 which are involved in 
steroidogenic conversions (Figure 5.5(b) (amino acids 352-366 in Figure 
5.4). mHctl shares a number of conserved amino acids, however once 
again, there is a non-conserved change from proline to valine at 
position 340. 
5.2 Sexually dimorphic regulation of Hctl in the rat 
A number of cytochromes P-450 are expressed in the liver in a 
sexually dimorphic pattern (for review, see Morgan and Gustaffson, 
1987). In addition, Roof and Havens (1992) have observed a sexual 
dimorphism in the size of the granule cell layer of the dentate gyrus. 
Sexually dimorphic gene expression of Hctl was examined in the rat 
liver and hippocampus. The 1.4 kb Hctl done was labelled with 32P by 
random primer labelling, and was used to probe a Northern blot of 
RNA samples extracted from the liver and hippocampus of female and 
male adult rats (Fig. 5.6). 
No changes in Hctl expression levels were observed in the male 
and female hippocampus. However, Hctl expression in the liver was 
found to be sexually dimorphic (Figure 5. é). Hctl is expressed in the 
male liver, while Hctl mRNA in the female liver was detected by 
Northern blot analysis only after prolonged exposure. 
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Figure 5.6 Sexually dimorphic expression of Hctl in the rat. 
Hippocampus RNA samples were po1yA-se1ected, while liver 
samples were prepared as total cytoplasmic RNA. I j.tg of polyA 
samples and 10 p.g of total cytoplasmic RNA was used for Northern 
analysis. Hybridisation to ribosomal protein S26 was used to 
determine equivalent loading of samples. 
hippocampus liver 
female male female male 
5.0 kb 
2.2 kb 
1.8 kb 	of 
.OSS 
5.3 Expression of Hctl protein for enzymatic activity analysis 
Sequence comparisons predicted an enzymatic activity for mHctl, 
but not a substrate preference. Thus, to confirm catalytic activity and 
substrate specificity, a yeast heterologous expression system was used to 
produce recombinant Hctl protein. Because clones 35 and 40 of mHctl 
varied in 5' and 3' non-coding sequences (see section 4.3 and Figure 4.3) 
which could possibly affect Hctl expression, both cDNA clones were 
used in the expression experiments. 
The pYES II expression vector and the S. cerevisiae strain, INVSc1, 
were provided by Dr. J. Tsang, Dundee. mHctl clones were inserted 
into the vector using restriction sites in the polylinker. The correct 
orientation of the inserts was checked using unique Sacl and BamHI 
sites contained within the cDNA (refer to Figure 4.3). The constructs, 
containing mHctl under the control of the inducible promoter, Gall, 
were transformed into INVScI. pYES II plasmids contain the URA3 
gene, allowing selection of transformants on minimal medium 
without uracil. A plasmid containing no mHctl cDNA insert was also 
transformed into yeast. 
The recombinant yeast were grown to late logarithmic phase with 
appropriate selection in minimal medium containing 2% glucose. To 
induce expression, the medium was changed, replacing the glucose 
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Figure 5.7 Expression vector for Hctl production in yeast. 
The full length cDNA of Hctl, clone 35 from the mouse, was inserted 
into the pYES II expression vector using a NotI site in the polylinker 
located between the Gall promoter and the termination signal. Correct 
orientation was determined by restriction enzyme analysis. The 
plasmid was transformed into yeast as described in Section 7.2.8. To 
induce Hct-1 expression, cultures were grown to late log phase in 
minimal media with uracil selection and glucose as a carbon source. 
Expression of Hctl was induced by replacing glucose with galactose. 
Northern blot analysis was used to examine Hctl mRNA 
production. Total cytoplasmic RNA was extracted from culture samples 
96 
Figure 5.8 Expression of mHctl RNA in induced yeast cultures. 
Culture samples were taken at 0 (uninduced), 2, 4, 6, 8, 10, 12, and 24 
hours after induction, and total cytoplasmic RNA prepared. 
Timecourse of mHctl induction: (a) mHctl (clone 35) expression, (b) 
mHctl (clone 40) expression, and (c) vector only, all probed with 
mHctl clone 35. (d) The 'vector only' filter reprobed with a 1.3 kb 
BglI fragment from pBluescript II SK. The arrows indicate the 
position of the mouse Hctl transcript (1.8 kb) in liver RNA (the 
exposure time was insufficient to visualise endogenous mHctl 
message). 













taken at each of the induced timepoints and the uninduced sample. 
Each RNA sample was fractionated through a denaturing agarose gel, 
transferred to a Hybond membrane by Northern blotting, then probed 
with the full length mouse Hctl cDNA labelled with 32P by random 
primer labelling (Figure 5.8). 
The mouse Hctl cDNA probe hybridised to both induced and 
uninduced samples for both clone 35 and clone 40 (Figure 5.8(a) (b)). 
This is not due to cross-hybridisation to endogenous yeast transcripts, 
as mHctl does not hybridise to the 'vector only' samples (Figure 5.8(c)). 
In addition, there was no apparent increase in transcripts of the 
expected size of 1.8 kb. There were transcripts of 0.56 kb, 1.1 kb and 6.6 
kb which did increase with galactose induction, however it was not 
clear whether these could correspond to transcribed Hctl. 
The possibility that the range of bands observed corresponded to 
contaminating plasmid was tested. The pYes II plasmid is a high copy 
number plasmid, and although the RNA preparation method should 
exclude DNA contamination, even minute amounts of plasmid 
contamination could result in the observed hybridisation pattern. A 1.3 
kb piece of pBluescript II was generated by BglI digestion, and was used 
to reprobe the 'vector only' filter (Figure 5.8(d)). The same pattern of 
hybridisation was found using a pBluescript II probe, thus it was 
concluded that the bulk of the signal was contributed by plasmid 
contamination. The 0.56 kb 'induced' band was not recognised by the 
vector probe, while the 1.1 kb and 6.6 kb 'induced' bands were 
recognised by the plasmid probe. However the results from the RNA 
analysis were inconclusive, and because ultimately Hctl protein 
production must be demonstrated, RNA analysis was not pursued 
further. 
To detect Hctl protein production, total protein extracts were 
prepared from uninduced cultures and cultures after 8 hours of 
induction. In the absence of an antibody specific for Hctl, 30 .tg of each 
protein extract was fractionated on a 10% SDS-PAGE gel, and then 
stained using Coomassie brilliant blue (Figure 5.9). 
The products of most cytochrome P-450 genes, like their transcript 
sizes, tend to be of similar size, with protein molecular weights 
Figure 5.9 Expression of Hctl protein in yeast after an 8 hour 
induction. 30 tg of total protein extract was fractionated through a 
10% SOS-PAGE gel, followed by staining with Coomassie brilliant 
blue. 
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between 49 kD and 55 kD (Paine, 1991). Thus Hctl protein in the 
induced samples was predicted to be in this range. A band in the correct 
size range was present in the induced sample of clone 40, and absent in 
the uninduced sample, as indicated by the arrow in Figure 5.8. An 
induced band of weaker intensity can also be seen in the clone 35 
sample at the same position, however this is concealed somewhat as 
the uninduced sample is overloaded. 
5.4 Discussion 
The Hctl gene is present in rat, mouse and human, and appears to 
be a single copy gene. While cytochrome P-450 genes are scattered over 
both mouse and human chromosomes, cytochrome P-450 subfamilies 
tend to be clustered together on the same chromosome. The human 
CYP2A and 2B subfamilies are linked to chromosome 19, CYP2C and 2E 
subfamilies are located on human chromosome 10, and the mouse 
cyp2a, 2b, and 2e subfamilies are linked to mouse chromosome 7 
(reviewed by Paine, 1991). Human cholesterol 7a-hydroxylase (CYP7) is 
located on chromosome 8q11-q12 (Cohen et a!, 1992). It will therefore be 
of future interest to examine the chromosomal location of the human 
orthologue of Hctl as a measure of linkage to the CYP7 family. In 
addition, should Hctl map to a known genetic locus, this may suggest a 
function for Hctl in human. 
The structure of mHctl and its similarity to other cytochromes P-450 
suggests a possible function for Hctl. Hctl is most homologous to 
cholesterol 7a-hydroxylase, both of which are more similar to each 
other than any other cytochrome P-450. The striking conservation of 
amino acid sequence between the two proteins (described section 5.2) 
suggests that CYP7 and Hctl are most likely members of the same 
cytochrome P-450 family, and that these two enzymes have similar 
activities. Based on the Hctl leader sequence, Hctl most likely resides 
in the endoplasmic reticulum and not in the mitochondria, the other 
principal cellular site of cytochrome P450 activity. In general, enzymes 
that form bile acids from cholesterol can be divided into two groups: 
those which catalyse oxidation of the cholesterol side chain tend to be 
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located in the mitochondria, like CYPIIAI (Morohashi et a!, 1987), 
while those enzymes like cholesterol 7a-hydroxylase which modify the 
ring structure of cholesterol are located on the surface of the 
endoplasmic reticulum (Bjorkhem, 1985). Considering the similarities 
between CYP7 and Hctl, it might therefore be suggested that Hctl 
enzymatic activity is directed to the cholesterol ring structure. 
The domain which is most highly conserved in steroidogenic 
cytochromes P-450 is also conserved in mHctl (Figure 5.5(b)). This once 
again supports a possible role for mHctl in the modification of 
cholesterol-based molecules. This helix K region is thought to 
participate in binding substrate (Li et a!, 1990). However the non-
conserved proline at position 340 may indicate a different substrate 
interaction with mHctl. 
The structure of the 02-binding  pocket of mHctl and CYP7 is not 
conserved as proposed by Poulos (1988). Crystallographic studies of the 
bacterial CYPI01 indicate that the corresponding threonine at position 
252 disrupts the helix formation in that region, and is important in 
providing a structural pocket for an oxygen molecule (Poulos et a!, 
1987). In addition, Imai and Nakamura (1989) have shown by site-
directed mutagenesis of the conserved threonine in both CYP4AI and 
CYP2C1I that this region can also influence substrate specificity and 
affinity. This modified region in CYP7 and mHctl suggests that these 
proteins are structurally different on the distal side of the haem, and 
this may be reflected both in a modified oxygen interaction and in 
substrate choice. 
While Hctl hippocampus expression is equivalent in both male and 
female rats, Hctl expression in male rat liver is not unlike other 
cytochromes P-450. CYP2C1 2 is expressed preferentially in the liver of 
the female rat, while CYP2C11 is expressed similarly to Hctl in male rat 
liver (Donahue et a!, 1991). This expression pattern for the CYP2C 
family members has been shown to be regulated by the sexually 
dimorphic growth hormone secretory pattern (Morgan and Gustaffson, 
1987). It is possible that Hctl is under the same regulatory controls 
which govern CYP201 expression but, because Hctl is so distantly 
related to this family, it is possible that separate regulatory mechanisms 
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exist. Whatever the mechanism, Hctl expression in the hippocampus 
appears to be excluded from such regulation. 
Sexually dimorphic Hctl expression was only examined in the rat, 
and it cannot be assumed that the same regulation of Hctl expression 
exists in other species. Indeed, it has been shown by Noshiro et a! (1988) 
that sexually dimorphic expression is not always conserved even 
within mouse strains. Nevertheless, Hctl expression in the rat liver is 
sexually dimorphic. The consequences of such gene expression may 




Hctl was identified during a differential screen designed to isolate 
rat cDNA clones corresponding to transcripts enriched or uniquely 
expressed in the hippocampus. Within the brain, rat Hctl is expressed 
predominantly in the hippocampus, with very low levels of expression 
detectable in cortex and other brain areas. In addition, low level 
expression of rHctl is detected in liver and kidney but not in any other 
tissues tested. In contrast to rat, the expression pattern of the mouse 
orthologue is widespread in adult brain, showing no compelling 
enrichment in hippocampus. 
A full-length mouse cDNA of Hctl shows significant nucleic acid 
and amino acid homologies to cholesterol 7a-hydroxylase (CYP7), an 
enzyme required for the conversion of cholesterol to bile acids. CYP7 
belongs to the cytochrome P-450 superfamily of monooxygenases, a 
large group of enzymes involved in diverse processes including 
steroidogenesis and metabolism of exogenous compounds. Based on 
sequence homology, it is likely that Hctl constitutes the second 
member of this cytochrome P-450 family. 
Hctl was cloned originally to assess its suitability for use as a 
promoter to drive hippocampus-specific transgene expression. The 
potential use of Hctl regulatory elements in transgenesis and the 
function of Hctl as a cytochrome P-450 in the hippocampus remain to 
be determined. The application of Hct promoters, and possible roles 
and substrates for Hctl are discussed. 
6.1 The application of Hct promoters in transgenesis 
The use of promoters which can direct transgene expression 
specifically to the hippocampus would provide a means of 
investigating the effects of modified gene expression in the 
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hippocampus, without affecting other areas of the animal. 
Furthermore, the use of tissue-specific gene targeting in mice further 
necessitates the isolation of hippocampus-specific promoters. 
As discussed previously (section 1.4.2(a)), the consequences of a 
developmental role for gene products such as Fyn can complicate 
analyses of possible adult phenotypes. An Hct gene promoter may help 
to distinguish between developmental effects and a specific role for Fyn 
in spatial learning. Directed expression of Fyn to the hippocampus of 
the null mouse should "rescue" the learning deficit if Fyn plays a 
specific role in learning. Similarly, LTP should be restored in "Fyn-
rescued mice" if Fyn is an essential component of signalling in LTP. 
This rationale can be applied also to the CaMKII and PKCy null mice, 
where any non-specific effects of gene inactivation in other cell types 
can be eliminated with a hippocampus-specific rescue of the learning 
deficit. 
The use of the Cre/IoxP system to inactivate gene expression or to 
introduce gene variants at a specific location (see section 1.4.2(c)), 
expands the potential of transgenic analysis in the study of 
hippocampus function. Specifically, the use of hippocampus-targeted 
gene inactivation can facilitate the analysis of protein function where a 
conventional knockout results in lethality. For example, the NMDAR1 
subunit knockout mouse (Li et al., 1994), if inactivated in the 
hippocampus alone, may result in viable offspring allowing analysis of 
an adult hippocampus phenotype. 
Another example of the potential application of Hct promoters 
would be to target subtle modifications of a gene specifically to the 
hippocampus, rather than generating a null allele. Again with the 
example of the NMDAR1 receptor subunit, subtle changes to the 
subunit could be made by altering the endogenous gene in the 
hippocampus. For instance, the role of phosphorylation of the NMDA 
receptor subunits in LTP and subsequent behavioural effects could be 
assessed in the animal by mutation of one or all phosphorylation sites. 
Mice could be generated which have subtle changes in all of the 
receptor subunits of the NMDA receptor, which, upon breeding, could 
allow the analysis of combinations of modified NMDA receptor 
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subunits. It should, however, be re-emphasised that tissue-specific gene 
inactivation, such as the preceding examples, is still limited by the lack 
of hippocampus-specific promoters. 
It is worth noting that while mouse transgenesis is of great 
potential, the rat is the preferred experimental model for behavioural 
analysis. The use of mice for behavioural analyses is at an early stage 
and extrapolating data from the rat system directly to mice may not be 
completely valid. It may therefore be necessary to repeat the 
hippocampus ablation studies in the mouse to confirm the legitimacy 
of the mouse system, taking into account genetic background. Studies 
have shown that different strains of mice exhibit varying abilities in 
spatial learning in the water maze. For example, C57 mice performed 
better than DBA mice in one study (Upchurch and Wehner, 1988). In 
addition, the water maze spatial learning test, used to assess rat 
hippocampus-dependent learning, may need adaptation to 
accommodate mouse analysis. Thus the size of the pool and the age of 
the animals used may need to be considered when assessing the ability 
of the mouse to perform the task. Finally, patterns of gene expression 
may not necessarily be conserved between species. Such differences in 
gene expression between mouse and rat, as seen with Hctl, again 
support the idea that mouse and rat are two unique experimental 
systems that do not necessarily overlap. 
6.2 The suitability of Hctl regulatory elements for transgenesis 
The use of Hctl regulatory elements to direct expression to the 
hippocampus is currently restricted to rat transgenesis or the use of the 
rat gene promoter in the mouse. As described in section 3.3, mouse 
Hctl is expressed throughout the brain, showing no enrichment in the 
hippocampus. Transgenic analysis of Hctl function in the 
hippocampus therefore would also be restricted to addition 
transgenesis, as gene inactivation using homologous recombination is 
not yet possible in rat. 
Rat Hctl is enriched in the hippocampus, however very low level 
expression is found outside the hippocampus and in extraneuronal 
105 
tissue. Thus Hctl promoter elements are unlikely to be capable of 
directing gene expression exclusively to the hippocampus. The use of 
the Hctl promoter, however, may still be possible in some types of 
experiments where transgene expression in extrahippocampal tissue 
and at very low levels would be unlikely to lead to ambiguities of 
interpretation. Ectopic expression of molecules such as the NMDA 
receptor subunits in liver, for example, may not bear any consequence 
on behavioural analyses and would be unlikely to affect the 
electrophysiology of the hippocampus. In addition, it may be possible to 
use the Hctl promoter when relatively high levels of transgene 
expression are required. Expression outwith the hippocampus of a 
transgene modified to exert a dominant-negative effect, would not be 
expected to compete with the endogenous protein if expressed at very 
low levels. 
An alternative route to exploiting the Hctl promoter would be to 
determine which elements in the promoter are responsible for the 
spatial regulation of expression (described further in section 6.3). 
Deletion analyses, as described in section 6.3, may identify regions 
within the promoter specifically responsible for Hctl expression in 
liver or hippocampus. Thus, through such analyses, the possibility 
exists to create artificial hippocampus-specific promoters from Hctl. 
6.3 Regulation of gene expression in the hippocampus 
Gene transcription by RNA polymerase II is controlled by the 
interaction of trans-acting proteins at specific DNA elements in the 
promoter or enhancer. It is this assembly of tissue-specific and 
ubiquitous transcription factors together with the basal transcription 
machinery that direct the initiation of transcription. Promoter deletion 
studies and protein-DNA binding studies have identified DNA 
elements required for tissue-specific expression, and the transcription 
factor which bind to such elements. The identification of promoter 
elements and transcription factors which control hippocampus 
expression would be of potential utility. 
Purkinje cell protein 2 (Pcp-2) is expressed in cerebellar Purkinje 
cells and retinal bipolar neurons. The regulatory elements which direct 
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expression to these two cell types were dissected using deleted 
promoter constructs to drive expression of a lacZ reporter gene in 
transgenic mice (Vandaele et al., 1991). A DNA element conferring 
neuronal expression was identified and was shown to be present in a 
number of other promoters of neuronal genes. In addition, cerebellar 
expression could be separated from retinal expression. Similarly, genes 
expressed specifically in neurons of the olfactory epithelium all contain 
DNA binding sites for the olfactory-specific transcription factor, Olf-1 
(Wang et al., 1993). 
The analysis of Hct promoters may similarly reveal consensus sites 
for transcription factors required for hippocampus expression. A very 
simple approach would be to examine promoter sequences for 
conservation of sequence motifs. A more thorough analysis would 
involve promoter deletion constructs and examination of reporter 
gene expression in transgenic mice. This can be followed by analysis of 
in vitro protein-DNA interactions (for example see Somma et al., 1991) 
and finally by in vivo analysis of protein interactions at the promoter 
(Mueller and Wold, 1989). Such strategies could be applied, for 
example, to the serotonin receptor where expression is restricted to two 
distinct regions in the brain (Wisden et al., 1993). Transgenic 
approaches, like those used for Pcp-2 by Vandaele et al. (1991), may 
discriminate between DNA regions directing gene expression in the 
hippocampus or in the habenulae. By this approach, it is possible that 
artificial Hct promoters could be created by removing the promoter 
region required for expression in the habenulae. 
6.4 Cytochrome P-450 gene expression in the brain 
The exact role of cytochrome P-450 activity in brain is not defined, 
however the detection of multiple forms of cytochrome P-450 in brain 
suggests a variety of functions. A summary of reported expression or 
activity of cytochromes P-450 in the central nervous system is described 
in Appendix I. The emerging pattern of expression appears to be largely 
restricted to members of CYP1, CYP2, and CYP3 families, proteins 
involved largely in foreign compound metabolism and procarcinogen 
activation, and CYP4 family members which hydroxylate fatty acids 
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such as arachidonic acid. The CYP2 family which is involved in the 
metabolism of foreign compounds are expressed widely throughout 
the brain, and are induced upon different treatments such as ethanol 
and nicotine administration (Warner et al., 1994; 
Anandatheerthavarada et al., 1993). The existence of these CYP proteins 
in the brain suggests a capacity for the brain to metabolise foreign 
compounds. This is supported by the upregulation of CYP1A, CYP2C 
and CYP4A in brain on partial hepatectomy (Warner et al., 1993). P-450-
dependent metabolism is thus of particular relevance in the design of 
neuro-specific drugs which may affect a drugs action as well as the 
potentially deleterious effects of the resulting metabolites. 
Interestingly, Strornstedt et al. (1993) have detected 6-alpha and 7-
alpha hydroxylation activities on the anaesthetic steroid 3a-hydroxy-
5a-pregnan-20-one, which was shown to be cytochrome P-450-
mediated. The expression of CYP7 in brain is not known, however 
these hydroxylation activities could be mediated by CYP7 and perhaps 
Hctl. Finally, expression of cytochromes P-450 is not restricted to 
neurons as CYP2E1 is expressed in glial cells of the cerebellum 
(Hansson et al., 1990) and expression of several CYP genes has been 
shown in the rat glioma cell line C6 (Geng and Strobel, 1993). Thus, 
both sub-populations of neurons and glia possess functional 
cytochrome P-450 systems. 
6.5 A role for Hctl in the hippocampus 
Until the preferred substrate for Hctl is identified, prediction of a 
role for Hctl in the hippocampus can only be speculative. However, a 
suggested role for Hctl in cholesterol homeostasis is not unreasonable, 
given the significant sequence homology between Hctl and CYP7. 
Cholesterol is a major constituent of plasma membranes and changes 
in membrane structure might be predicted as a result of cholesterol 
mobilisation. It should again be noted, as discussed in section 1.3.4(a)), 
that nucleic acids encoding the enzyme responsible for the 12a-
hydroxylation of cholesterol in the bile acid biosynthetic pathway have 
not as yet been cloned. Hctl must be considered a candidate for this 
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enzymatic activity in the liver, but would presumably act in another 
context in the hippocampus. 
In liver, nitric oxide (NO) has been shown to inhibit the activity of 
CYP enzymes (Stadler et al., 1994). This occurs at the level of 
transcription, by an unknown mechanism, as well as post-
translationally, by binding to the haem cofactor so as to inhibit catalytic 
activity. Although the subcellular distribution of Hctl in neurons is 
not known it might be predicted that, if Hctl is postsynaptic, 
cytochrome P-450 activity would be down-regulated by NO produced 
during LTP. The consequences of possible Hctl-NO interactions at the 
postsynapse may be related, for example, to downregulation of 
cholesterol mobilisation from the plasma membrane. It should be 
noted that carbon monoxide, another putative retrograde messenger, 
would also be expected to bind to the haem group and disrupt 
cytochrome P-450 activity. 
Arachidonic acid might also be considered a candidate substrate for 
Hctl, although arachidonic acid is a known substrate for members of 
the CYP4 family of cytochromes P-450 (section 1.3.4(a)), and Hctl shows 
only weak homology to this family. However the pathways of 
arachidonic acid metabolism are not yet fully elucidated, and it has 
been proposed that other cytochrome P-450-like activity may be 
involved in some of these pathways (Piomelli and Greengard, 1990). 
For example, the enzymes which participate in the pathway which 
produces arachidonylethanolamide (also known as "anandamide") are 
not characterised. Anandamide was identified as a possible endogenous 
ligand for the cannabinoid receptor (Devane et al., 1992) and is most 
likely a product of arachidonic acid metabolism. 
It is also possible that a P-450-derived metabolite of arachidonic acid 
is responsible for the effects attributed to arachidonic acid itself. For 
example, it will be of interest to investigate the role of possible Hctl 
metabolites as retrograde messengers in long-term potentiation; so far, 
only cyclooxygenase and lipoxygenase derivatives of arachidonic acid 
have been addressed (Williams et at., 1989a). 
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6.6 A role for Hctl in neurodysfunction? 
Associations have been observed between cholesterol and a number 
of human neurodegenerative diseases. Thus proteins which are 
involved in the regulation of cholesterol levels may also have a role in 
processes leading to neurodegeneration. Parkinson's disease, 
Adrenoleukodystrophy, Type C Niemann-Pick disease and 
Alzheimer's disease are examples of neurodegenerative disease 
associated with changes in cholesterol homeostasis. 
Wilson and Sargent (1993) have noted a 25% increase in cholesteryl 
ester levels in the brain of patients with adrenoleukodystrophy, a fatal 
disease resulting from the progressive demyelination of the CNS and 
PNS, as well as adrenal insufficiency. In contrast, a reduced biosynthetic 
cholesterol capability has been shown in fibroblasts from patients with 
Parkinson's disease (Musanti et al., 1993). In neurological deterioration 
characteristic of Niemann-Pick disease type C there is a defect in 
intracellular cholesterol transport. Exogenous cholesterol from 
lysosomes, the principal site of cholesterol storage, is not transported 
for processing, resulting in an accumulation of cholesterol in the cell 
(Vanier et al., 1991). 
A possible link between Alzheimer's disease and cholesterol 
metabolism was described when the frequency of a particular allele of 
the apolipoprotein E gene was found to be elevated in patients with 
late onset Alzheimer's disease (Corder et at., 1993). ApoE is a 
component of plasma lipoproteins which are responsible for the 
transport and clearance of cholesterol. The ApoE type 4 allele is found 
in 80% of familial late onset Alzheimer's disease while in control 
patients the E3 allele predominates. The E4 allele has a single amino 
acid change from the most common E3 allele. The effects of carrying 
one or two type 4 alleles and an association with Alzheimer's disease is 
not known, however ApoE4 is a component of amyloid plaques found 
in Alzheimer's brains. Further, the amyloid (the PA4 peptide) binds to 
ApoE with high avidity (Strittmatter et al., 1993). Thus ApoE is 
implicated in the pathogenesis of Alzheimer's disease, with the 
suggestion of resulting effects on cholesterol homeostasis. 
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Alzheimer's disease is associated with the deposition of amyloid 
(3A4 peptide) produced by enzymatic cleavage of the amyloid precursor 
protein gene (APP). APP is a membrane-spanning protein, however 
the cleavage point on APP to produce the 13A4 peptide is within the 
membrane. It is thus not clear how the enzyme responsible for the 
cleavage might access the cleavage site. One interesting hypothesis is 
that Alzheimer's pathology results from an increased mobilisation of 
cholesterol from the plasma membrane, causing structural 
perturbation of the membrane. Mason et al. (1992) have shown a 
decrease in the thickness of the lipid bilayer of the plasma membrane, 
and a 30% decrease in cholesterol content in plasma membranes from 
Alzheimer's patients. It was proposed that this might result in 
exposure of the cleavage site on APP, allowing for the abnormal 
production of the PA4 peptide. Based on such hypotheses it could be 
suggested that an enzyme such as Hctl, which is expressed in one of the 
preferred sites of amyloid deposition and which may be involved in 
cholesterol metabolism, could play a role in Alzheimer's disease. A 
gene for Hctl has been detected by Southern blot analysis in human, 
and the preceding hypothesis assumes that human Hctl is expressed in 
the hippocampus. Experiments are however underway to test this 
prediction by genetic mapping of the Hctl orthologue in human. 
6.7 The future for Hctl 
The normal function of Hctl and the suitability of the Hctl 
promoter for use in hippocampus transgenics will be the focus of 
future experiments. 
Immediate experiments will focus on the substrate preference for 
Hctl. This involves addition of a candidate substrate to a microsomal 
preparation from the recombinant yeast expressing mouse Hctl. The 
substrate, appropriately labelled, can be assayed for modification by thin 
layer chromatography (TLC) or high performance liquid 
chromatography (HPLC). More detailed analysis of the product can be 
achieved using mass spectroscopy. The enzymatic activity of Hctl may 
not be confined to a single compound, or conversely, the substrate 
specificity may be strict, acting on a particular stage in a metabolic 
pathway. However, once the substrate is known for Hctl, then a role 
for the enzyme in the hippocampus may be more directly addressed. 
The substrate analysis is dependent on the formal identification of 
recombinant Hctl protein produced in yeast. As this can only be done 
with a specific antibody against Hctl, such antibodies will be raised for 
Hctl. The antibodies will be of further use in defining Hctl protein 
distribution in the hippocampus. Subcellular localisation of Hctl 
should contribute to our understanding of Hctl function. If, for 
example, Hctl protein were to be concentrated at the postsynapse, as is 
the case for CaMKII (Schulman and Lou, 1989), a function in 
postsynaptic signalling or modification could be addressed. If, in 
addition, arachidonic acid was found to be a substrate for Hctl, then a 
role in the production of retrograde messengers could be investigated. 
The use of an antibody to block Hctl function or the development of a 
specific inhibitor of Hctl activity could be used to assess its 
involvement in LTP. 
Evidence for a role in synaptic plasticity for Hctl could be addressed 
further by changes in gene expression. Synaptic activity can be induced 
in live animals using a number of different paradigms such as seizure 
or LTP. Changes in gene expression can be detected using in situ 
hybridisation. This has been applied to a number of genes already. The 
inducible cyclooxygenase, COX-2, (Yamagata et al., 1993) and tissue 
plasminogen activator (tPA) (Qian et al., 1993) are both immediate early 
genes which are upregulated after induced seizure, implying a role for 
these genes in effecting synaptic plasticity. Based on the observation by 
Stadler et al. (1994) that nitric oxide downregulates CYP activity, it 
might be interesting to determine whether Hctl expression levels are 
altered during LTP. 
As described in section 6.5, involvement of cytochromes P-450 such 
as Hctl in neurodegenerative disease is a possibility worthy of further 
investigation. Efforts are in progress to clone the human orthologue of 
Hctl, and to use the cDNA as a probe on human metaphase 
chromosome preparations. Once the chromosomal location of the 
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human gene is mapped, the position can be compared with the 
mapped loci of known human neurodegenerative diseases. 
The rat Hctl promoter may not prove to be useful for transgenic 
studies, as there is low level expression in brain regions outside the 
hippocampus. The precise level of this expression is still slightly 
ambiguous as the signal was close to background levels. Confirmation 
of the rat expression pattern will however require analysis of reporter 
gene expression patterns under the control of the isolated rat promoter 
in transgenic animals. To confirm the mouse Hctl expression pattern 
in the adult, during development, and thus assess its suitability as an 
Hct promoter, an attractive option would be to introduce a reporter 
gene into the Hctl locus. A dicistronic targeting vector, such as that 
described by Mountford et al. (1994), can be used to report chromosomal 
gene expression. This vector inserts a !acZ gene prefixed by a 
picornoviral Internal Ribosome Entry Site (IRES) to permit internal 
reinitiation of translation. The vector can be introduced into a defined 
genetic locus using homologous recombination in ES cells, resulting in 
a mouse expressing 13-galactosidase under the transcriptional control of 
the endogenous gene. This approach is dependent on expression of the 
gene in ES cells, and Hctl can be weakly detected in ES cells by 
Northern analysis (data not shown). The advantages of such a strategy 
are twofold: the endogenous expression pattern of Hctl is revealed, 
while the reporter gene insertion can result in inactivation of the gene 
product; deficits revealed by crossing such animals to homozygosity 
would shed light on the biological role of Hctl. 
The application of Hct promoters and their practical contribution to 
the understanding of hippocampal function encourages further 
characterisation of gene expression in the hippocampus. In addition to 
more refined versions of differential screens (see Chapter two), an 
alternative approach to the identification of Hct genes which is proving 
successful is the analysis of mice with gene trap insertions (for review 
see Joyner et al., 1992). Gene trap vectors contain a splice acceptor site 
upstream of a !acZ/neomycin fusion gene. Integration into a gene and 
correct use of the splice acceptor results in production of the fusion 
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protein in ES cells. Mice generated from these ES cells will bear a 
marker of expression of the endogenous gene. The analysis of 3-
galactosidase expression patterns in a number of gene trap lines has 
uncovered three expression patterns where lacZ staining is highly 
enriched in hippocampus (personal communication, Dr. M. Steel). One 
line is of particular interest as expression is largely restricted to the CA 
areas of the hippocampus with no staining apparent in the dentate 
gyrus. These mice may be additionally valuable as the lacZ insertion 
not only reveals the expression pattern but may also result in 
inactivation of the endogenous gene. 
There are also recently published reports of genes which may 
qualify as an Hct promoter. The recent cloning of a serotonin receptor 
which is expressed in the CAl of the rat hippocampus and the medial 
habenulae may be of potential use (Wisden et al., 1993; Erlander et al., 
1993). In the intact transgenic animal, effects on the habenulae must be 
considered, but isolated analysis on transgenic hippocampal slices 
would be possible. A recent abstract also reported a novel protein 
tyrosine kinase receptor which is expressed solely in the hippocampus 
of the adult mouse (Rogers et al., 1994). With further analysis of 
developmental expression patterns and expression levels, these genes 
may be of potential use as sources of Hct promoters. 
The development of transgenic technology, and more recently 
tissue-specific gene inactivation, necessitates the identification of 
promoters capable of directing defined expression patterns. In the 
understanding of hippocampus-dependent learning and memory, the 
use of such promoters to direct modified gene expression or gene 
inactivation to the hippocampus will contribute to an understanding 
of the biochemical and molecular mechanisms underlying memory 
formation. 
The identification and preliminary characterisation of Hctl in the 
hippocampus has raised a number of questions regarding Hctl function 
and its potential role in synaptic plasticity. A possible role in 
neurodegenerative conditions has also been proposed for Hctl. Indeed, 
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future experiments may lead to a greater understanding of cytochrome 
P-450 function in the brain. 
115 
CHAPTER SEVEN 
MATERIALS AND METHODS 
7.1 Materials 
Unless otherwise stated, all chemicals were of analytical grade, and 
supplied by BDH Laboratory Supplies or Sigma. Phenol saturated in 
Tris buffer was supplied by Fisons Bioscience (P/2318/05). Synthetic 
oligonucleotides were supplied by Oswel, Scotland. Ethanol was 
supplied by Hayman. Kodak XAR-5 X-ray film was supplied by H.A. 
West, Scotland. Radioisotopes were supplied by Amersham and New 
England Nuclear. 
Table 7.1: Standard Solutions 
EDTA 	 0.5 M Na2EDTA (pH 8.0) 
TE 	 10 mM Tris. Cl (pH 7.4), 1mM EDTA 
TAE 	 1X: 40 mM Tris-acetate, 1 mM EDTA 
TBE 	 1X:45 mM Tris-borate, 1 mM EDTA 
SM (phage storage) 100 mM NaCl, 10 MM MgSO4, 50 mM 
Tris. Cl (pH 7.5), 0.01% gelatin 
SSC 	 20X: 3 M NaCl, 0.3 M Na citrate 
Formamide 	98% formamide, 10 mM EDTA, 0.025% 
loading dye 	xylene cyanol FF, 0.025% bromophenol 
blue 
Non-denaturing 4 M urea, 50% sucrose, 50 mM EDTA, 
loading dye 	0.025% bromophenol blue 
116 
Computer software packages used for DNA and protein analyses were 
the DNAstar computer package and the University of Wisconsin 
Genetics Computer Group, (1991), GCG package version 7 (UWGCG). 
7.2 Methods 
Many of the methods described in this work were based on those 
described by Sambrook et al. (1989). 
7.2.1 General Cloning Techniques 
Restriction Digestion of DNA 
Restriction enzymes and buffers were supplied by Boehringer. The 
conditions recommended for DNA digestion by the Boehringer 
catalogue were generally followed. 
The products of DNA restriction digests were analysed by 
electrophoresis using agarose gels (Seakem LE agarose, FMC 
Bioproducts, 50004) at appropriate concentrations in TAE buffer. 
Precipitation of nucleic acids 
DNA or RNA was precipitated by the addition of a Oi volume 3 M 
sodium acetate (pH 5.2), followed by 2.5 volumes of -20°C ethanol. The 
mixture was held at -20°C for 30 minutes, and the nucleic acids pelleted 
by centrifugation, at 12,000g, 4 0C. Very small fragments of DNA (<200 
nucleotides) were precipitated as above, with the addition of 1 .t1 of 
salmon sperm DNA (20 mg ml -1 , Boehringer, 12463420). To remove 
trace amounts of salt remaining from the precipitation, the nucleic acid 
pellet was washed in 500 tl of 70% (v/v) ethanol, recovered by 
centrifugation, air dried, and dissolved in an appropriate volume of 
dH20 or TE buffer. 
(c) Dephosphorylation of linearised plasmid DNA 
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Removal of the 5' terminal phosphate groups of linearised plasmid 
DNA with identical termini was required to prevent recircularisation 
of the plasmid DNA in subsequent ligation steps. 
After restriction digestion of DNA, an equal volume of TE was added 
to the digested DNA. 
1 Unit of alkaline phosphatase (Boehringer, 713 023) was added 
directly, and incubated at 370C for 15 minutes. 
EDTA was added to a final concentration of 5 mM, and the 
phosphatase inactivated by heating the reaction mixture to 75 0C for 10 
minutes. 
An equal volume of phenol /chloroform was added, vortexed briefly, 
and centrifuged at 12,000g before recovering the aqueous phase. 
The DNA was ethanol precipitated (Section 7.2.1(b)) and resuspend 
inTE. 
Ligation of DNA fragments 
Generally 10 nmol of vector DNA was ligated to approximately 50 
nmol of insert DNA. A control ligation containing no insert DNA was 
always included to assess the extent of self-ligation. T4 DNA ligase 
(Boehringer, 716 359) was added in the presence of 66 mM Iris. Cl (pH 
7.5), 5 mM MgC12, 1 mM DTT, and 1 mM ATP. The reaction 
components were assembled fresh each time. The reaction was left to 
proceed overnight at 15 0C. 
Preparation of competent cells for E.coli transformation. 
Typically, the efficiency of transformation from such competent 
cells was 10 6 - 107/pg DNA. 
A fresh overnight culture of E.coli cells was diluted 1:100 in LB, and 
grown at 370C with shaking until mid-exponential phase (0D600 = 0.5). 
Cells were immediately chilled on ice. 
Cells were harvested by centrifugation at 3000g for 5 minutes at 4 0C. 
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A half volume of ice cold 50 mM CaC12 was added, and the cells 
gently resuspended by pipetting. The cells were left on ice for 20 
minutes, then harvested (as in step 3). 
A 1/10 volume of ice cold 50 mM CaCl2 was added, gently 
resuspending the cell pellet by pipetting. The cells were left on ice for 1-
2 hours before use. 
These cells could be frozen in 15% glycerol and stored at -70 0C. 
LB medium (per litre): 10 g tryptone (Difco, 0123-01-1) 
5 g yeast extract (Difco, 0127-01-7) 
5 g NaCI 
+1- 15 g agar (Difco, 0140-01) 
(f) Transformation of competent E.coli cells 
100-200 41 of competent cells were aliquoted into a sterile Eppendorf 
tube for each transformation. (Frozen competent cells were first thawed 
on ice). 
DNA was added to each transformation reaction, and left on ice for 
40 minutes. Typically, half of the ligation reaction (Section 7.2.1(d)) was 
used for each transformation. 
Cells were heat-shocked by placing at 370C for 2 minutes. 
The cells were returned to ice and 200 j.il of LB medium was added to 
each. The cells were incubated in a 37 0C shaking incubator for 0.5-1 
hour to allow the cells to express -1actamase and confer ampicillin 
resistance. 
Cells were spread onto selective medium. Unless specified, most 
plasmids used conferred ampicillin resistance. Thus 100 .tg/ml of 
ampidihin (Boehringer, 835 269) was added to each LB plate to select for 
transform ants. 
Transformants appeared after overnight incubation at 37 0C. 
7.2.2 Nucleic acids isolation 
(a) Preparation of plasmid DNA (small scale) 
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This method was appropriate for a 2-3 ml overnight culture. The 
resulting DNA could be used for sequencing directly. 
Cells from a 2-3 ml overnight culture were harvested in 1.5 ml 
Eppendorf tubes by centrifugation at 12,000g for 2 minutes. 
All traces of supernatant was removed by aspiration, and the cells 
resuspended in 100 jil 50 mM glucose, 10 mM EDTA (pH 8.0), 25 mM 
Tris. Cl (pH 8.0). 
200 pl of freshly prepared 0.2 M NaOH, 1% SDS was added, mixed by 
gentle inversion, and left on ice for 5 minutes. 
150 41 of cold 5 M potassium acetate* (pH 5.8) was added, then mixed 
gently. 
The mixture was centrifuged in a microfuge at 12,000g for 10 
minutes, and the supernatant recovered into a fresh Eppendorf tube. 
An equal volume of phenol/ chloroform was added, vortexed briefly, 
then centrifuged at 12,000g for 5 minutes. 
The aqueous phase was recovered into a fresh Eppendorf tube, and 
the DNA precipitated by adding 800 41 ethanol. After 5 minutes on ice, 
centrifuge at 12,000g for 5 minutes. 
The resulting pellet was resuspended in 50 jil of 10 jig/ml RNaseA 
(Sigma, R-5000) in TE, and incubated at 370C for 30 minutes. 
After RNase treatment, the plasmid DNA was purified by adding 30 
jil 20% PEG 8000, 2.5 M NaCl, and allowing to precipitate at 4 0C 
overnight (1 hour - overnight). 
The PEG mixture was centrifuged at 12,000g in a microfuge for 15 
minutes, and the pellet washed thoroughly with 2-3 changes of 70% 
ethanol. 
The pellet was dried, then resuspended in 20 jil TE. 
*5 M potassium acetate was prepared by dissolving 73.5 g of potassium 
acetate and 28.8 ml of acetic acid in water to a final volume of 250 ml. 
The resulting solution was 5 M with respect to acetate, and 3 M for 
potassium. 
(b) Preparation of Plasmid DNA (large scale) 
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Large scale purification of plasmid DNA was prepared from a 250 
ml bacterial culture grown in LB*.  A Qiagen Plasmid Purification Kit 
(Qiagen, 12162) was used to purify the plasmid DNA. 
Typically, 0.5-1 mg of plasmid DNA was recovered and was quantitated 
by absorbance at A. = 260 nm, assuming 1 O.D. Unit = 50 .tg/m1. 
*Terr ific  Broth, an enriched medium, was substituted for LB when the 
DNA inserted into the vector was very large and sometimes unstable. 
(see Sambrook et al., 1989) 
(c) Preparation of bacteriophage lambda DNA (small scale) 
To 0.6 ml of a phage liquid lysate, an equal volume of a DEAE-
cellulose slurry equilibrated with LB medium was added. (Phage lysate 
titre must be at least 1010  pfu/ml). 
The slurry and lysate were mixed by gently inverting the tube 20-30 
times. 
The DEAE-cellulose was removed by centrifugation in a microfuge at 
12,000g for 5 minutes. The supernatant was transferred to a fresh tube 
and centrifuged again to remove any remaining traces of DEAE-
cellulose. 
To 0.8 ml of the resulting supernatant was added 100 pi of 5 M NaCl 
and 540 p1 of isopropanol, then chilled at -20 0C for 20 minutes. 
The isopropanol precipitate was centrifuged for 5 minutes at 12,000g 
in a microfuge. 
The pellet was washed with 1 ml of 70% ethanol, then centrifuged 
for 5 minutes at 12,000g to remove all traces of supernatant. 
The pellet was resuspended in 200 j.il TE. 
An equal volume of phenol was added, and vortexed briefly. 
The mixture was centrifuged at 12,000g in a microfuge for 5 
minutes. 
The upper aqueous phase was transferred to a fresh Eppendorf tube 
containing 200 p.1 of phenol, and vortexed briefly. 
The mixture was centrifuged at 12,000g in a microfuge for 5 
minutes, and the upper aqueous phase recovered. 
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The DNA was ethanol precipitated, washed with 70% ethanol and 
air-dried (Section 7.2.1(b)). 
The pellet was resuspended in 20 p.1 of TE. This yielded enough 
DNA for one restriction enzyme reaction. 
Preparation of DEAE-cellulose (Whatman, 4057 050): 
DEAE-cellulose was suspended in several volumes of 0.05 M HCI. 
With stirring, 10 M NaOH was added to pH 6.8 The resin was left to 
settle, the supernatant decanted, then resuspended in LB. This was 
repeated until the pH is 6.8. The slurry was then resuspended in a final 
ratio of about 75% resin and 25% LB. 0.1% sodium azide was added and 
stored at 40C. 
(d) Preparation of Bacteriophage lambda DNA (large scale) 
500 ml of LB medium was inoculated with 1 ml from an overnight 
culture of an appropriate bacterial strain. The diluted culture was 
incubated at 370C with vigorous shaking until the culture had reached 
an 0D600 of 0.5. 
The culture was inoculated with 1010 pfu of a phage lysate. The 
incubation at 370C with shaking was continued until the culture had 
lysed. This was typically 3-4 hours. 
10 ml of chloroform was added, and the incubation at 370C with 
shaking continued for 10 minutes. 
The lysate was centrifuged at 4000 rpm for 5 minutes (Sorvall GS3) to 
remove the bacterial particulate matter. 
DNase (Boehringer, 104 159) and RNaseA (Sigma, R-5000)) were each 
added to a final concentration of 1 p.g/ml, and incubated at room 
temperature for 30 minutes. 
Solid NaCI was added to a final concentration of 1 M (29.2g/500ml). 
Once the NaC1 was dissolved, solid PEG 8000 was added to the lysate 
to a final concentration of 10% (wlv). The PEG was dissolved by 
swirling. 
The lysate was left at 4 0C overnight. 
The phage were pelleted by centrifugation at 11,000g for 15 minutes. 
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The phage pellet was resuspended in 5 ml of SM buffer by gentle 
pipetting, then centrifuged at 7500g for 15 minutes to remove debris. 
The supernatant was recovered, and layered carefully onto a CsC1 
step gradient (Figure 7.1). 
lysate 	A = 4.5 g CsCI in 10 ml SM (1.5 ml) 
B = 8.2 g CsC1 in 10 ml SM (1.5 ml) 
, Re'll 	C = 6.4 g CsCI in 5 ml SM (2.5 nil) 
Figure 7.1: CsCI step gradient 
The CsC1 gradient was centrifuged at 11,000g for 90 minutes at 4 0C 
in a Beckman 5W41 rotor. 
The resulting band of bacteriophage particles were recovered by 
puncturing the side of the tube with a 21 gauge needle. The phage band 
appeared at the interface of the first two layers as a bluish band. 
The phage particles were dialysed overnight in 10 mM NaCl, 50 mM 
Tris. Cl (pH 8.0), 10 mM M902. 
The dialysed phage were transferred to an Eppendorf tube. An equal 
volume of phenol was added to the phage and vortexed thoroughly. 
The mixture was centrifuged at 12,000g in a microfuge for 5 minutes, 
and the upper aqueous phase transferred to a fresh tube. This phenol 
extraction was repeated twice. 
After the third extraction, an equal volume of chloroform was 
added to the aqueous phase and vortexed thoroughly. 
The mixture was centrifuged at 12,000g in a microfuge for 5 
minutes. 
123 
The aqueous phase was recovered to a fresh tube. 
The phage DNA was hooked out of the aqueous phase by layering 2 
volumes of absolute ethanol onto the DNA solution, and, using a glass 
hook, spooling the DNA onto the hook as it mixed with the ethanol. 
The DNA-covered glass hook was snapped off into an Eppendorf 
tube containing 1 ml of TE. The DNA was allowed to dissolve by 
rotating the tube overnight at 4 0C. 
(e) Preparation of genomic DNA 
Fresh or frozen tissue was homogenised in guanidinium thiocyanate 
solution (see section 7.2.2 (g)) using an Ultra-Turrax T25 homogeniser 
at high speed for 1 minute. Generally, 0.5 g of tissue was homogenised 
in 10 ml of guanidinium solution. If the homogenate was too viscous, 
more guanidinium solution was added. 
The homogenate was gently mixed at room temperature for 
approximately 1 hour. The homogenate could be stored at 4 0C at this 
point. 
1 ml of the homogenate was layered at the bottom of 3 ml of ethanol. 
Using a glass hook made from a Pasteur pipette, the homogenate was 
looped up into the ethanol, allowing the genomic DNA to adhere to 
the glass. This was done repeatedly until the ethanol/guanidinium 
interface had disappeared. 
The tip of the hook with the DNA, appearing as white strands, was 
snapped off into an Eppendorf tube containing 500 jil of TE. 
The DNA dissolved into the TE by rotating the tube overnight at 
room temperature. Yields varied between amount and type of tissue. 
DNA was quantitated by absorbance at X = 260 nm, assuming 1 O.D. 
Unit = 50 .tg/ml. 
(f) General Considerations in the preparation of RNA. 
During the preparation and manipulation of RNA, all plasticware 
was sterile and glassware baked at 180 0 C. Gloves were used 
throughout, and all solutions were treated with 0.1% DEPC (Sigma D- 
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5758) and then autoclaved. Solutions containing Tris.Cl were not 
treated with DEPC. 
(g) Total RNA from mammalian tissues 
This method is based on that described in Chirgwin et al. (1979). 
Frozen or fresh tissue samples were homogenised in guanidinium 
thiocyanate solution, using a Ultra-Turrax T25 homogeniser at high 
speed for 0.5 - 1 minute. Usually, 0.25 - 0.5 g of tissue was homogenised 
in 6.ml of guanidinium solution per centrifuge tube. 
DNA in the homogenate was sheared by passing the homogenate 
through a 21G needle attached to a syringe several times. 
6 ml of 5.7 M CsCI, 10 mM EDTA was aliquoted into each centrifuge 
tube (Beckman polyallomer tubes, 331372), onto which was carefully 
layered the homogenate. 
Samples were centrifuged in a Beckman SW41 rotor for 15 hours, at 
30,000 rpm, at 150C. 
The supernatants were aspirated, firstly removing the interface, and 
then all the guanidinium phase. The clean' CsC1 was then removed 
until approximately 0.5 ml remained. The tubes were then inverted to 
drain. 
Once thoroughly drained, the tube was cut leaving the bottom part 
containing the RNA pellet. 
The RNA pellet was washed by gently adding 200 41 of 70% ethanol 
and then immediately inverting the tube. 
The RNA was briefly air-dried, then resuspended in 200p.l of 
guanidinium solution. This required a lot of pipetting to resuspend the 
RNA. 
The RNA was transferred to an Eppendorf tube containing 400 p.1 of 
isopropanol. Any remaining RNA was recovered by a second 200 p.1 of 
guanidinium solution, which, too, was added to the isopropanol. 
The precipitated RNA was washed with 70% ethanol, air-dried 
briefly, and resuspended in 400 p.1 of TE. 
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The RNA was added to an Eppendorf tube containing 400 .tl of hot 
phenol (650C). The mixture was incubated at 65 0C for 2 minutes with 
frequent vigorous vortexing. 
Samples were centrifuged at 12,000g for 5 minutes. The upper 
aqueous phase was transferred to a fresh tube containing 400 tl of 650C 
phenol, and the extraction repeated. 
After the second extraction, the aqueous phase was transferred to a 
fresh tube containing 400 j.tl of phenol/ chloroform at room 
temperature. The samples were vortexed thoroughly, and centrifuged 
at 12,000g for 5 minutes. 
The aqueous phase was transferred to a tube containing 400 t1 of 
chloroform at room temperature. Samples were vortexed thoroughly, 
and the aqueous phase recovered by centrifugation at 12,000g for 5 
minutes. 
The RNA was ethanol precipitated, washed in 70% ethanol, and air-
dried (Section 7.2.1(b)). 
The RNA pellet was resuspended in TE. Quantitation was by 
absorbance at ? = 260 ran, assuming 1 O.D. Unit = 40 jtg/ml. Yields 
varied depending on tissue type and amount. 
Guanidinium Thiocyanate Solution: 
4 M guanidinium thiocyanate (Fluka, 50990) 
25 mM sodium citrate 
10 mM N-lauryl sarcosine 
20 mM -rnercaptoethanol (Sigma stock is 14.2 M) 
a few drops of antifoam 
(h) mRNA isolation from mammalian tissues. 
mRNA from the hippocampus of rats or mice was extracted using 
the Fast Track mRNA isolation kit Version 3.1 (Invitrogen Cat. K1593-
02). 
For all other tissues described, the following mRNA isolation 
method was used. 
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Approximately 0.5 g of fresh or frozen tissue was homogenised for 
0.5 - 1.0 minutes at high speed using an Ultra-Turrax T25 homogeniser, 
in freshly prepared STE/SDS buffer containing 300 p.g/ml proteinase K 
(Sigma, P-0390). 
The proteinase K was predigested at 37 0C for 1 hour before use. 
The homogenate was incubated at 37 0C for 1-2 hours with occasional 
swirling. 
The NaCl concentration of the homogenate was adjusted to 0.5 M, 
followed by addition of 0.5 - 1.0 ml (packed volume) of pretreated oligo-
(dT)-cellulose (Boehringer, 808 229). 
The oligo-(dT)-cellulose was pretreated by suspending in 0.1 M NaOH, 
and rotating for 20 minutes at room temperature. The oligo-(dT)-
cellulose was then washed six times in DEPC-treated water. 
The homogenate was incubated at room temperature for 1 - 2 hours 
with vigorous shaking. 
The oligo-(dT)-cellulose suspension was centrifuged at 3000g for 5 
minutes, and the supernatant removed. 
The oligo-(dT)-cellulose was resuspended in 5 ml of prewarmed 
Binding Buffer by gentle shaking, then allowed to settle. 
The supernatant was applied to a pretreated Biorad 'Econo-column 
(731-1550), equilibrating the column to the high salt condition, and 
allowed to drain. 
The column was pretreated by filling with 0.1 M NaOH, allowing to 
drain, and then washing through with 6 volumes of DEPC-treated 
water. 
The oligo-(dT)-cellulose was resuspended in 1 ml of binding buffer 
and was applied to the column. 
A further 3 x 1 ml of binding buffer was applied to the column, 
draining inbetween each application. 
2 x 1 ml of prewarmed wash buffer was applied to the column, and 
allowed to drain. 
The RNA was eluted by applying 4 x 1 ml of elution buffer to the 
column, allowing the column to drain between applications. The 
eluate was collected into a tube containing 4 ml of phenol /chloroform. 
The eluate was gently mixed, then centrifuged at 3000g for 5 
minutes. 
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The upper aqueous phase was transferred to a tube containing 4 ml 
of chloroform, gently mixed, and centrifuged at 3000g for 5 minutes. 
The aqueous phase was transferred to a 15 ml corex tube containing 
400 tl of 3 M sodium acetate and 8.8 ml of ethanol. 
The RNA was precipitated overnight at -70 0C, recovered by 
centrifugation at 10,000 rpm (Sorvall, HB-4) for 30 minutes. 
The RNA pellet was resuspended in DEPC-treated water, and stored 
at -700C. The RNA was quantitated by absorbance at ?. = 260 nm, 
assuming 1 O.D. unit = 40 jig/mi. 
STE /SDS: 
0.1 M NaCl 
10 mM Tris. Cl (pH 7.4) 
1 mM EDTA 
0.5% SIDS 
Binding Buffer (prewarmed to 370C): 
0.5 M NaCl 
10 mM Tris. Cl (pH 7.4) 
1 mM EDTA 
0.1% SDS 
Wash Buffer (prewarmed to 37 0C): 
0.1 M NaCl 
10 mM Tris. Cl (pH 7.4) 
1 mM EDTA 
0.1% SDS 
Elution Buffer (prew armed to 65 0C): 
10 mM Tris. Cl (pH 7.4) 
0.1 mM EDTA 
0.1% SDS 
(i) Total RNA from yeast 
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This method is based on that of Mclnerny et al.(1994). 
25-50 ml cultures of mid-exponential stage of growth yeast cells were 
prepared and harvested by centrifugation at 3000g for 10 minutes in a 
50 ml Falcon tube. 
Each pellet was resuspended in 1 ml of sterile saline and transferred 
to an Eppendorf tube; cells were pelleted by centrifugation at 12,000g, 
and the supernatant discarded (cells could be stored at 70 0C at this 
stage). 
Cells were resuspended in 75 gl of STE. 
Hydrochloric acid-washed beads (425-600 micron, Sigma G-9268) were 
added to just beneath meniscus, and the cells briefly vortexed. 
600 j.tl of NTES was added, and the mixture briefly vortexed again. 
500 il of hot phenol (65 0C) was added, and the mixture immediately 
vortexed. 
The mixture was incubated at 65 0C for 5 minutes with frequent 
vortexing. 
The mixture was centrifuged for 1 minute at 12,000g, and the 
aqueous phase was removed to a second 500 jil aliquot of hot phenol. 
This was incubated at 65 0C for 2 minutes with frequent vortexing. 
The mixture was centrifuged for 1 minute at 12,000g, and again the 
aqueous phase was removed to a third 400 il aliquot of hot phenol. 
The mixture was incubated at 65 0C for two minutes with frequent 
vortexing. 
The aqueous phase was removed into 400 jil of phenol/ chloroform 
at room temperature, vortexed, and centrifuged at 12,000g for 1 minute. 
The aqueous phase was re-extracted with 300 itl of chloroform, 
vortexed, and centrifuged for 1 minute at 12,000g. 
Aqueous phase was ethanol precipitated (Section 7.2.1(b)). 
The RNA pellet was resuspended in 55 jil of ice cold DEPC water, 
and stored at -70 0C. 
Sterile saline: 0.9% (w/v) NaCl, autoclaved. 
STE: 	0.32 M sucrose 
20 mM Tris. Cl (pH 7.5) 
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10 mM EDTA (pH 8.0) 
0.5 mg/mi heparin (Sigma H-7005) added just 
prior to use. 
NTES: 	100 mM NaCl 
5 mM EDTA (pH 8.0) 
50 mM Tris. Cl (pH 7.5) 
1% (w/v) SDS 
0.5 mg/ml heparin added just prior to use. 
(j) Southern Blot 
This method was based on that described by Southern et al. (1975) 
After electrophoresis, the gel was stained in 0.5 p.g/ml ethidium 
bromide in dH20 for 30 minutes, after which the gel was destained in 
dH20 for the same time. 
The gel was photographed, and then denatured in 0.5 M NaOH, 1.5 
M NaC1 for 60 - 90 minutes. 
Following denaturation, the gel was neutralised in two changes of 1 
M Tris. Cl (pH 7.4), 1.5 M NaCl for 60 minutes each. 
The gel was rinsed briefly in 6XSSC, and then transferred by capillary 
blot (Figure 7.2) overnight. The membrane used in all transfers was 
Hybond-N (Amersham, RPN.303N). The transfer buffer was 20XSSC. 
After the transfer, the filter was rinsed briefly in 2XSSC, then baked at 










Figure 7.2: Construction of Northern or Southern Blot. 
(k) Northern Blot 
RNA samples were ethanol precipitated (Section 7.2.1(b)). 
The RNA samples were resuspended in 1xMOPS, 50% (v/v) 
formamide, 7% (v/v) formaldehyde and 1 p.g/ml ethidium bromide, 
and heated at 650C for 15 minutes. 
Formamide loading dye (Table 7.1) was added to each sample before 
being loaded onto a 1% agarose gel containing 1xMOPS and 7% (v/v) 
formaldehyde. 
The gel was electrophoresed for 2-3 hours at 1OV/cm, until the 
bromophenol blue was 12 -14 cm from the origin. 
After electrophoresis and photography, the gel was ready to blot 
directly. The capillary transfer of RNA to a Hybond-N (Amersham, 
RPN.303N) membrane was exactly the same as for DNA (see Figure 
7.2). 
10 x MOPS 0.4 M MOPS (pH7.0) 
100 mM sodium acetate 
10 mM EDTA (pH8.0) 
7.2.3 Radiolabelling of DNA 
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(a) Oligonucleotide-labelling of DNA fragments 
This method was from Feinberg and Vogeistein (1984). 
DNA fragments for radiolabelling were firstly excised from agarose 
gels. The DNA was purified using the Geneclean II kit (Bio 101, 3106). 
10-25 ng of DNA in a final volume of 31 .t1 of water was denatured by 
heating at 950C for 2 minutes. 
Tubes were placed on ice, then centrifuged briefly in a microfuge to 
collect the contents to the bottom. 
The following 50 uI reaction was assembled: 
DNA 	31p1 
"OLB" 10 iii 
10mg/mi BSA 2 jii (Boehringer, 711 454) 
a.-32P-dCTp 50 pCi (3000Ci/mmol) 
Kienow 	2 Units (Boehringer, 1008 412) 
The reaction was incubated at room temperature for 1-2 hours (up to 
overnight). 
The reaction was stopped by adding 0.1 M EDTA. 
Labelled DNA was purified from unincorporated a- 32P-dCTP using 
the spun column method. 
Solution A: 625 p1 2M Tris.Ci (pH8.0), 25 .fl  5M M902, 350 p1 
dH20, 18 p.1 3-mercaptoethano1, 5 p1 each of 0.1 M dATP, dTTP and 
dGTP 
Solution B: 2 M Hepes (pH 6.0). Store at 4 0C 
Solution C: Hexadeoxyribonucieotides (Pharmacia, 27-2166-01) 
evenly suspended in 3 mM Tris. Cl, 0.2 mM EDTA (pH 7.0) at 90 
O.D. units/mi. Store at -20 0C 
"OLB" is a mixture of solutions A, B and C in a ratio of 2:5:3. 
(b) T4 poiynucleotide kinase-labelling of 5' termini. 
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Oligonucleotides could be labelled directly using this method, 
however DNA fragments would first be dephosphorylated. 
10 pmoles of oligonucleotide was combined with 50 mM Tris.Cl 
(pH8.2), 10 mM MgCl2, 0.1 mM EDTA, 5 mM DTr, 0.1 mM spermidine 
(lOX buffer supplied by Boehringer), and 50 iCi of y- 32P-ATP (5000 
Ci/mmol). 10 Units of T4 polynucleotide kinase (Boehringer, 174 645) 
was added and incubated at 37 0C for 45 minutes. The kinase was 
subsequently inactivated by heating at 68 0C for 10 minutes. The 
labelled oligonucleotide was purified by ethanol precipitation with 10 
Vg of yeast tRNA (Section 7.2.1(b)), and resuspended in 100 p1 of dH20. 
(c) Terminal Transferase tailing of 3' termini. 
This method was used to label oligonucleotides with a tail of 35S for 
in situ hybridisation. 
10 ng of oligonucleotide was tailed in a 20 t1 reaction. The following 
were added in order: 
3j.tldH2O 
2 p1 oligonucleotide (0.5 - 1.0 nmol) 
4 tl 5X terminal transferase buffer (supplied by Boehringer) 
6 p1  5 MM  C0C12 
25 Units terminal transferase (Boehringer, 220 582) 
40 pCi a-35S-dATP (1000 Ci/mmol) 
The reaction was incubated at 37 0C for 1 hour. 
80 p1 of TE and 20 pg yeast tRNA were added to quench the reaction. 
100 p1 of phenol /chloroform was added, vortexed briefly, then 
centrifuged at 12,000 g in a microfuge for 5 minutes. 
The upper aqueous phase was transferred to a screw-capped 
microfuge tube containing 10 p1 3 M sodium acetate and 250 p1 of 
absolute ethanol. 
The labelled oligonucleotide was precipitated, washed in 70% 
ethanol and dried (Section 7.2.1(b)). 
The labelled oligonucleotide was resuspended in 50 p1 TE*. 
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* If the labelled oligonucleotide was to be used for in situ hybridisation, 
the TE for resuspension contained 10 mM DTF. 
7.2.4 Hybridisation Conditions. 
Hybridisation conditions used were based on those described by 
Church and Gilbert (1984). 
Filters were pre-wet in 2XSSC. 
The hybridisation was performed in a rotating glass cylinder (Techne 
Hybridiser ovens). 10 ml of Hybridisation Buffer was added to the 
cylinder with the filter. 
Prehybridisation and hybridisation were carried out at 68 0C unless 
otherwise specified. 
The filters were prehybridised for 30 minutes, after which the probe 
was added directly and hybridisation proceeded overnight. (Double-
stranded probes were denatured by boiling for 2 minutes, then placing 
on ice). 
Washes were performed at 68 0C (unless otherwise stated) with 2 
changes of Wash Buffer I for 10 minutes each, followed by three 
changes of Wash Buffer H each for 20 minutes. 
The filters were blotted dry, but not allowed to dry out, then placed 
between Saran wrap, and against X-ray film for autoradiography. 
Hybridisation Buffer: 
0.25 M sodium phosphate pH 7.2 
1 mM EDTA 
7% SDS 
1% BSA 
Wash Buffer I: 




1 mM EDTA 
Wash Buffer H: 
20 mM sodium phosphate pH 7.2 
1 mM EDTA 
1% SDS 
7.2.5 Screening of Bacteriophage lambda libraries. 
The rat hippocampus cDNA library was oligo-(dT)-NotI primed and 
cloned in lambda ZAP II (Stratagene) with an EcoRI adaptor at the 5' 
end, and was prepared in the lab by Miss M. Richardson and Dr. I. 
Mason. 
The mouse liver cDNA library was oligo-(dT)-primed and cloned 
into lambda gtlO with EcoRl/NotI adaptors, and was a gift from Dr. B. 
Luckow, Heidelberg. 
The mouse ES cell genomic library was cloned from a partial Sau3A 
digest into lambda DASH II (Stratagene), and was a gift from A. 
Reaume, Toronto. 
A 1:50 diluted culture of an appropriate bacterial strain was grown to 
mid-log phase (0D600 = 0.5) in LB supplemented with 0.2% maltose 
and 10 MM MgSO4. 
The cells were chilled on ice, harvested by centrifugation in a screw-
capped Falcon tube at 3000g for 5 minutes, then resuspended in 0.5 
volume of ice-cold 10 mM MgSO4. 
600 i11 of cells were infected with 50,000 recombinant phage (diluted 
in SM), incubating at 370C for 15 minutes. 
10 ml of 0.7% agarose in LB, supplemented with 10 mM MgSO4 
(melted and warmed at 450C) was added. The tube was inverted slowly 
to mix, and then poured evenly over a dried LB/agar plate (15 cm 
diameter). 
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Once the top layer was set, the plates were inverted and incubated at 
370C until the appearance of plaques in the bacterial lawn. This time 
varied between 7 - 10 hours. 
The plaques were grown until they were touching each other but not 
confluent. The plates were then chilled. 
Replica lifts of the phage were made by layering a piece of Hybond-N 
nylon membrane (Amersham RPN.132N) onto the plaques for 1 
minute. The orientation of the filter was marked. The second lift was 
layered on to the plaques for 2 minutes, and the same orientation 
marked. 
The filter was lifted off carefully with forceps and placed in 0.5 M 
NaOH, 1.5 M NaCl for 4 minutes. 
The filters were neutralised in 1 M Tris. Cl (pH 7.4), 1.5 M NaCl for 4 
minutes. 
The filters were washed briefly in 2XSSC and then air-dried, before 
baking for 2 hours at 80 0C. 
The filters were then hybridised with the selected probe (Section 
7.2.4). 
In vivo excision of pBluescript from lambda ZAP II vector was 
performed using the ExAssist/SOLR system (Stratagene, 200253). 
7.2.6 Dideoxy-termination sequencing of double-stranded DNA 
templates. 
Approximately 2 'g of uncut plasmid DNA was denatured by 
incubating in 200 mM NaOH for 5 minutes at room temperature. The 
DNA was precipitated with 1/5 volume of 10 M ammonium acetate 
and 4 volumes of absolute ethanol at 20 0C for 15 minutes. 
The DNA precipitate was washed with 1 ml of 70% ethanol, dried 
and resuspended in 7 p.1 of water. 
The sequencing reactions were prepared using the Sequenase 
Version 2.0 kit (USB, 70770). 
Products were electrophoresed through a 0.2 mm 6% denaturing (i.e. 
8M urea) acrylamide gel in TBE. 
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After electrophoresis, the gel was soaked in 10% methanol, 10% 
acetic acid for 10 minutes to leach out the urea and to fix the DNA. The 
gel was dried at 80 0C under vacuum. 
Sequencing products were visualised by autoradiography using 
Kodak XAR-5 film. 
To sequence the full length of a DNA insert, nested deletions in the 
inserted DNA were made using the Erase-a-Base System (Promega, 
E5750), with the following modifications: 
Before the ligation to circularise the deletion-containing vectors, the 
deleted DNA was purified by agarose gel electrophoresis, and the 
excised DNA purified using GeneClean. This was found to increase the 
proportion of the correct size deletion. 
In each case, Bluescript II (KS and SK) were used. The restriction 
sites in the polylinker used for Exonuclease Ill-sensitive and 
-insensitive cleavage were Sail and KpnJ respectively. 
Competent XL1 blue cells (Section 7.2.1(e)) were used for the 
transformation. 
7.2.7 In situ hybridisation 
Frozen 10 t coronal sections of rat and mouse brains were provided 
by Dr. M. Steel. 
(a) Preparation of frozen sections for in situ hybridisation 
All manipulations were carried out at room temperature. All 
solutions were 0.1% (v/v) DEPC-treated and autoclaved. Microscope 
slides were placed back-to-back in Coplin jars, with the following 
solutions poured on or off for each step. For each step, 30-35 ml of each 
solution per Coplin jar was required. 
Sections were fixed in 4% (w/v) paraformaldehyde in PBS for 10 
minutes. 
Sections were rinsed in two changes of PBS for 5 minutes. 
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Sections were proteinase K treated by immersing in 20 tg/ml 
proteinase K in 50 mM Tris. Cl (7.4), 5 mM EDTA for 5 minutes. 
Sections were rinsed in PBS for 5 minutes. 
Sections were fixed again in 4% (w/v) paraformaldehyde in PBS for 
10 minutes. (The same solution was reused from step 1). 
Sections were rinsed in water for 5 minutes. 
The sections were acetylated by placing in 0.25% (v/v) acetic 
anhydride* for 10 minutes. 
The sections were rinsed briefly in PBS. 
The sections were rinsed in saline for 5 minutes. 
The sections were dehydrated by passing through each of the 
following ethanol concentrations: 
30% ethanol, for 1 minute 
50% ethanol, for 1 minute 
70% ethanol, for 5 minutes 
85% ethanol, for 1 minute 
95% ethanol, for 1 minute 
100% ethanol, for 1 minute 
100% ethanol, for 1 minute. 
Sections were immersed in chloroform for 5 minutes, rinsed briefly 
in two changes of absolute ethanol, and a final rinse in 95% ethanol. 
The slides were removed from the Coplin jars and allowed to air 
dry before hybridisation. 
Paraformaldehyde: 	PBS was heated to 65 0C on a stirrer, then the 
paraformaldehyde was added to 4% (w/v). 5 M 
NaOH was added to help the paraformaldehyde 
to dissolve (approximately 5 drops). Once in 
solution, the solution was cooled to room 
temperature and adjusted to pH 7.4 with 
concentrated HCI. 
Saline: 0.8% (w/v) NaCl 
Acetic anhydride: 0.25% (v/v) was added to 0.1 M triethanolamine in 
0.8% (w/v) NaCl. 
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*(Acetic  Anhydride is very unstable and was made 
as close to usage time as possible). 
(b) Hybridisation Conditions 
All probes were oligonucleotides which were labelled by 
homopolymer tailing using a-35S-dATP and terminal transferase as 
described (Section 7.2.3 (c)) 
The sequences or references of the oligonucleotides used as probes 
for in situ hybridisation were as follows: 
rat Hctl (a 45-mer, beginning 26 nt 5' from the polyA tail, nucleotides 




mouse Hctl (nt 1558-1599) (also see Figure 4.3) 
5'ATCACGGAGCTCAGCACATGCAGCCTFACTCTGCAAAGCTFC3' 
rat clone 13 (a 42-mer, beginning 112 nt 5' from polyA tail) 
5'-TATATCCATACCAACTTATTGGGAGTCCCATCCTACCTCATCA 
GC-3' 
rat/mouse muscarinic receptor Ml (Buckley et al., 1988) 
rat/mouse opsins (Nathans et al., 1986) 
The prepared 35S -tailed probe (resuspended in 10 mM DIT in TE) 
was diluted to 2 x 10 6 cpm/ml in hybridisation buffer. DTT is also 
added to this mixture to a final concentration of 50 mM. 
100 p.l of the probe mixture was carefully layered onto each 
microscope slide. A piece of parafilm cut to the size of the microscope 
slide was then layered over the probe mixture, allowing the probe and 
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hybridisation mixture to cover all the sections. Air bubbles under the 
parafilm were avoided. 
The slides were placed in a humidified container, sealed, and 
incubated at 370C overnight. 
After hybridisation, the parafilm was carefully removed using 
forceps. 
The slides were placed back in Coplin jars, and the hybridised 
sections washed in four changes of 1XSSC for 15 minutes at 55 0C or 
60 0C, and then two changes of 1XSSC for 30 minutes at room 
temperature. 
The slides were rinsed briefly in dH20, then left to air dry. 
Hybridisation Buffer * : 
4XSSC 
50% (v/v) deionised formamide 
10% (w/v) dextran sulphate 
1X Denhardt's solution 
0.1% (w/v) SDS 
500 jig/ml ssDNA 
250 jig/ml yeast tRNA 
*buffer was de-gassed before use 
(c) Autoradiography 
Detection of hybridisation signals was by autoradiography. Slides 
were placed against Kodak XAR-5 film for 2-7 days for a low resolution 
image. For a high resolution image, a photographic liquid emulsion 
(LM-1, Amersham RPN.40) was used. All manipulations were carried 
out under safelight conditions. 
The emulsion was melted by placing in a 43 0C water bath. 
Once melted, the emulsion was poured into a dipping vessel. 
Blank microscope slides were first dipped into the emulsion until no 
bubbles could be seen on the slides. 
Each test slide was dipped evenly into the emulsion vertically for 1-2 
seconds. 
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Slides were withdrawn from the emulsion, allowed to drain briefly 
then the back of each wiped with a tissue to remove excess emulsion. 
The slides were laid flat to dry. 
Once dry, the slides were laid flat in a container containing silica gel, 
and left at room temperature overnight. 
The slides were transferred into a plastic slide box containing more 
silica gel, and sealed with tape. The box was covered with two layers of 
aluminium foil and stored at 4 0C for exposure. 
When ready for developing, the emulsion-dipped slides were 
brought back to room temperature. 
Hybridised sections were placed in D19 developer (Kodak, 502 7065) 
for 2 minutes, then transferred to 1% (v/v) acetic acid, 1% (v/v) 
glycerol for 1 minute, then to 30% (w/v) sodium thiosulphate for 2 
minutes. 
The sections were finally washed in a large volume of running 
water for 10 minutes. 
(d) Counterstaining and Mounting of Sections. 
While the sections were still wet, the slides were placed in 1.0% 
(w/v) methyl green stain (Sigma, M-8884), and stained for 1-2 minutes. 
The sections were briefly rinsed in water to remove excess stain and 
left to air dry. 
Sections were mounted in DePeX (BDH, 36125), and covered with a 
glass coverslip. 
7.2.8 Transformation of Yeast 
This method was from Dr J. Tsang, Dundee. 
A 100 ml culture (2-6 x 10 6 /ml) of budding yeast cells grown in YEPD 
was prepared. The cells were harvested by centrifugation at 3000g for 5 
minutes and washed in TE. 
The cells were resuspended in 0.1 M lithium acetate in TE to a 
concentration of approximately 5 x 108 /ml, and left to shake in a 30 0C 
incubator for 1 hour (1-24 hours). 
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To 100 t1 of competent cells, 40-80 pg carrier DNA, and 0.1-5 j.tg of 
plasmid DNA was added in a 10 id volume. 
Cells were incubated at 300C for 30 minutes. 
0.7 ml of 40% PEG 4000 in 0.1 M lithium acetate was added, and the 
cells incubated for 30 minutes (0.5-2.5 hours). 
Cells were heat-shocked at 42 0C for 15 minutes. 
The cells were collected by centrifugation at 5000g in a microfuge for 
45 seconds, and then washed twice with TE. 
The cells were resuspended in 100-200 pl TE, and plated onto 
selective medium. 
Transformants appeared after 3-5 days incubation at 30 0C. 
YEPD: 2% glucose 
1% peptone 
1% yeast extract 
7.2.9 Preparation of yeast total protein extract 
This method was from Mclnerny et al. (1994). 
25-50 ml cultures of yeast cells in mid-late exponential stage of 
growth were harvested by centrifugation at 3000g for 5 minutes. 
The cell pellet could be frozen at -70 0C. Cell pellets were resuspended 
in 100 pl of lysis buffer in Eppendorf tubes. Acid washed glass beads 
(425-600 micron, Sigma G-9268) were added to just below the meniscus. 
Cells were broken by vigorous vortexing: 15 minutes of 30 seconds, 
with 30 second intervals on ice. 
Cell walls were pelleted by 5 minute centrifugation at 12,000g. 
Supernatants were transferred to another Eppendorf tube, and the 
protein extract clarified by centrifugation at 12,000g for 30 minutes at 
4°C. 
Supernatants were transferred to a fresh Eppendorf tube. Samples 
were snap-frozen on solid CO2 and stored at -70 0C. 
Lysis buffer: 
50 mM KC1 
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50 mM Tris. Cl (pH 7.4) 
25% (v/v) glycerol 
2 mM DTT 
0.1% (v/v) Triton X-100 
25 pg/ml chymostatin (Sigma, C-7268) 
25 .ig/rn1 antipain (Sigma, A-6271) 
25 pg/ml leupeptin (Sigma, L-2884) 
25 p.g/ml aprotonin (Sigma, A-6279) 
25 .ig/ml pepstatin (Sigma, P-4265) 
0.2 mM pefabloc (Boehringer, 1429 868) 
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APPENDIX I CYTOCHROME P-450 EXPRESSION OR ACTIVITY IN BRAIN 
P-450 SPECIES EXPRESSIQN METHOD 
CYP1A rat increase after partial Western 
hepatectony 
CYPIAI rat brain RT-PCR 
CYP1A2 rat glioma cell line (C6) RT-PCR 
CYP2A1 rat glioma cell line (C6) RT-PCR 
CYP213I rat brain RT-PCR 
mouse spinal cord, medulla oblongata, Immunohistochemistry 
pons, cerebellum, dorsal raphe nuclei, 
hippocampal pyramidal cells 
CYP2132 rat brain RT-PCR 
CYP2131/2 rat induced in brain upon chronic Western 
nicotine administration 
CYP2C6 rat ethanol-induced RT-PCR 
olfactory bulb 
CYP2C7 rat glioma cell line (C6) RT-PCR 
rat ethanol-induced brain Western 
CYP2CII rat ethanol-induced brain Western 
REFERENCE 
Warner et al., 1993 
Hodgson et al., 1993 
Geng and Strobel, 1993 
Geng and Strobel, 1993 
Hodgson et al., 1993 
Volk et al., 1991 
Hodgson et al., 1993 
Anandatheerathavarada et al., 1993 
Zaphiropolous and Wood, 1993 
Geng and Strobel, 1993 
Warner et al., 1994 
Warner et al., 1994 
CYP2CU rat ethanol-induced RT-PCR 
olfactory bulb 
CYP2Cl2 rat ethanol-induced RT-PCR 
olfactory bulb 
CYP2C23 rat ethanol-induced RT-PCR 
olfactory bulb 
CYP2C rat increase after partial Western 
hepa tectomy and ethanol induction 
CYP21D rat brain RT-PCR 
CYP2134 rat cerebral cortex RT-PCR 
CYP2D6 rat brain ? 
CYP2EI rat glioma cell line (C6) RT-PCR 
rat brain RT-FCR 
rat basal ganglia Immunohistochemistry 
cerebellar cortices 
ethanol induction: 
basal ganglia (increase) 
cerebellar cortices (increase) 
substantia rtigra 
hippocampus 
rat ethanol-induced brain Western 
Zaphiropolous and Wood, 1993 
Zaphiropolous and Wood, 1993 
Zaphiropolous and Wood, 1993 
Warner et al., 1993 
Hodgson et al., 1993 
Komori, 1993 
Wolf (pers. comm.) 
Geng and Strobel, 1993 
Hodgson et al., 1993 
Sohda et al., 1993 
Warner et al., 1994 
CYP2EI rat neurons and glia Inimunohistochemistry Harisson et al., 1990 
neocortex, olfactory bulb, piriform 
cortex, several thalamic nuclei, 
cerebellum (exclusively glial) 
hippocampal pyramidal cells 
striatum, substantia nigra, brain stem 
CYP4A2 rat cerebral cortex RT-PCR Stromstedt et al., 1994 
hypothalamic preoptic area 
cerebellum 
brainstem 
CYP4A3 rat cerebral cortex RT-PCR Stromstedt et al., 1994 
hypothalamic preoptic area (cant detect 
cerebellum by Northern) 
brainstem 
rat ethanol-induced brain Western Warner et al., 1994 
CYP4A8 rat cerebral cortex RT-PCR Stromstedt et al., 1994 
rat ethanol-induced brain Western Warner et al., 1994 
CYP4A rat 10-fold increase in hypothalamic Western Warner et al., 1993 
preoptic area and olfactory lobes 
during lactation/ pregnancy 
rat Increase after partial hepatectomy Western Warner et al., 1993 
and ethanol induction 
Hctl rat hippocampus in situ hybridisation Stapleton (thesis, 1994) 
(CYP7B?) 
CYP19 	rat 	preoptic area 	 RNase protection 
medial basal hypothalamus 
amygdala 
hippocampus 
rat 	intense staining in amygdaloid 	Immunocytochemistry 
structures and supraoptic nucleus 
moderate - light staining in paraventricular 
and arcuate nuclei and hippocampus 
Abdelgadir et al., 1994 
Sanghara et al., 1991 
P450 spectral activity detected in human brain: highest activity detected in brain stem 
and cerebellum; lowest in striaturn and hippocampus 
Mouse hepatic P450s (liver microsome membrane preparation) can metabolise brain 
anandamide (a brain constituent which binds to the cannabinoid receptor)to at least 
10 different metabolites 
P-450-mediated activity (rat brain microsornal fractions) results in 6-alpha and 7-alpha 
hydroxylations of the steroid anaesthetic 3a-hydroxy 5a-pregnan-20-one 
Catechol estrogen-forming enzyme activity in brain is inhibited by cytochrome P-450 inhibitors 
Bharmre et al., 1993 
Bornheim et al., 1993 
Stromstedt et al., 1993 
Paul et al., 1977 
This summary is not exhaustive and is possibly biased as in each case, detection of a specific P450 was addressed only with 
the available probes or antibodies. In addition, some discrepancies were noted in expression detected in different species 
and in different methods used (CYP2BI expression was detected in rat brain by PCR (Hodgson et al., 1993)but not by 
Western blot (Warner et al., 1994), while a spatially regulated pattern of cyp2b-1 protein was reported in a separate study 
in mouse brain (Volk et al., 1991). 
APPENDIX II CELL TYPE-SPECIFIC INTERACTIONS OF 
TRANSCRIPTION FACTORS WITH A HOUSEKEEPING PROMOTER IN 
VIVO 
The work contained in Appendix II represents that conducted over 
the first eighteen months of this four year Ph.D. As this has not 
contributed to the main project presented in the thesis and is not 
connected to or continued in the main project, it has not been presented in 
full detail. This work was performed under the supervision of Dr. Patrizia 
Lavia, a visiting fellow, and Dr. Patrizia Somma from Centro di Genetica 
Evoluzionistica del CNR, Universita La Sapienza" (Rome, Italy). The 
project was discontinued at the Centre for Genome Research on the 
departure of Dr. Lavia. 
Housekeeping genes comprise a subset of genes which have 
particular regulatory requirements and most likely differ from tissue-
specific genes in the mechanisms used to initiate and maintain 
transcription. Housekeeping genes for the most part are constitutively 
expressed in all cell types and through all stages of development. 
Structurally, housekeeping promoters usually lack a canonical TATA box 
and are invariantly associated with CpG islands. It has been shown that 
other mechanisms exist for the initiation of transcription from TATA-less 
promoters; other elements appear to specify the transcription start site (for 
example, Smale and Baltimore, 1989). 
The mouse CpG island, Htf9, contains a promoter region 
responsible for the expression of two divergently transcribed genes which 
are expressed in all cell types tested (Lavia et al., 1987). In previous studies 
using in vitro protein binding studies and deletion assays, an extensive 
analysis of this promoter revealed two important points of interest: firstly, 
Htf9 contains several potential sites for transcription factor interaction, 
however only a subset of these are required to drive expression of a 
reporter gene (Somma et al., 1991a); secondly, there appears to be tissue-
specific differential usage of transcription factors by the promoter, 
depending on the availability of transcription factors supplied by that cell 
type (Somma et al., 1991b). Both findings suggested a mechanism of 
redundancy to ensure transcriptional activation in all cell types. 
To test this hypothesis, protein interactions at the Htf9 promoter 
were assessed in vivo by genomic footprinting, using ligation-mediated 
PCR (Mueller and Wold, 1989). In vivo footprinting permits protein 
binding sites to be indentified in the context of modulatory factors such as 
chromatin structure and DNA methylation. In contrast, in vitro analyses 
such as gel retardation, transcription using nuclear extracts and 
transfection experiments rely on the use of cloned DNA segments. Thus 
in vivo genomic footprinting offers perhaps the most reliable 
understanding of protein-DNA interactions within a cell. A number of 
different cell lines of different origins and differentiation states were used 
to examine the transcription factor occupancy of Htf9. 
The procedure followed for genomic footprinting is summarised: 
Cells were exposed to a DNA modifying agent (dimethyl sulphate) 
which methylates guanine residues except where access is blocked by the 
presence of a bound protein. 
Genomic DNA was prepared, followed by piperidine cleavage at every 
modified base. 
- cleaved genomic DNA 
- 	 extension reaction using 
- 	 genomic primer 
- I 	ligation of common linker 
- PCR with nested primer 
and linker sequence 
A summary of ligation-mediated PCR. 
Ligation-mediated PCR then requires a DNA polymerase-mediated 
extension reaction from a primer specific for Htf9 extending up to each 
cleavage point to create a double-stranded blunt molecule. 
At the unknown blunt cleavage point, a double-stranded linker is added 
by ligation, creating a segment of DNA which can now be amplified by 
conventional polymerase chain reaction, using a nested genomic primer 
and a primer based on the linker sequence. 
The amplified products are fractionated on a sequencing gel, followed by 
electro-transfer of the DNA to a membrane and probing with the cloned 
sequence. Footprints are visualised as a disappearance of bands 
corresponding to occlusion of DMS by template-bound proteins and quite 
often the appearance of hypersensitive bands at the borders of footprints. 
In vivo footprinting confirmed the differential occupancy of the 
Htf9 promoter in different cell types. A footprint which overlaps one of 
the transcription start sites was detected in all cell types except an 
embryonic stem cell line, cpl, which was subsequently shown not to 
express the factor (designated GBF). A protection over a CCAAT box was 
detected only in an hepatic cell line but in none of the others tested. 
Fibroblasts and a neuroblastoma cell line utilise two high affinity Spi sites 
to maintain transcription, the neuroblastoma cell line showing an 
additional protection over an APi element. A previously undetected 
interaction was revealed using in vivo footprinting, present in all cell 
types except embryonic stem cells. This occupied site corresponds to an E2F 
site. Full details are presented in Stapleton et al. (1993); appended. 
Clearly the maintenance of ubiquitous expression of the Htf9 
transcripts relies on a combination of the available transcription factors 
supplied by different cellular environments. Questions raised from this 
work focus on the possible identification of GBF as a novel initiator' 
factor for TATA-less housekeeping promoters and the role of E2F in the 
regulation of one of the Htf9 transcripts, Htf9-a. Preliminary results from 
Lavia and colleagues show that Htf9-a expression and E2F occupancy of the 
promoter is associated with cycling cells, while H ff9-a is under the 
negative control of the retinoblastoma gene product in quiescent cells 
(unpublished). 
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ABSTRACT 
Mammalian housekeeping promoters represent a class 
of regulatory elements different from those of tissues-
specific genes, lacking a TATA box and associated with 
CG-rich DNA. We have compared the organization of 
the housekeeping Htf9 promoter in different cell types 
by genomic footprinting. The sites of in vivo occupancy 
clearly reflected local combinations of tissue-specific 
and ubiqitous binding factors. The flexibility of the Htf9 
promoter in acting as the target of cell-specific 
combinations of factors may ensure ubiquitous 
expression of the Htfg-associated genes. 
INTRODUCTION 
Over 10.000 genes in higher eukaryotes are thought to encode 
proteins with 'housekeeping' functions, which are required for 
survival, growth and duplication of all cells. Such genes are active 
in all developmental stages and tissues, despite the differences 
in the transcriptional apparatus of different cell types. Mammalian 
housekeeping promoters lie within 1 —2 kb CG-rich DNA 
stretches (1-2), exceeding by far the average promoter size. 
Functional studies indicate that they represent a class of regulatory 
elements distinct from those of tissue-specific genes. An obvious 
difference is the absence of the TATA box, which results in 
heterogeneous transcription initiation (1) often on both DNA 
strands (3-5). On the other hand, elements that are potential 
targets of factors with CG-rich recognition sequences (such as 
SpI, AP2, MLTF or E2F) occur frequently. 
The mouse 1-1(19 locus contains a typical housekeeping promoter 
(3) shared by two genes, Htf9a and H(19c, that are transcribed 
from complementary DNA strands in opposite directions. Both 
genes are evolutionary conserved, and their expression in all 
tissues and cell lines suggests that they both encode proteins with 
basic functions (6). The Htf9a gene is the mouse homolog of 
a novel yeast gene (SF01) recently identified in a search for 
mutations suppressing the mating deficiency of fis1 mutants, 
which are defective in cell fusion (J.Trueheart and J.Thorner, 
manuscript in preparation). The product of the H(J9c gene remains 
unidentified. 
In a previous study the HtJ9 promoter was characterized by 
combining protein-binding and deletion mapping assays (7. 8). 
* To whom correspondence should be addressed  
The results indicated two novel features of this promoter. Firstly, 
we identified multiple factor-binding sites resulting in a complex 
architecture, yet only a subset was required for expression of 
a reporter gene in both orientations (7): thus the Htj9 promoter 
elements were redundant. This characterization is consistent with 
results obtained from deletion analysis of unrelated housekeeping 
promoters (5, 9-12). whose transcriptional activity is also 
confined to short DNA fragments. Secondly, alternative promoter 
elements were required for activity in different cell types (8). 
We have hypothesized that different elements are trans-activated 
in a cell-specific manner by factors varying from type to type: 
thus, the apparent redundancy of binding sites might in fact 
provide the structural basis for ubiquitous expression. 
To assess this hypothesis we have examined the organization 
of the nativeH(19 promoter in different cells by genomic 
footprinting. The results presented here show that the interactions 
between factors and single HtJ9 elements in vivo differ in cell 
lines of different origin and with different levels of specialization. 
This gives rise to different combinations, involving both 
ubiquitous and cell-specific factors, which are assembled in a 
cell type-specific manner. 
MATERIALS AND METHODS 
Cell lines 
The following cell lines were used: mouse C3H/10 T 1/2 (ATCC 
CCL 226) and NIH/3T3 fibroblasts (ATCC CRL 1658), rat C6 
glioma (ATCC CCL 107), mouse S-20Y neuroblastoma (13), 
rat H4-11-E-C3 hepatoma (ATCC CR1 1600) and human HepG2 
hepatocyte carcinoma cells (ATCC HB 8065). Cells were grown 
in D-MEM medium supplemented with L-glutamine and 10% 
fetal calf serum under 5% CO2 . Growth conditions for the 
embryonic stem cell line CPI and inhibition of differentiation 
with differentiation inhibitory activity (DIA/LIF) were described 
in (14). 
Gel-shift assays 
Protein extracts were prepared following published methods (15, 
16). Gel shift assays were carried out as previously described 
(7, 8) using routinely 1. 10 cpm of end-labeled probe and I jug 
of double-stranded poly (dI.dC) as a non-specific competitor. 
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In vivo footprinting 
The protocol for genomic footprinting using ligation-mediated 
PCR (LM-PCR) (17) was kindly provided by G. Pfeiffer and 
generally followed. Cell monolayers were exposed to dirnethyl 
sulfate (DMS) concentrations ranging from 0.05% to 0.5%. In 
most experiments the effective concentrations fell between 0.1 
and 0.3%. Following exposure to DMS cells were collected and 
DNA extracted by standard methods. After piperidine cleavage 
the DNA was processed for LM-PCR. To circumvent 
compressions or stops in regions of high guanine content, 
Sequenase was replaced with Taq polymerase in the extension 
step and the temperature was raised to 74°C. PCR-amplified 
products were run on 60 cm gradient gels and electroblotted onto 
GeneScreen (Dupont) membranes (18). DNA was UV cross-
linked under a 30 Watt lamp from a 80 cm-distance. Single-
stranded probes were prepared by primer extension using 4 g 
of pH9.2 plasmid containing H1J9 annealed to 0.5 pmol of the 
appropriate primer, in the presence of 100 JLM dNTPs, 50 tCi 
of c-32P-dCTP and Sequenase. Filters were hybridized and 
washed as described in (18). In experiments with whole tissues 
and DNAse I as the cleaving agent nuclei were isolated through 
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Figure 1. A. Map of the H(J9 locus, showing the arrangement of the first exons 
of the Hj9a (remaining exons are not located) and Ht/9c genes. Major 
transcriptional start sites (TS) of both genes are arrowed. B. The bidirectional 
promoter region in detail: open boxes represent the protein-binding sites identified 
in vitro (7). The position of the PCR primers (shaded boxes) is shown. Lines 
represent restriction fragments used in gel shift assays. C. Sequence of the H/9 
promoter. Potential protein-binding sites are indicated. 
terminal-transferase reactions before LM-PCR were carried out 
as described in (20). 
Oligonucleotides 
Two combinations (labeled A and C) of nested primers were 
copied from the upper strand and one set (B) from the lower 
strand of Hf9 (accession number X05830). HPLC-purified 
primers (Oswel Service, Department of Chemistry, University 
of Edinburgh) had the following sequences: Al (5 '-ACGGTCT-
CGACTAGCTCA-3'), A2 (5' -TAGCTCAGGCGTCGC-
TGGC-3'), A3 (5 '-TGGCTCGGCGGCCTCTGG-3'), Cl 
(5'-CCTACCCCACCCGGACCT-3') and C2 (5'-GGACC-
TCGCTGTACCTT-3'), corresponding to positions 734-751, 
745-763, 760-777, 680-697 and 692-708; BI (5'-
TGCGCGCGTGGGTCGCCG- 3') and B2 (5'-TCGCCGGG-
AGAGCGCGCT- 3') correspond to positions 1039— 1022 and 
1027-1010. The universal linker was composed of a partially 
complementary 25-mer and I 1-mer of respective sequence 
5 '-GCGGTGACCCGGGAGATCTGAATTC-3' and 5 '-CIA-
GACTTAAG-3'. HPLC-purified oligonucleotides for in vitro 
assays (Genenco Service, Dipartimento di Genetica e Biologia 
Molecolare, Université di Roma) were as follows: 5'-CGTCA-
CAAAGAGGCGGGGCTATGCGCATAG-3' and its 
complement represent a high-affinity Sp 1 -binding site; 5 '-AGC-
TTGAACCCTGACCCCTGACCCCAGCA-3' and its 
complement represent the Ht/9 GBF-binding site; 5 '-CGCTGT-
CGGAGCCAATAAAGCTACAC-3' and its complement 
represent the i-.09 CCAAT site. Double-stranded oligonucleotides 
carrying the c/EBP (5'-GATCCAGGAATTACGAAATGG-
AGGAG-3') and the E2F- (5'-TAGTTTTCGCGCTTAAA-
TTTGA-3') binding sites were kindly given by A. Vitelli (IRBM 
Istituto di Ricerche in Biologia Molecolare, Pomezia, Italy) 
and A. Felsani (CNR, Istituto di Tecnologie Biomediche, 
Rome, Italy) respectively. API- (5 '-TTCCGGCTGACTCATC-
AAGCG-3') and AP2- (5'-GATCGAACTGACCGCCCGC-
GGCCCGT-3') binding oligonucleotides were from Promega. 
RESULTS 
The mouse Hrj9 locus contains two divergent genes that are both 
ubiquitously transcribed from a shared bidirectional promoter (3). 
In the promoter region (Fig. 1) several factor-binding sites were 
identified in vitro (7). Transient expression assays showed that 
the CCAAT box was a major promoter element in hepatoma cells 
while being dispensable in fibroblasts: conversely, a major 
contribution of the Sp 1.2 site to the overall promoter activity was 
observed in fibroblasts (8). To establish wheter these different 
requirements reflected cell-type specific patterns of trans-
activation, we compared the in vivo interactions of nuclear factors 
with the Hhf9 promoter in different cell lines. To this aim cells 
were subjected to in vivo footprinting aided by ligation-mediated 
PCR. Cell lines with different biological characteristics and 
transcriptional abilities were chosen, though the process of in 
vitro adaptation may have somewhat quenched the original 
differences between cell types. The following lines were 
examined: NIH/3T3 and C3H/I0T 1/2 cells, independently 
derived from mouse embryonic fibroblasts, with the lOT 1/2 cells 
retaining a broader pluripotency: rat liver hepatoma H4-II-E-C3 
cells, expressing a large number of hepatic functions, such as 
albumin, tyrosine aminot.ransferase, transferrin, prothrombin: rat 
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rotein, typycal of vertebrate neural tissues; mouse S-20Y cells, 
cholinergic neuroblastorna line retaining the choline 
tcetyltransferase enzymatic activity (13); mouse CPI embryonic 
tern cells, whose differentiation was prevented by differentiation 
nhibitory activity DIA/LIF (14). DMS titration experiments were 
nitially carried out to establish the effective concentrations in 
,ach cell line and for particular sites. Thereafter three 
:oncentrations were routinely used in each experiment and a trend 
tnalysis enabled us to appreciate the protection of individual sites. 
rotected Htf9 elements in H4-II-E-C3 hepatoma cells 
[he in vivo pattern of the Htf9 promoter in hepatoma nuclei is 
hown in Fig. 2. A protection was observed at position 859-875, 
)verlapping one major transcriptional origin of both divergent 
;enes. The protected element consisted of a direct repeat (GGG-
CTGGGGACTGGGG) recognized by a novel factor called G-
)inding factor, GBF (8; G. Di Matteo and P. L., unpublished). 
n vivo the element was protected on both strands and the binding 
was accompanied by the appearance of an additional band 
(position 856) at the 5' edge of the protection (Fig. 2A). 
Another footprint was evident over the sequence GAGCC-
AATAAAGCTA (position 911-925), harboring a CCAAT box 
(Fig. 2A and 2B). The protection was flanked by hypersensitive 
bands on either side (positions 940 and 914 respectively, 
Fig. 2B). Fig. 2C shows the CCAAT site in different cell lines: 
a distinct footprint was seen in H4 cells only. Because H4 cells 
are derived from rat hepatoma. rat DNA was sequenced in vivo 
to assess any divergence which may have occurred between 
mouse and rat: in the rat sequence one A to G transition (position 
926) was found 5' to, but not affecting, the CCAAT site. Rat 
C6 cells, derived from a glial tumor, were also analysed as a 
species-specific control: no CCAAT protection was observed 
(Fig. 2C). On the other hand, a footprint of similar extension 
to that seen in H4 cells was mapped in mouse liver nuclei using 
DNase I (not shown): thus the CCAAT protection is indeed 
restricted to cells of hepatic origin regardless of the species. 
A Upper strand 	B Lower strand 
Mouse 	 Rat 	 0 	H4 
0 H4 	G ElI 
ElF--___1 M 










Mouse 0 	H4 	C6 	G 	S20Y CP1 
I 	I 	ii 	r1 	i•i 	II 
? I-P 
'4 dot




1 2 	3 	4 5 	6 7 8 	9 	10 1112 1314 
:>- 
X C) 
— S I 
CCAAT • 
1 	234 
'igure 2. A. Genomic footprints on the HrJ9 promoter in H4 cells. I. Mouse control DNA: 2-4: H4 cells exposed to 0.1. 0.2 and 0.3% DMS: 5: rat control 
)NA. Footprints at the GBF and CCAAT sites are bracketed. The arrowhead marks an extraband 5' to the GBF protection. B. Genomic footprint of CCAAT box 
n the lower strand. I: mouse control DNA. 2-4: H4 cells treated as for panel A. Asterisks mark DMS-hypersensitive sites. C. In vivo footprinting of the CCAAT 
ox (upper strand) in all cell types. 1-3: mouse control DNA: 4-5: rat H4 hepatoma cells: 6-8: rat glioma C6 cells; 9: rat control DNA: 10: mouse tO T1/2 
ibroblasts: 11-12: neuroblastoma S-20Y cells; 13-14: mouse CPI cells. DMS concentrations ranged between 0.1 and 0.3%. D. Gel shift assay of Heft)- probe 
carrying the CCAAT box (see Fig. I). Extract types (4 zg) are indicated above each lane, in lane 6 the reaction was preincubated with a 50-fold excess of c/EBP-
inding oligonucleotide prior to addition of the probe. 
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Figure 3. In vivo footprints on the HJ9 promoter in fibroblast lines. A. Upper 
strand. 1: lOT 1/2 cells exposed to 0.3% DMS. 2-3: 3T3 cells exposed to. 0.1 
and 0.2% DMS. 4-5: G ladder. The GBF protection is bracketed; the 5' extraband 
is arrowed. B. Sites Spl.2 and GBF (lower strand). DMS concentrations ranged 
between 0.1 and 0.3%. C. Sites Spl.3 and E2F (lower strand). I. CPI cells 
(0.3% DMS); 2-3. 0 ladder control; 4-6: 3T3 cells treated as for panel B. 
Asterisks mark hyperreactive bands. Protein-binding sites are indicated. No binding 
activity was identified corresponding to the 0396 protection in 3T3 cells (see text). 
The potential binding ability of the CCAAT site was assessed 
in gel-shift assays. A synthetic 26-mer copied from the protected 
CCAAT window gave an identical shift upon incubation with 
all extracts (not shown); however, when we assayed a 40 bp-
fragment (probe 2 in Fig. 1) carrying flanking sequences on both 
sides of the CCAAT box, both ubiquitous and hepatocyte-
enriched protein complexes were detected (Fig. 213): thus the 
HtJ9 sequences surrounding the core CCAAT box participate in 
stabilizing the binding of a hepatic factor. Several hepatic 
CCAAT-binding factors are known (21, 22). The largest family 
of liver-enriched factors includes the c/EBP protein group (22), 
whose binding specificity includes CCAAT boxes, the enhancer 
core motif and c-AMP response elements. We have established 
that the Htf9-CCAAT factor does not belong to the c/EBP family 
by site-specific competition assays (Fig. 2D), but have not 
pursued its identity any further. 
Finally, a distinct footprint was seen at positions 964-974 
(Fig. 213) protecting the sequence TTTGGCGG, which matches 
a high-affinity site for the p105'/E2F complex (23). The 
protection was also visible on the complementary strand (not 
shown). 
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Figure 4. In vivo footprints on the H(J9 promoter in S-20Y neuroblastoma cells. 
A. Lower strand. Lanes 1-2: 0 ladders from naked DNA controls 3-5: DNA 
from S-20Y cells exposed to 0. 1, 0.2 and 0.3% DMS. Protections are bracketed. 
hypersensitive bands are marked by an asterisk. B. Upper strand. Footprints of 
the GBF-. API-, Spl.3 and E2F-binding sites. 1-2: S-20Y cells were exposed 
to 0. I and 0.3% DMS, 3: G control ladder. The arrowhead marks the extraband 
5' of the GBF protection; asterisks mark hypersensitive bands. C. The API site 
in different cell lines. Cell types are indicated. 
Protected HtJ9 elements in 3T3 and 10 T 1/2 fibroblasts 
In both 313 and lOT 1/2 fibroblast lines protection of the GBF-
binding site was visible on both strands (Fig. 3A and 313), as 
in hepatoma cells. Three potential SpI sites occur in the Hf 
promoter (see map in Fig. I). No interaction was seen with site 
Spi.!, whose sequence matches a reported medium-affinity 
binding site (24). On the other hand, sites Spl.2 
(CTCCGCCCCC, 840-849) and Spl.3 (CCCGCCCC. 
950-957) both match high-affinity sites for SpI (24). In vitrc 
binding of fibroblast extracts to both Htf9 sites was very efficient 
and was competitively inhibited by an excess of Sp 1 -binding 
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Figure 5. In vivo footprints in CPI embryonic stem cells. A. Spl .2 and GBF 
sites (lower strand). I. 2 and 6: G ladder; 3-5: ES cells exposed to 0.1. 0.2 
and 0.3% DMS: site Spl.2 is footprinted while site GBF is not. B. Gel shift 
assay of probe I. carrying both Spl.2 and GBF sites. Lanes I and 2: 3 Ag and 
5 jcg of 3T3 extract; lane 3: 5 jg of 3T3 extract preincubated with a 50-fold 
excess of Spi-binding oligonucleotide: two complexes unaffected by the SpI 
competitor represent different froms of GBF complexes (G.Di Matteo, 
unpublished); Lanes 4-6: same reactions as in I —3 using ES cell extracts: no 
complex is formed after preincubation with the Spi oligonucleotide. Migration 
of the free probe is indicated. C. The E2F site in different cell lines (upper strand). 
Cell types are indicated above each lane. DMS concentrations were between 0.1 
and 0.5% DMS. Lanes 1-2 and 13-14: control G ladders. All lines but CPI 
show a distinct E2F footprint (bracketed). 
oligonucleotide. In vivo protection of both sites Spl.2 (Fig. 313) 
and Spl.3 (Fig. 3C) was evident on the G-rich lower strand. 
The region surrounding site Spl.3 showed an altered 
organization compared to the control ladder on the lower strand. 
Three footprints were individually distinguishable (Fig.3C). 
Inspection of the DNA sequence (Fig. IC) revealed close 
recognition sites for known factors: site Spl.3 (950-957) was 
preceded by the E2F-binding sequence TTTGGCGG (964-974) 
on the lower strand: the latter overlapped with a potential 
AP2-binding site (976-985) on the complementary strand. Site-
specific competition assays were carried out to disentangle the 
binding events: binding to Htf9-probe 3 (see Fig. IB) was 
competitively inhibited by an excess of both Spi- and E2F-
binding oligonucleotides, while remaining unaffected by an 
Figure 6. Summary of the in vivo protections detected at the Hf9 promoter in 
hepatoma cells and in fibroblasts: the orientation of Ht19-a transcription is shown. 
TS-1 and TS-2 indicate the preferred sites of transcription initiation (see ref.3). 
The asterisk shows the hypersensitive band flanking the GBF protection. 
AP2-binding competitor (not shown). Thus, both E2F and Spl 
factors are involved in binding to the region and respectively 
generate the footprints at sites 964-974 (E2F) and 950-957 
(Spi), flanked by hypersensitive bands at positions 946-947. 
No further binding activity was identified in vitro, though the 
G-residue at position 936 was clearly quenched in vivo (Fig. 3C). 
On the upper strand only the E2F footprint was apparent (see 
below and Fig. 5C). 
Protected Htf9 elements in S-20Y neuroblastoma cells 
In S-20Y neuroblastoma nuclei the GBF-binding site was fully 
protected on both strands and was bordered by the characteristic 
5' band seen in all other cell lines (Fig. 4A-B). Adjacent to that 
site an element of similar sequence (TGATTC, position 
895-900) to the recognition site for API (TGAGTC) occurs, 
which was found to be a genuine API-binding site by gel-shift 
assays using a specific competitor (not shown). The AP  site was 
protected and flanked by hypersensitive bands in S-20Y cells 
(Fig. 4A—B). No protection was seen in other examined cell lines 
(Fig. 4C). 
The target sites for Spi and E2F showed a similar in vivo 
occupancy to that observed in fibroblast cells: both Sp 1 sites were 
protected on the lower strand (Fig. 4A): the E2F site was 
protected on both strands (Fig. 4A-4B): adjacent footprints at 
sites E2F, Spl.3 and G 936 on the lower strand generated an 
in vivo ladder similar to that seen in fibroblasts (compare Fig. 3C 
and 4A). 
Protected HtJ9 elements in CP1 embryonic stem cells 
In all somatic cell lines examined thus far the GBF site had been 
found to be similarly protected in vivo. An exception is 
represented by the CPI embryonic stem cell line, in which no 
GBF footprint was detected (Fig. 5A); the adjacent Spl.2 site 
was protected by an independent binding event on the lower 
strand. In vitro assays confirmed that embryonic cell extracts do 
not in fact express GBF (Fig. SB). The pattern of the Spl.3/E2F 
region in undifferentiated CP 1 cells also differed from that seen 
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in other cell types: site SpI .3 was protected on the the lower 
strand as in fibroblasts and neuroblastoma cells (Fig. 4C); in 
contrast the E2F site was not protected: therfore the lower strand 
footprint was of limited extension, and no protection at all was 
seen on the complementary strand. Fig. 5C shows that the lack 
of E2F protection is characteristic of ES cells. 
DISCUSSION 
During the process of differentiation and development the pool 
of transcription factors is diversified in different cell types. In 
addition the availability of the so-called general factors also 
fluctuates, as single promoters have different requirements for 
the factors involved in basal complexes (25). Housekeeping 
promoters are ubiquitously active despite these variations. In vitro 
evidence for cell-specific interactions was reported for the 
promoters of the HtJ9 (8), aldolase (26), B-polymerase (27) and 
Na,K-ATPase (28) housekeeping genes. Based on the in vitro 
results, one can predict that the trans-activated elements in 
housekeeping promoters vary from cell to cell: ubiquitous 
expression will result from cell-specific patterns of transcriptional 
activation. 
Genomic footprinting provides the most reliable picture of the 
interactions occurring within the cell (rev. 29) and has proved 
extremely powerful in pinpointing the onset of activation in 
inducible (30-32) and developmentally regulated genes (18, 
33-35). The technique has also depicted the alternative 
organization of the X-linked PGK promoter in its active and 
inactive state (20, 36). In these studies the occupancy of critical 
cis-active sequences appeared to be an all-or-nothing event related 
to the acquisition of an open chromatin conformation which 
triggered transcription. We have employed genomic footprinting 
to study the native organization of the Htf) promoter. We have 
regarded as informative the Ht/9 sites showing unambiguous 
protections in at least one cell type—though these may not 
represent the only functionally relevant elements—and have 
compared their status in cells expressing different specialized 
functions. An important point emerging from this study is that 
in vivo protections of the H09 promoter reflected cell type-specific 
combinations of factors. In contrast, in vitro studies using isolated 
promoter elements often reflected all potential binding events. 
H/9, like most housekeeping promoters, lacks a TATA box; 
TATA-less promoters are thought to assemble transcriptional 
complexes via interactions differing from those occurring at 
TATA-containing promoters (37) and involving distinct initiators 
which are only beginning to be identified (38, 39). In this study 
one major divergent origin of transcription, coinciding with the 
GBF-binding element, was found to be fully protected on both 
strands in all differentiated cell lines. The GBF element is 
included in the shortest DNA fragment required for transcription 
in both orientations (7). Protection of the GBF site was 
accompanied by the appearance of a flanking band, which might 
either indicate a displacement of the 0 residue 856 at the 5' border 
of the protected site, or cleavage of an exposed adenine at position 
857, which would also be methylatable by DMS. Both 
possibilities suggest an altered chromatin structure around the 
transcription start site. It is noteworthy that the preferrred site 
of Ht9-a RNA initiation is located exactly at 857 (3). It is possible 
that GBF is a novel member of the protein group involved in 
transcription initiation in the absence of a TATA box—this 
question is currently being addressed in our laboratory. 
Embryonic stem cells, which are the only type lacking GBF, are  
known to express specific variants of certain somatic' factors 
the elements required for promoter activity often differ ii 
embryonic and differentiated cells. It will be interesting to aJ 
whether the absence of GBF alters transcription initiation of thi 
HzJ9- transcripts in ES cells. 
The Hj9 promoter carries a CCAAT box in the orientatior 
of the H#9-a gene transcripition. Deletion of the CCAAT ho, 
is detrimental for transcription in hepatocytes but not it 
fibroblasts; in addition the Ht19-CCAAT box can replace th 
endogenous CCAAT box in the albumin promoter (8). The result 
reported here show in vivo occupancy of the CCAAT box it 
the nuclei from rat hepatoma and from mouse liver. Retentior 
of the footprint during liver nuclei isolation—a procedure durin 
which most factors fall off their target sites (19)—suggests tha 
the interaction is remarkably stable. 
On the other hand, a promoter fragment containing only th 
GBF and Spl .2 sites was previously found to be sufficient fo: 
high expression in fibroblasts. In the present study site Spl. 
appeared to be effectively protected on the lower strand. Th 
presence of one single guanine in the site made the protectior 
difficult to assess on the upper strand, thus we could not establisi 
whether the asymmetrical footprint at the Spl .2 site reflects 
technical or a biological feature. Site Spl.2 was footprinted it 
several cell lines (313, lOT 1/2, S-20Y and ES cells) but no 
in hepatoma cells: it is possible that the simultaneous bindin1 
of GBF and of a CCAAT-binding factor in hepatoma nude 
generates a steric hindrance incompatible with the further bindin 
of Spi to site Spl.2. Fig. 6 schematically summarizes th 
hepatocyte-type and fibroblast-type organization of the HtJ 
promoter: together the in vivo footprinting data are consisten 
with, and retrospectively provide an explanation for, the result: 
of expression assays in mammalian cell types. 
A few novel promoter features have also emerged from thi: 
study. A cell-type restricted interaction was seen at the AP 1 sit 
in S-20Y cells though no functional analysis was carried out it 
this cell line. The footprint did not require TPA-induction a: 
reported for the in vivo binding of API to the c-fos promote 
(40). The footprint might be due to a neuronal API subtyp 
indistinguishable from the API factor in gel-shift assays, or t 
the interaction of neuronal factor(s) with API (or the AP 1 -relate 
protein) which might stabilize the binding to the Hrf9 promoter 
The distal promoter region showed an interesting organization 
which has not yet been functionally dissected but may have 
significant role in control of 1-1119-a transcription. A comple: 
pattern was seen in neuroblastoma and fibroblast cells. Alternatinl 
hypersensitive and protected elements indicated that more that 
one protein were involved in the footprint. Sp I was one of th 
factors involved and protected the Sp 1.3 box on the lower stran 
in fibroblasts, neuroblasts and embryonic stem cells—the siti 
could not be unambiguously resolved in hepatoma nuclei becaus 
of its compression between the E2F and CCAAT protections 
The element TTTTGGCGGG was also protected in fibroblast 
and neuroblastoma cells. The protected site represents a perfec 
match to sites selected in vitro by complexes containing th 
pl05kH( retinoblastoma) protein (23)—to which the E21 7 facto 
is also thought to associate—and is identical to the E2F site ii 
the c-nr,'b promoter (rev. 41). The involvement of E2F i: 
compatible with the lack of protection in undifferentiate 
embryonic stem cells, as published evidence reported very by 
levels of the embryonal E2F-like factor DRTFI it 
teratocarcinoma cells prior to retinoic acid-induced differentiatiot 
(42-43). To our knowledge this is the first demonstration o 
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he in vivo occupancy of an E2F-binding site in proliferating cells. 
Ln the light of our observations that Hf]9-a is expressed in cycling 
ells in which the plO5RB protein was sequestrated by the E1A 
)ncogene, while being repressed in cells transfected with EIA 
mutants failing to interact with p105RB (A.Bressan, M.Caruso, 
A.Felsani and P.L., unpublished), occupancy of the 
pl05'/E2F target is very intriguing. 
In fibroblast and neuroblastoma nuclei the promoter ladder 
appeared to be altered beyond site Spl .3 on the lower strand. 
No corresponding alteration was seen on the upper strand, which 
parallels the strand-specificity of the SpI .3 footprint. The altered 
organization was apparent in cell types in which both Spl.3 and 
E2F-binding sites were occupied, and in our opinion may reflect 
a local distortion resulting from the simultaneous binding of E2F 
and SpI to adjacent sites, rather than the binding of a novel 
protein to an independent sequence. Spl .3 and E2F are separated 
by the sequence 5'-GGAAGCGCGG-3', which is part of the 
recently described SCE element separating the CG-box 1 from 
the E2F site in the dhfr promoter (44). The SCE is not a protein-
binding site, yet exerts a repressive function and is thought to 
generate a distortion of the DNA structure characteristically 
framed by hypersensitive sites: this would prevent the 'cross-
talk' between the Spl and E2F proteins when dhfr expression 
is not required. It is tempting to suggest that the altered structure 
in the distal region of Hi/9 also indicates an element of structural 
distortion which could serve a similar function and inhibit H(J9-a 
expression in GO cells. 
Our current understanding of transcriptional regulation is based 
on combinatorial models. TheH/9 promoter shows an intrinsic 
flexibility to act as the target of different combinations of factors, 
which may enable it to direct transcription in cells equipped with 
different transcriptional machineries. The cooperation between 
cell-specific and ubiquitous factors in activating different sets of 
regulatory elements may represent a generalised mechanism 
maintaining the ubiquitous expression of housekeeping functions 
during differentiation. 
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